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Science	  cannot	  solve	  the	  ultimate	  mystery	  of	  nature.	  	  
	  
And	  that	  is	  because,	  in	  the	  last	  analysis,	  	  
we	  ourselves	  are	  a	  part	  of	  the	  mystery	  	  
that	  we	  are	  trying	  to	  solve.	  	  	  
Max	  Planck	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1. Introduction 
1.1. Discovery of protein functions 
Whenever two or more proteins come into contact, they also may interact. A protein-
protein interaction (PPI) occurs between individual proteins if one of them influences 
the other, they affect each other reciprocally or a sheer spatial recruitment takes 
place. These mechanisms rest upon non-covalent interactions like van der Waals 
forces, hydrogen bonds as well as electrostatics of surface-resident amino acid 
residues of involved proteins. PPIs play a key role in virtually all biological processes 
where proteins are involved. Amongst them are processes of signal transduction, 
trafficking, enzymatic degradation and transcriptional regulation (Aebersold and 
Mann, 2003; Fields and Song, 1989). The entire set of proteins expressed by an 
analyzed cell, tissue or a complete organism at a particular time is called proteome 
and can change in its composition due to environmental or developmental influences. 
The sum of all molecular interactions present in an organism or a cell - concerning a 
certain protein - was termed interactome, which is partly synonymous with “biological 
network” (Sanchez et al., 1999). Generally, an interactome describes the molecular 
interactions within a given proteome. 
In human genomics, remarkable progress has been made by identification of mutants 
linked to diseases, including neurological, amongst others. While these observations 
provided evidence for the involvement of a certain gene product in disease 
processes, its molecular function and integration into protein cascades or pathways 
often remained unattainable. As observations linking particular mutations of a gene 
with a well-known interaction network to a certain disease can help to establish the 
mechanism of its interactions, a similar approach for genes with a yet unknown 
interaction network remains a challenge. One approach to solve this problem is 
proteomic mapping, whereby physical relationships and pathways are identified that 
can serve as scaffolds for subsequent functional analysis. Since the proteome of a 
cell is subject to change due to immense dynamics, variations and fluctuations in the 
protein composition, the establishment of a universal PPI network, comparable to 
data generated by genome sequencing, is unattainable. Currently, the only suitable 
approach towards the generation of a universal PPI network is the description of 
individual protein core complexes – protein interactions present in the majority of cell 
types and states, often species-spanning – that are much less susceptible to decay 
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or variations. These core complexes then can be connected with each other to 
provide a core complex network. Such approaches were previously used in simple 
model organisms like yeast for the determination of the composition of hundreds of 
protein core complexes (Benschop et al., 2010; Cusack, 1999). A characterization of 
protein core complexes, the identification of their dynamics and interaction with other 
core complexes therefore should represent the first steps in any PPI analysis as such 
data then can serve as foundation and scaffold for understanding transient and 
regulated interactions. 
1.1.1. Approaches for the determination of protein functions 
Historically, basic mechanisms of the developmental processes and cellular 
machinery were studied by disturbing existing regulatory pathways through knockout 
or classical transgenic approaches in Drosophila melanogaster, Caenorhabditis 
elegans and mammalian cells (Folger et al., 1982), and by the establishment of 
embryonic stem (ES) cell technology including their subsequent manipulation to 
generate transgenic mice lacking, overexpressing or replacing specific genes and 
other more complex organisms (Nagy et al., 1993; Thomas and Capecchi, 1987; Zan 
et al., 2003). Here, site-directed mutagenesis was often used to investigate the 
function of a gene product by causing a complete ablation of the protein of interest 
(knock-out) rather than altering specific binding sites. The impact of these 
mutagenesis studies was rather observed on a phenotypic level than allocating the 
modified protein to existing complexes or pathways. By analyses of presumably 
affected proteins on a molecular level (e.g. Western immunoblotting, protein 
localization), metabolic and signaling pathways could be deduced by demonstration 
of variably regulated target proteins (Wang et al., 2009b). Many, now well 
established, pathways and regulatory mechanisms were initially described using 
knockout strategies. The circumstance that the depletion of a protein in a highly 
complex system like a cell or even a complete organism may elicit compensatory or 
secondary mechanisms complicates succeeding analyses: The observed effects do 
not necessarily reflect the physiological influence of the analyzed protein in a highly 
dynamic and fluctuating PPI network. 
For that reason, alternative methods for the analysis of protein functions have been 
developed over the years, directly or indirectly detecting the physical interaction of 
proteins in vitro or in vivo. Hereby, differential focus has been laid on the aspects of 
sensitivity and specificity. While the focus of studies investigating whether protein a 
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interacts with protein b lies on high specificity, approaches for high sensitivity try to 
detect as many interaction partners of protein a as possible. Methodically, two 
strategies can be distinguished: (A) One strategy intends to provide evidence that 
two given proteins interact, while (B) the other strategy aims at the identification of 
the identity of all interactors of one specific protein.  
In typical approaches to provide answers to (A), both proteins to be investigated 
have to be labeled. Then, their spatial interaction can be analyzed by biological 
screening methods like the Yeast-2-hybrid (Y2H) technique or fluorescence 
resonance energy transfer (FRET). Y2H relies on the fusion of a bait protein – the 
protein that is being used to screen for potential interactors – to a GAL4-BD binding 
site whereas prey proteins – the proteins binding to the bait - possess the GAL4 
transcription factor-activating domain (GAL4-AD), together reconstituting the 
expression of a reporter gene (Fig. 1.1 a). While proteins investigated by Y2H can 
originate from any species, this system is restricted to the detection of direct PPI of 
small proteins that are able to pass the nuclear pore (Suter et al., 2008).  
However, proteins isolated from their physiological compartment may have altered 
affinities for interactors and could give rise to false-positive results. Therefore, bait 
and prey interaction also can be analyzed in any tissue that can be modified to 
express tagged proteins in order to provide a suitable proteomic environment. A 
common technique applied here is FRET, which measures the energy transfer from 
one fluorophore to another fluorophore. For PPI analysis, the protein pair of cyano-
fluorescent protein (CFP) and yellow-fluorescent protein (YFP) is typically used due 
to their overlapping emission/excitation spectra (Fig. 1.1 b). Because of the 
mechanism of dipole-dipole coupling, the efficiency of transfer is highly sensitive to 
small distances and represents a reliable methodology to assess distances of 
proteins exclusively present during direct interactions (C. Harris, 2010; Ciruela et al., 
2010; Helms, 2008). 
A commonly used assay for the analysis of PPI is co-immunoprecipitation. Here, the 
bait is isolated from whole cell lysate using a specific antibody bound to the bait 
protein (Dwane and Kiely, 2011; Elion, 2006). Physically interacting proteins then co-
purify with this protein and can subsequently be identified by immunoblotting 
techniques. A prerequisite for the applicability of this technique is the correct 
anticipation of a PPI as well as the availability of highly specific antibodies for both 
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the protein of interest as well as the anticipated interactor, rendering this technique 
unsuitable for screening approaches. 
 
Figure 1.1: Yeast two-hybrid and Fluorescent resonance energy transfer (FRET) 
a: In a yeast two-hybrid (Y2H) experiment, the interaction of two proteins can be studied by fusion of 
one protein to the DNA-binding domain (DBD) of Gal4 (the bait) and fusion of the other protein to the 
activation domain (AD) of Gal4 (the prey). Once bait and prey interact, the binding of Gal4 DBD to the 
upstream activating sequences (UAS) of the reporter gene mediates the recruitment of the basal 
transcriptional machinery and expression of the reporter. Adapted and modified from Stynen et al 
2012. b: The interaction of two proteins can be visualized using the technique of fluorescent 
resonance energy transfer (FRET). Here, the FRET-based probe consists of two different proteins that 
are labeled with cyan fluorescent protein (CFP) and yellow fluorescent protein (YFP), respectively. 
Upon interaction of both proteins, the fluorophores are brought into close proximity and YFP is excited 
by FRET. Adapted and modified from Zhang et al 2002. 
 
(B) If all prey-bound proteins are to be identified, other methods of detection are 
required. Mass spectrometry represents an analytical method which is capable to 
determine the identity and quantity of individual proteins within thousands by 
detection of the mass-to-charge ratio of charged particles and can be performed after 
co-immunoprecipitation followed by high resolution liquid chromatography (David 
Sparkman, 2000; Hubner et al., 2010a). Furthermore, quantitative or tandem affinity 
purification can be used in conjunction with co-immunoprecipitation to further 
enhance specificity and sensitivity (Puig et al., 2001; Rigaut et al., 1999). By 
expression of tagged proteins and a subsequent generic affinity chromatography, 
core proteomes of the yeast have been mapped on a genome-scale approach and 
were found to show strong concordance with genetic interactions (Collins et al., 
2007a; Collins et al., 2007b; Gavin et al., 2006; Krogan et al., 2006). Furthermore, 
interactomes have been established for higher organisms including mammals, at 
least for designated cell lines. However, the need to identify PPIs in a more 
physiological setting is still insufficiently met and demands the development of 
techniques suitable to detect physiological PPIs. 
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Figure 1.2 LC-MS/MS-based 
interaction proteomics 
For detection of specific binding 
partners of a tagged (e.g. by 
GFP, green circles) protein of 
interest, the abundance of 
affinity-purified potential 
interaction partners is compared 
with the abundance of the same 
protein from a mock purification 
under expression of an untagged 
version of the protein. Protein 
extracts of SILAC-labeled cells 
expressing the tagged protein 
(left, blue) or control populations 
(right, ochre) are subjected to 
affinity purification and eluates 
mixed before analysis by the 
proteomics pipeline. Following a 
proteolytic digest, peptides are 
separated by liquid 
chromatography (LC) coupled to 
electro-spray ionization, 
analyzed by mass spectrometry 
(MS), fragmentation of selected 
peptides and analysis of the 
resulting MS/MS spectra. 
Subsequent computational 
analysis is then applied for the 
identification and quantification 
of proteins based on the 
presence of detected peptides. 
By evaluation of the ratio of 
proteins labeled with heavy 
amino acids versus unlabeled 
proteins, a prediction of 
interactors (rectangular) and 
background binders (red circles) 
can be made. Adapted and 
modified from Walther et al 
2010. 
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1.1.2. Expression systems for tagged proteins 
In order to study protein-protein interactions, the technique of quantitative affinity 
purification followed by mass spectrometry (AP-MS) was developed over the last 
years and became a powerful approach for the analysis of PPIs in an unbiased 
manner (Paul et al., 2011). This technique relies on the biochemical enrichment of 
the protein of interest together with its interaction partners. Subsequently quantitative 
mass spectrometry analysis is used to detect proteins that are enriched when 
compared to controls. While this technique generally yields faithful results and is 
particularly suitable for singular experiments, such an approach is impractical when 
aiming for the precise acquisition of large interaction networks encompassing a 
multitude of different proteins that have to be used as bait. The application of various 
antibodies requires an individual determination of their epitope detection specificity 
and non-specific binders or the conduction of laborious validation experiments, 
rendering this approach unsuitable for high-throughput screening approaches 
(Schirle et al., 2012). Therefore, streamlined methods for the investigation of PPIs 
rely on the utilization of a protein tag fused to the protein of interest. Hereby, a small 
set of specific antibodies with well-known recurring unspecific interactors can be 
used that proved to be suitable in AP-MS studies conducted in arthropodan or 
mammalian systems. 
In order to introduce an adequately tagged protein into a cell, techniques most 
commonly used in the field of PPI studies rely on the application of overexpression 
systems since broadly used strong small promoters provide high amounts of proteins 
for subsequent AP-MS, thereby increasing the sensitivity (Table 1.1). Classically, 
expression plasmids containing a cDNA of the respective protein are used for 
transient overexpression and represent a convenient and straightforward approach to 
yield large data sets. However, as cells acquire different levels of plasmid or lose it 
after a few days, results often cannot be reproduced reliably. To overcome this issue, 
stable cell lines using retro- or lentiviral vectors can be generated in a similarly 
convenient and efficient manner (Ni et al., 2011). The highly efficient viral 
transduction of a multitude of recipient cell lines hereby represents a valuable tool for 
the analysis of cells resistant to efficient transfection by plasmid-based approaches. 
Whereas such systems unequivocally have significant advantages such as 
straightforward construction of expression constructs commonly in connection with a 
high protein expression, the specificity of derived interaction data is inferior to 
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classical AP-MS. While these approaches have yielded fundamental insights into 
protein networks and became more relevant as techniques of quantitative proteomics 
evolved over the last years, they generally suffer from unphysiological high protein 
levels often leading to false-positive interactome data, for example via misguided 
localization caused by the abundance of the overexpressed proteins, incorrect 
protein folding, protein complex assembly and altered downstream regulation 
(Vermeulen et al., 2008).  
The introduction of a tagged gene via homologous recombination offers a 
perspective to study PPIs at physiological expression levels (Haber et al., 2004; 
Marcon and Moens, 2005). Here, highly homologous linear DNA constructs are 
incorporated into chromosomes by homologous recombination, retaining their 
endogenous regulatory sites. In theory, this process would be perfectly suitable to 
examine proteins expressed at endogenous levels, as these modified variants 
possess the same regulatory sites and intron/exon composition than their non-
modified analog. However, the efficiency of integration is very low and therefore 
unsuitable for the establishment of larger numbers of cell lines (Porteus, 2011; 
Smithies et al., 1984). 
For the insertion of a DNA construct into a specific site of the chromosome, a 
multitude of suitable techniques, termed genome editing, were developed over the 
last years. The application of zinc finger nucleases is a highly efficient process, 
capable to precisely introduce double stand breaks at predetermined loci mediated 
by a fusion protein of the type II restriction endonuclease FokI and engineered DNA 
sequence-specific zinc finger domains. These double strand breaks increase the 
efficiency of the integration of introduced linear DNA by homologous recombination 
(Ramalingam et al., 2012). Similarly, the transcription activator-like effector 
nucleases (TALEN), are composed of a FokI endonuclease cleavage domain fused 
to a TALE DNA binding domain that can be readily manipulated to target any 
genomic site of interest (Miller et al., 2011). The most recent technique for genome 
editing, the clustered, regularly interspaced, short palindromic repeats (CRISPR)–
CRISPR-associated protein (Cas) system utilizes the CAS endonuclease that is 
guided to genomic sequences by artificial RNA sequences and thus can be easily 
customized without changing the protein component (Chang et al., 2013; Cho et al., 
2013). However, all methods bear the risk for off-target effects (e.g. non-specific DNA 
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cleavage) and therefore have to be tightly monitored for inadvertently introduced 
aberrations (Cheng et al., 2012; Urnov et al., 2010). 
An alternative technique for genome editing exploits the guided genomic integration 
properties at low frequencies of the adeno-associated virus (AAV), which typically 
integrates into the AAVS1 site on the human chromosome 19 (Kotin et al., 1990; 
Surosky et al., 1997). The modification of AAV recognition sites enabled the precise 
targeting of a specific genomic locus and the introduction or manipulation of small 
sequences (Vasileva and Jessberger, 2005). By exploiting the virus-mediated 
homologous recombination system, efficiencies for targeting are much higher 
compared to cell-intrinsic homologous recombination but struggle with size limitations 
of sequences to be introduced. While homologous recombination typically is 
conducted in pluripotent cell populations, the AAV system can also be employed to 
target somatic cells (Bronson et al., 1996; Kohli et al., 2004). Thus, the application of 
homologous recombination is not easily accessible for streamlining and high-
throughput screens – even with modern tools like Zinc finger nucleases, TALENs, 
CRISPR or AAV vectors -, and require the application of alternative techniques for 
the expression of engineered proteins at endogenous levels. 
When aiming for endogenous expression levels of tagged proteins that are regulated 
comparably to their unaltered counterparts, the majority of the genomic locus of a 
gene should be included in constructs encompassing its endogenous promoter as 
well as naturally occurring regulatory elements. Frequently, such DNA constructs are 
available as bacterial artificial chromosomes (BAC) and can have a size of more than 
300 kb (O'Connor et al., 1989). Traditionally, linearized BAC constructs are employed 
in studies conducting homologous recombination, providing large homologous 
regions that facilitate a site-directed and relatively efficient integration to predefined 
sites in pluripotent cell populations (Thomas and Capecchi, 1987). However, 
standardized approaches for the generation of transgenic mice employ techniques 
like pronuclear microinjection or electroporation into embryonic stem cells and result 
in random rather than site-directed integration of the DNA construct into the genome 
(Tunster et al., 2011). The alternative integration of DNA constructs typically is 
mediated by non-homologous end joining (NHEJ), resulting in an integration of the 
DNA at random loci (Guirouilh-Barbat et al., 2004). However, integration efficiencies 
are much higher and therefore are applicable for streamlined applications. Hereby, 
the large size of the BAC transgenes ensures the presence of most, if not all, 
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regulatory elements and results in an expression that closely resembles that of the 
endogenous genes (Poser et al., 2008). Unlike small expression constructs stably 
integrating into a cell’s genome, BACs are less likely to be influenced by cis-acting 
regulatory elements or silencing events caused by chromatin positional effects as 
they contain their own natural chromatin domains (Blaas et al., 2012). Stable BAC-
transgenic cell lines therefore represent an attractive system expressing tagged 
proteins including different splice variants with expression levels similar to 
endogenous variants. 
 
Table 1.1: Characteristics of different expression systems 
 
1Campeau et al., 2001; 2Stadler et al., 2004; 3Kumar et al., 2001; 4Naldini et al., 1996; 5Grossmann et al., 1993; 6Cepko et al., 
1984; 7Folger et al., 1982; 8Bronson et al., 1996; 9Sung et al., 2006; 10Cho et al., 2012; 11Mali et al., 2013; 12Miller et al., 2011; 
13Hockemeyer et al., 2011; 14Urnov et al., 2010; 15Khan et al., 2010; 16Kim et al., 2008; 17Poser et al., 2008; 18Rostovskaya et al., 
2012 
 
1.1.3. Model systems for protein-protein interactions 
Protein-protein interaction (PPI) studies are conducted in a large variety of systems 
and provide results for different scientific questions. Hereby the quality of generated 
data is dependent on the system itself, the method of measurement and the class of 
protein investigated. In principle, two modes of protein-protein interaction systems 
can be distinguished: Systems where prey and bait proteins are known and brought 
in direct vicinity in order to analyze their interaction, termed binary PPI as results can 
only be “true” or “false” and quantitative PPI, as preys are more or less enriched, not 
yielding a binary result. For the analysis of protein-complex formation or for 
assessing subtle changes in complex compositions, only quantitative PPI can provide 
suitable results as in some conditions only fractions of complexes in a subgroup of 
cells may differ. When screening for yet unknown interactors of a tagged protein, the 
proteomic context in which PPI measurements are conducted is of significant 
importance as any interaction candidates originate from this environment. For that 
reason, human cell lines like HeLa cells were used for PPI studies of tagged human 
protein variants in multiple studies rather than employing cells derived from different 
Plasmid(
1,2
Lentivirus(
3,4
Retrovirus(
5,6
homologous(
recombination(
7,8,9
genome(editing(
10,11,12,13,14
AAV8mediated(
integration((((
15,16
BAC(((((((((((((((((((
17,18
Stable2integration no yes yes yes yes yes yes
Specific2integration2site no no no yes yes yes no
Introduction2into2non@dividing2cells + + @ @ +/@ +/@ no
Expression2level ++ ++ ++ endogenous endogenous endogenous endogenous@like
Efficiency ++ ++ ++ @@ +/@ +/@ +
Protein@protein2interaction2specificity ? ? ? reference to2be2evaluated to2be2evaluated to2be2evaluated
Typical2size2of2introducable2DNA ~2202kb ~2102kb ~2102kb ≥23002kb ≥23002kb ~242kb ≥23002kb
1Campeau2et2al.,22001;22Stadler2et2al.,22004;23Kumar2et2al.,22001;224Naldini2et2al.,21996;225Grossmann2et2al.,21993;226Cepko2et2al.,21984;27Folger2et2al.,21982;28Bronson2et2al.,21996;29Sung2et2al.,22006;210Cho2et2al.,22012;211Mali2et2al.,22013;212Miller2et2al.,22011;2132Hockemeyer2et2al.,22011;214Urnov2et2al.,22010;215Khan2et2al.,22010;216Kim2et2al.,22008;217Poser2et2al.,22008;218Rostovskaya2et2al.,22012
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species (Hubner et al., 2010a; Poser et al., 2008). In these and similar studies the 
cell lines used were primarily derived either from tumor-tissue or immortalized 
primary cells to exploit the potential of unlimited self-renewal and lack of senescence 
(Graham et al., 1977; Ivanković et al., 2007; Tsuchiya et al., 1980). Although the 
dynamic equilibrium of PPI networks substantially varies between different cell types, 
tissues and differentiation stages, our current understanding of protein interaction 
networks is mainly based on overexpression paradigms in non-human or transformed 
cell lines (Schirle et al., 2012). Therefore, physiological regulation of cell cycle or 
apoptotic control-associated proteins - amongst others - is not guaranteed and could 
lead to an erroneous model of cellular processes and conditions in somatic tissue. 
Hence, it would be desirable to generate protein-specific PPI networks in a proteomic 
environment similar to physiologically relevant cell types. Although the majority of 
basic cellular processes are comparable in different cell lines, cell type specificity is 
of utmost importance for the validation and discovery of disease processes that are 
directly linked to specific tissues with unique proteomes. Therefore, human tissue 
samples should ideally be equipped with an endogenously expressed, regulated and 
spliced tagged protein for AP-MS analysis. Unfortunately, our current techniques 
allow for the introduction of complex expression cassettes with insufficient 
efficiencies, demanding a proliferating cell population amenable to genetic 
manipulation and subsequent enrichment of transgenic cells by chemoselection or 
other means of purification. Somatic tissue samples largely consist of post-mitotic 
cells, which have long lost their ability for self-renewal and therefore render 
themselves unsuitable for such approaches. In particular, this concern appears to be 
highly relevant for the central nervous system, as postmitotic neurons are highly 
specialized cells with unique protein compositions, impossible to cultivate as required 
for the generation of a homogenous cell population facilitating the expression of 
tagged proteins at physiological levels (Uhlen et al., 2010a).  
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1.2. Stem cells 
Stem cells represent the most competent cell population in the development of an 
organism. In mammals, two main stem cell types can be distinguished, the cell 
population able to develop all three germ layers of an organism - embryonic stem 
(ES) cells - and adult- or somatic stem cells, whose purpose is the homeostasis and 
replenishment of organs like the liver, hair follicles or the intestinal system (Baddour 
et al., 2012; Boehnke et al., 2012; Radtke and Clevers, 2005). All stem cell 
populations share the ability for continuous self-renewal and differentiation into more 
restricted specialized somatic cells. Thereby, the range of distinct cell types a stem 
cell is able to generate defines its potency. Adult stem cells are multipotent and 
therefore have the ability to generate progeny of several distinct cell types like 
neurons and glial cells derived from neural stem cells or myeloid and lymphoid 
lineages that are generated from hematopoietic stem cells (Clements and Traver, 
2013). Embryonic stem (ES) cell cultures are established by extraction of the inner 
cell mass of blastocysts during the early phases of embryonic development and can 
give rise to all three germ layers - ectoderm, mesoderm and endoderm. 
The areas of application in research projects using stem cells are widespread. 
Classical studies examining hypotheses associated with processes during the early 
development of an organism often use mouse ES cells as a tool to create transgenic 
mice as model systems. Another key field is the generation of specific tissues or 
cellular subtypes by establishment of suitable differentiation protocols. Here, adult 
stem cells serve as a naturally occurring somatic stem cell population and usually 
can be readily differentiated into mature postmitotic cells of a certain fate. These 
specialized subtypes then are either used for an in vitro modeling of disease-related 
processes, screening of pharmacological compounds influencing these mechanisms 
or evaluated for their ability to serve as a cellular replacement in diseases associated 
with cellular loss. Furthermore, basic cellular mechanisms like the core transcriptional 
regulatory circuitry or the comparability of different PS cell lines themselves are 
subject of intense research (Boyer et al., 2005; Initiative et al., 2007). While adult 
stem cells are residing in the majority of the somatic tissues, only a fraction of these 
populations is readily accessible for purposes of fundamental research. This 
circumstance is negligible when investigating such populations in animal models but 
represents a great challenge in human systems, as here only a limited number of 
populations are accessible by reasonable clinical intervention. These populations 
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encompass stem cells derived from bone marrow, adipose tissue and blood yet 
especially exclude the central nervous system. 
 
1.2.1. The scientific history of human pluripotent stem cells 
While in 1981 Evans and Kaufman reported the establishment of mouse pluripotent 
cell lines directly from in vitro cultures of mouse blastocysts, the inner cell mass from 
human blastocysts was extracted and cultivated only in 1994 by the group around 
Bongso (Bongso et al., 1994; Evans and Kaufman, 1981). Four years later, Thomson 
and colleagues established the first human embryonic stem (hES) cell lines 
(Thomson et al., 1998). Subsequently, techniques involving the derivation and 
maintenance of hES cells rapidly evolved, and the field of stem cell biology 
significantly improved. Highly sophisticated methods, including immunosurgery or 
mechanical and laser-assisted isolation of the inner cell mass from the morula were 
developed (Kim et al., 2006; Peura et al., 2008; Strelchenko et al., 2004; Turetsky et 
al., 2008; Unger et al., 2008). With the perspective of a future application in 
regenerative medicine, culture conditions were improved to meet the requirements 
for the regulations for medical products and good manufacturing practice (GMP) 
guidelines by replacing compounds of animal origin with chemical compounds (Unger 
et al., 2008). Quickly, protocols for the generation of specific human somatic cells of 
high purity were developed. These encompass cells of the central nervous system 
(Perrier et al., 2004; Zhang et al., 2001), cardiomyocytes (Kehat and Gepstein, 
2003), hepatocytes (Hay et al., 2008) and pancreatic cells (Wang and Sander, 2012). 
The analysis of fundamental processes defining pluripotency employing murine and 
human ESCs led to a deeper understanding of the molecular processes of 
pluripotency (Cartwright et al., 2005; Chambers et al., 2003) and culminated in the 
discovery of its basic regulatory and determining machinery when Takahashi and 
Yamanaka demonstrated that the four transcription factors (TF), Oct3/4, Klf4, Sox2 
and c-Myc were sufficient to reprogram somatic cells to the state of induced 
pluripotent stem cells (iPSC) (Nakagawa et al., 2008; Takahashi et al., 2007). The 
advent of iPSCs provided a tool for the scientific community enabling the examination 
of all cell types that can be derived from PS cells in any genetic background. 
Although some studies reported occasional cases of increased tumorigenesis of 
iPSC chimeric mice (Okita et al., 2007; Okita et al., 2011) or cultivation-induced 
chromosomal aberrations (Ronen and Benvenisty, 2012), iPSCs are considered 
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largely identical to ES cells in terms of their capacity for self-renewal and 
differentiation potential (Gore et al., 2011; Hussein et al., 2011; Lister et al., 2011). 
With the perspective of using iPSC-derived cell populations one day as material for 
cell replacement therapy in regenerative medicine, safer and more sophisticated 
methods for the generation of iPSCs were demanded (Okita et al., 2011). Emphasis 
was laid on avoiding integration-prone or viral methods of reprogramming during 
iPSC generation to avoid genetic alteration of the cells, which was addressed by 
multiple measures: (I) A reduction of transcription factors (TF) necessary for 
reprogramming (Nakagawa et al., 2008), (II) their replacement by chemical 
compounds (Zhu et al., 2010) and (III) development of integration-free methods. 
These include excision of expression vectors after reprogramming (Sommer et al., 
2010), protein transduction of the TF (Grant et al., 2009) transfection of modified 
mRNA (Warren et al., 2010) and the transfection of mature microRNAs (Anokye-
Danso et al., 2011; Miyoshi et al., 2011; Sommer et al., 2010). One of the most 
efficient and broadest applicable method to date is transient expression of TFs by 
using non-integrating Sendai virus (Fusaki et al., 2009). However, mastering the 
complex differentiation of authentic somatic cell types in vitro remains a key 
challenge. The availability of pluripotent stem cells of non-embryonic origin 
ameliorates the ethical situation and most legal issues in many countries and 
facilitates the access of a broader community to this valuable scientific resource. 
1.2.2. Differentiation potential of human pluripotent and neural stem cells 
Human pluripotent stem cells (hPSCs) as the most immature cell population have the 
potential to differentiate into all three embryonic germ layers (Thomson et al., 1998). 
Hereby, the maintenance of a finely balanced signaling network that enables the 
preservation of a complex functional network of protein-protein interactions together 
with miRNA-regulation is critical to maintain hPSCs (Dalton, 2012; Lichner et al., 
2011; Smith et al., 2011). While hPSC generation methods were improved 
successfully by employing integration-free techniques that enable comparability and 
largely avoid the formation of degenerated cell populations, defined differentiation 
into specific somatic cell types still poses major obstacles (Initiative et al., 2007; Lee 
et al., 2012; Ohmine et al., 2011; Okita et al., 2011; Park et al., 2012).  
While many tissues show a pronounced regeneration potential with the ability to 
replace lost cells, the human central nervous system has a limited capacity for 
regeneration. For that reason, the development of biological models aiming to 
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describe molecular processes during traumata and the generation of cell populations 
fit to serve as cell replacement or model system for neurodegenerative diseases are 
focus of many research projects. Although a number of studies showed that upon 
withdrawal of factors used in standard proliferation conditions murine and human 
ESCs tend to show a neuroectodermal “default” mechanism for differentiation, the 
resulting neural populations show distinct variations in their cellular composition 
along with unsatisfactory neural purities (Hsu et al., 2007; Muotri et al., 2005; 
Reubinoff et al., 2001; Vallier et al., 2004). In order to provide suitable tools for the 
generation of mature human cell types, individual differentiation protocols were 
developed – either relying on directed differentiation or on lineage selection 
approaches (Barberi et al., 2005; Ladewig et al., 2008; Laflamme et al., 2007; Nistor 
et al., 2005; Wernig et al., 2002; Yan et al., 2005; Zhang et al., 2001). One major 
prerequisite for the successful utilization of hPSCs for the study of neurodegenerative 
diseases or other applications such as systems biological approaches is the efficient 
and robust differentiation of the required neuronal subtypes as defined cultures with 
minimized batch-to-batch differences. Initial methods for the derivation of neural cell 
types were based on ‘run-through’ protocols, where hPSC were directly differentiated 
into mature neuronal cultures, passing the state of multipotent progenitors and often 
resulting in decreased homogeneity due to incompletely differentiated cultures with 
individual features inherent to lengthy differentiation protocols (Kim et al., 2011). The 
isolation of neural tube-like structures, an intermediate precursor cell population 
emerging in cultures of plated embryoid bodies (EBs), resulted in the establishment 
of a highly homogenous long-term neural stem cell population (lt-NES). This cell 
population can be differentiated into glial or neuronal cells with highly reproducible 
neuronal differentiation rates, independent from variances in the neural differentiation 
propensity of the parental hPSC line. Furthermore, lt-NES cells remain susceptible to 
morphogens such as Sonic hedgehog (SHH), FGF8 and retinoic acid, facilitating the 
targeted generation of different subtypes such as midbrain dopamine neurons or 
spinal motor neurons even after long-term cultivation (Falk et al., 2012; Koch et al., 
2009). Notably, these neurons express functional K+ and Na+ channels, are able to 
fire action potentials, spontaneously form synaptic networks and receive synaptic 
input. These characteristics are generally considered as important hallmarks of 
neuronal maturity and enable these cells to form a functional synaptic network in vitro 
(Koch et al., 2009). Upon cerebral transplantation in laboratory animals, lt-NES cells 
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give rise to long-living mature neurons with a remarkable potential to generate 
functional long-range axonal projections to distant areas of the adult mammalian 
brain (Steinbeck et al., 2011).  
 
1.2.3. iPSC-based disease modeling 
While extensive efforts to establish animal models for various diseases in order to 
address their underlying molecular processes have been made, they do not 
necessarily provide results applicable to diseases in humans (Elder et al., 2010; 
Sager et al., 2010). Despite rich contributions to the field that substantially formed our 
current understanding of key processes in disease initiation and progression, these 
models ultimately fail to provide non-biased outcomes, which might be attributable to 
the xenobiotic setting or the late-onset of many diseases studied (Kunkanjanawan et 
al., 2011; Peters et al., 2010; Pournasr et al., 2011). With the advent of iPSC 
technology, new models for the analysis of molecular processes underlying disease 
onset and progression were established and provided a cellular system closely 
related to affected cell types and genotypic setting. In this context, an increasing 
number of human iPSC-based disease models was established, exploiting the 
capacity to generate and investigate the affected somatic cell population, providing 
valuable information regarding disease-development (Colman and Dreesen, 2009; 
Han et al., 2009; Koch et al., 2011). For instance, first insights into the pathological 
molecular mechanisms of the neurodegenerative late-onset Machado-Joseph 
disease (MJD; syn. spinocerebellar ataxia type 3; SCA3) were gained using afflicted 
lt-NES cells derived from a patient for the generation of homogenous, mature 
neuronal cultures.  In this disease, an abnormal expansion of trinucleotide CAG 
repeats within the Ataxin-3 gene (Atxn3) is assumed to lead to a loss of cells. The 
elongated isoform of ATXN3 leads to an aberrant protein conformation that initiates a 
pathogenic cascade leading to neuronal dysfunction and degeneration of neurons in 
the brainstem and other regions (Costa and Paulson, 2012; La Spada and Taylor, 
2010). By taking advantage of patient-specific lt-NES cells, a new mechanism for the 
formation of aggregates suspected to be involved in MJD-development was 
proposed: Upon activation-dependent Ca++ influx via voltage-gated Ca++ channels, 
extended ATXN3 is cleaved in a calpain-dependent process (Koch et al., 2011). 
These observations indicate that neurons derived from lt-NES cells closely resemble 
human neurons in vivo and are sufficiently mature to show features of late-onset 
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diseases. While in vitro generated neural derivatives certainly represent rather 
immature counterparts of neurons or glial cells found in the adult human brain, they 
nevertheless provide a suitable human cell source with respect to availability, 
homogeneity and genetic accessibility.	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1.3. Aim of the study 
While biomedical research made substantial progress employing cell-based systems 
for the investigation of disease processes, the majority of recent discoveries concern 
general metabolic, regulatory or developmental processes. The analysis of protein 
complex composition is an important part of studies exploring cell signaling 
cascades, cell-cell interactions as well as principles of signal transduction 
mechanisms. However, the majority of human interactome studies conducted was 
based on overexpression paradigms in tumor cell lines that often lead to common 
problems like unspecific interactions caused by supra-physiological protein 
expression levels, the use of transformed cells and non-tissue specific proteomic 
environments. 
The ability to generate human neurons from embryonic stem (ES) cells and induced 
pluripotent stem cells (iPSC) provides the perspective to conduct studies aimed at 
discovering the underlying molecular principles of disease processes in previously 
inaccessible cell populations. The objective of this study is to establish and evaluate 
techniques capable to perform protein-protein interaction analyses in vital human 
neurons generated from human PSC. 
In the first part, bacterial artificial chromosomes (BACs) will be used for the 
introduction of tagged proteins into PSC-derived long-term neuroepithelial-like stem 
(lt-NES) cells to facilitate their expression at endogenous levels. Following validation 
procedures, interactors of the introduced proteins can then be determined by affinity 
purification of proteins in combination with quantitative mass spectrometry. Data 
generated in this context will be used to comparatively characterize the composition 
of protein complexes in lt-NES cells and their neuronal progeny. Furthermore, the 
applicability of BAC transgenesis for iPSC-derived lt-NES cells will be assessed in 
order to evaluate the feasibility of quantitative BAC–green fluorescent protein 
interactomics (QUBIC) analysis in a diseased background. 
Although BAC-mediated protein expression is well suitable for most - if not all - 
proteins, the size of a GFP protein tag together with the probability of a mild 
overexpression due to the additional genomic locus caused by the BAC integration 
might be insufficient for some studies. Therefore, a further objective is to employ an 
AAV-based technique for epitope tagging of endogenous genes in order to generate 
lt-NES cell populations without modification of promoter-associated regulatory 
regions or exonic/intronic sequences.	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2. Materials 
2.1. Technical equipment 
Device Name Manufacturer Registered office 
Autoclave D-150 Systec Wettenberg, Germany 
Balance BL610 Sartorius Göttingen, Germany 
Balance LA310S Sartorius Göttingen, Germany 
Block heater Thermomixer compact Eppendorf Hamburg, Germany 
Bone drill (0.7-mm burrs) Micro Drill Fine Science Tools Hamburg, Germany 
Centrifuge (cell culture) Megafuge 1.0R Sorvall Hanau, Germany 
Centrifuge (table top) 5415D Eppendorf Hamburg, Germany 
Chemidoc Chemidoc 2000 BioRad Hercules, USA 
Concentrator Concentrator 5301 Eppendorf Hamburg, Germany 
Counting chamber Fuchs-Rosenthal Faust Halle, Germany 
Cryostat Cryostat HM 560 Microm Laborgeräte Walldorf, Germany 
Digital camera C 5050 Zoom Olympus Optical Hamburg, Germany 
Digital camera Canon Power Shot G5 Canon  Krefeld, Germany 
Electroporator Gene Pulser Xcell BioRad Hercules, USA 
FACS® analyzer FACS® Calibur BD Biosciences San Jose, USA 
FACS® sorter FACS® DiVa BD Biosciences San Jose, USA 
Freezer -80°C HERAfreeze Kendro Hanau, Germany 
Glass-Microelectrode Puller  PE-21 Tritech Research Los Angeles, USA 
Gel chamber Agagel Biometra Göttingen, Germany 
Geldoc GelDoc EZ BioRad Hercules, USA 
Incubator HERAcell Kendro Hanau, Germany 
Inverse light microscope Axiovert 25 Carl Zeiss Jena, Germany 
Liquid nitrogen store MVE 611 Chart Industries Burnsville, USA 
LED light source Colibri 2 Carls Zeiss Jena, Germany 
Microliterpipet Microliterpipet 1710N Hamilton Bonaduz, Switzerland 
Microscope Axiovert 40 CFL Carl Zeiss Jena, Germany 
Microscope Axiovert 200M Carl Zeiss Jena, Germany 
Microscope Axioskop 2 Carl Zeiss Jena, Germany 
Microscope IX 81 Confocal Olympus Hamburg, Germany 
Microscope camera Axiocam MRM Carl Zeiss Jena, Germany 
Microscope camera ProgRes C14 Jena Optic Jena, Germany 
Microscope laser Laser Mells Griot Griot Lasergroup Carlsbad, Germany 
Microscope slides  Superfrost plus Menzel-Gläser Braunschweig, Germany 
Nucleofector Nucleofector 2b Lonza Basel, Switzerland 
Operating microscope  OpMi Carl Zeiss Jena, Germany 
PAGE/Blot equipment Mini-PROTEAN 3  BioRad Hercules, USA 
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PAGE gel power supply PowerPac 200 Biorad Hercules, USA 
Plastic coverslips 
Thermanox®plastic 
coverslips 
Nunc Wiesbaden, Germany 
PCR cycler T3000 Termocycler Biometra Göttingen, Germany 
pH-meter CG840 Schott Mainz, Germany 
Pipetteboy Accu-Jet Brand Wertheim, Germany 
Platereader Infinite® 200 PRO Tecan Männedorf, Switzerland 
Polyester membrane Transwell-Clear Corning Bodenheim, Germany 
Real-time qPCR mashine Mastercycler realplex Eppendorf Hamburg, Germany 
Refrigerator G 2013 Comfort Liebherr Lindau, Germany 
Shaker Bühler Schüttler WS 10 Johanna Otto Hechingen, Germany 
Spectrophotometer Nanodrop ND-1000 Peqlab Erlangen, Germany 
Sterile laminar flow hood HERAsafe Kendro Hanau, Germany 
Stereo microscope STEMI 2000-C Carl Zeiss Göttingen, Germany 
Stereotactic Frame Stereotactic Frame Stoelting Illinois, USA 
Sterilizer Hot Bead Sterilizer Fine Science Tools Heidelberg, Germany 
Thermocycler T3 Thermocycler Biometra Göttingen, Germany 
Table centrifuge Centrifuge 5415R Eppendorf Hamburg, Germany 
Transplantation tools Transplantation Tool Set Fine Science Tools Heidelberg, Germany 
Ultracentrifuge Sorvall Discovery 90SE Hanau, Germany 
UV-Vis Spectrophotometer BioPhotometer Eppendorf Hamburg, Germany 
Vacuum pump Vacuubrand Brand Wertheim, Germany 
Vortex Vortex Genie 2 Scientific Industries New York, USA 
Water bath 1008 GFL Burgwedel, Germany 
Water bath WB7 Memmert Schwabach, Germany 
Water filter Millipak® 40 Millipore Eschborn, Germany 
 
2.2. Cell culture consumables 
Consumables Manufacturer Registered Office 
4 well culture dishes Nunc Wiesbaden, Germany 
6 well culture dishes PAA Pasching, Austria 
12 well culture dishes Nunc Wiesbaden, Germany 
96 well culture dishes PAA Pasching, Austria 
Cellstar TM 175 cm2 flasks Greiner Bio-One Solingen, Germany 
Cellsieve Nylon 40 µm  BD Falcon Bedford, USA 
Petri dishes ∅ 3.5 cm BD Biosciences Heidelberg, Germany 
Petri dishes ∅ 6 cm BD Biosciences Heidelberg, Germany 
Petri dishes ∅ 10 cm BD Biosciences Heidelberg, Germany 
Round bottom tubes - 12x75 mm BD Biosciences Heidelberg, Germany 
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Serological pipettes BD Biosciences Heidelberg, Germany 
Syringes 20 ml BD Biosciences Heidelberg, Germany 
Syringe filter 0.2 µm PALL Dreieich, Germany 
Syringe filter 0.45 µm Sarstedt Nuembrecht, Germany 
TC dishes ∅ 3.5 cm PAA Pasching, Austria 
TC dishes ∅ 6 cm PAA Pasching, Austria 
TC dishes ∅ 10 cm PAA Pasching, Austria 
TC dishes ∅ 15 cm SPL Eumhyeon-ri, Korea 
Tubes 0.5 ml Greiner Bio-One Solingen, Germany 
Tubes 1.5 ml Greiner Bio-One Solingen, Germany 
Tubes 15 ml Greiner Bio-One Solingen, Germany 
Tubes 50 ml Greiner Bio-One Solingen, Germany 
Cryovials 1 ml Nunc Wiesbaden, Germany 
Cryovials 1.8 ml Nunc Wiesbaden, Germany 
 
2.3. Chemicals and reagents 
Substance Manufacturer Registered office 
Acetic Acid Sigma Aldrich Deisenhofen, Germany 
30% Bis/Acrylamide Carl Roth Karsruhe, Germany 
Agar Sigma Aldrich Deisenhofen, Germany 
Agarose PeqLab Erlangen, Germany 
Ampiciline Sigma Aldrich Deisenhofen, Germany 
Ascorbic acid Sigma Aldrich Deisenhofen, Germany 
B27 supplement Invitrogen Karlsruhe, Germany 
Benzoase Sigma Aldrich Deisenhofen, Germany 
Bone wax Fine Scientific Tools Heidelberg, Germany 
Bromphenol blue Sigma Aldrich Deisenhofen, Germany 
BSA solution (7.5%) Invitrogen Karlsruhe, Germany 
CaCl2 Sigma Aldrich Deisenhofen, Germany 
cAMP Sigma Aldrich Deisenhofen, Germany 
Chemiluminescent Substrates Thermo Scientific Frankfurt, Germany 
Chloroquin Sigma Aldrich Deisenhofen, Germany 
Collagenase IV Sigma Aldrich Deisenhofen, Germany 
cOmplete ULTRA™ tablets Roche Diagnostics Basel, Swizerland 
CytocoonTM Buffer II  Evotec Technologies Hamburg, Germany 
DABCO Sigma Aldrich Deisenhofen, Germany 
DAPI Sigma Aldrich Deisenhofen, Germany 
DAPT Sigma Aldrich Deisenhofen, Germany 
DMEM high glucose Invitrogen Karlsruhe, Germany 
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DMEM/F12 (1:1) Invitrogen Karlsruhe, Germany 
DMSO Sigma Aldrich Deisenhofen, Germany 
DNA ladder (100bp / 1kbp) PeqLab Erlangen, Germany 
DNase (cell culture) Cell Systems St. Katharinen, Germany 
DNaseI (mol. bio.) Invitrogen Karlsruhe, Germany 
dNTPs PeqLab Erlangen, Germany 
Doxycycline Sigma Aldrich Deisenhofen, Germany 
EDTA Sigma Aldrich Deisenhofen, Germany 
EGF R&D Systems Wiesbaden, Germany 
Ethanol Sigma Aldrich Deisenhofen, Germany 
Ethidium bromide Sigma Aldrich Deisenhofen, Germany 
FCS Invitrogen Karlsruhe, Germany 
Fentanyl  Janssen-Cilag Beerse, Belgium 
FGF2  R&D Systems Wiesbaden, Germany 
Flumazenil 
Hikma-
Pharmaceuticals 
London, UK 
Forene® Abbott Baar, Switzerland 
G418 solution PAA Pasching, Austria 
Gelatine Sigma Aldrich Deisenhofen, Germany 
Glucose Sigma Aldrich Deisenhofen, Germany 
Glycerol Sigma Aldrich Deisenhofen, Germany 
Glycin Sigma Aldrich Deisenhofen, Germany 
H2O2 Sigma Aldrich Deisenhofen, Germany 
HCl Sigma Aldrich Deisenhofen, Germany 
HEPES Sigma Aldrich Deisenhofen, Germany 
Human brain RNA Aligent Technologies Santa Clara, USA 
Insulin Sigma Aldrich Deisenhofen, Germany 
Isopropanol Sigma Aldrich Deisenhofen, Germany 
IPTG Sigma Aldrich Deisenhofen, Germany 
Knockout-DMEM Invitrogen Karlsruhe, Germany 
L-glutamine (10x) Invitrogen Karlsruhe, Germany 
Laminin (Ln) Sigma Aldrich Deisenhofen, Germany 
Lysozyme  Sigma Aldrich Deisenhofen, Germany 
Matrigel (MG) BD Biosciences Heidelberg, Germany 
2-Mercaptoethanol Invitrogen Karsruhe, Germany 
Mowiol Sigma Aldrich Deisenhofen, Germany 
N2 supplement (100x) Invitrogen Karlsruhe, Germany 
N2 supplement (100x) PAA Pasching, Austria 
NaHCO3 Sigma Aldrich Deisenhofen, Germany 
Naloxon Ratiopharm Ulm, Germany 
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NaCl Sigma Aldrich Deisenhofen, Germany 
NaOH Sigma Aldrich Deisenhofen, Germany 
Neurobasal medium Invitrogen Karlsruhe, Germany 
Non-essential amino acids (10x) Invitrogen Karlsruhe, Germany 
Paraformaldehyde Sigma Aldrich Deisenhofen, Germany 
PBS Invitrogen Karlsruhe, Germany 
Penicillin Streptomycin Invitrogen Karlsruhe, Germany 
PFA Sigma Aldrich Deisenhofen, Germany 
PhosSTOP™ tablets Roche Diagnostics Basel, Swizerland 
Poly-L-ornithine Sigma Aldrich Deisenhofen, Germany 
Puromycin PAA Pasching, Austria 
RIPA Sigma Aldrich Deisenhofen, Germany 
SDS Sigma Aldrich Deisenhofen, Germany 
Serum Replacement Invitrogen Karlsruhe, Germany 
Sodium azide Sigma Aldrich Deisenhofen, Germany 
Sodium pyruvate (10x) Invitrogen Karlsruhe, Germany 
Sucrose  Sigma Aldrich Deisenhofen, Germany 
Taq DNA polymerase Invitrogen Karlsruhe, Germany 
TEMED Sigma Aldrich Deisenhofen, Germany 
Tissue-Tek® Weckert Labortechnik  Kitzingen, Germany 
Tris Sigma Aldrich Deisenhofen, Germany 
Triton-X-100 Sigma Aldrich Deisenhofen, Germany 
Trypanblue Invitrogen Karlsruhe, Germany 
Trypsin inhibitor (TI) Invitrogen Karlsruhe, Germany 
Trypsin-EDTA Invitrogen Karlsruhe, Germany 
Tryptone Sigma Aldrich Deisenhofen, Germany 
Vectashield®  mounting medium Vector Labs Burlingame, USA 
Xylene cyanol Sigma Aldrich Deisenhofen, Germany 
Yeast extract Sigma Aldrich Deisenhofen, Germany 
 
 
 
 
 
 
 
Materials 
 23	  
2.4. Cell lines and animals 
Cell line or mouse strain Source 
E. coli DH5a Invitrogen, Deisenhofen, Germany 
E. coli DH10b Invitrogen, Deisenhofen, Germany 
E. coli Stbl3 Invitrogen, Deisenhofen, Germany 
HEK-293FT  Leiden, Netherlands, Dr. Alex Van der Eb  
AAV-293 Agilent, Palo Alto, California, USA 
hESC line H9.2 Haifa, Israel (Itskovitz-Eldor et al., 2000) 
hESC line I3 Haifa, Israel (Itskovitz-Eldor et al., 2000) 
iPSC line MJD Bonn, Germany (Koch et al., 2011) 
iPSC line WT Bonn, Germany (Koch et al., 2011) 
iPSC line 4247#2 Bonn, Germany 
iPSC line 4247#8 Bonn, Germany 
Mouse strain C57BL/6 Charles River, Wilmington, USA 
Mouse strain C57BL/6 / Rag2-/- Charles River, Wilmington, USA 
 
2.5. Cell culture media 
All cell culture reagents are prepared under sterile conditions and stored at 4°C; % = v/v. 
Human pluripotent stem (hPS) cell medium 
Reagent Concentration Manufacturer Registered office 
Knockout-DMEM 79% Invitrogen Karlsruhe, Germany 
Serum replacement 20% Invitrogen Karlsruhe, Germany 
Non-essential amino acids 1x Invitrogen Karlsruhe, Germany 
L-glutamine 1x Invitrogen Karlsruhe, Germany 
2-Mercaptoethanol 0.1 mM Invitrogen Karlsruhe, Germany 
FGF2 4 ng/ml R&D Systems Wiesbaden, Germany 
Penicillin / Streptomycin  1x Invitrogen Karlsruhe, Germany 
 
Embryoid body (EB) medium 
Reagent Concentration Manufacturer Registered office 
Knockout-DMEM 79% Invitrogen Karlsruhe, Germany 
Serum replacement 20% Invitrogen Karlsruhe, Germany 
Non-essential amino acids 1x Invitrogen Karlsruhe, Germany 
L-glutamine 1x Invitrogen Karlsruhe, Germany 
Penicillin / Streptomycin  1x Invitrogen Karlsruhe, Germany 
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Neural stem cell (N2) medium 
Reagent Concentration Manufacturer Registered office 
DMEM:F12 (1:1) 98% Invitrogen Karlsruhe, Germany 
N2 supplement 1x PAA Karlsruhe, Germany 
Glucose 1.5 mg/ml Sigma Aldrich Deisenhofen, Germany 
Penicillin / Streptomycin  1x Invitrogen Karlsruhe, Germany 	  
Neuronal generation (NG) medium 
Reagent Concentration Manufacturer Registered office 
Neural stem cell (N2) 
medium 
50%   
Neurobasal medium 48% Invitrogen Karlsruhe, Germany 
B27 supplement 0.5x Invitrogen Karlsruhe, Germany 
cAMP 100 ng/ml Sigma Aldrich Deisenhofen, Germany 
Penicillin / Streptomycin  0.5x Invitrogen Karlsruhe, Germany 	  
Mouse embryonic fibroblast (MEF) medium 
Reagent Concentration Manufacturer Registered office 
DMEM high glucose 87% Invitrogen Karlsruhe, Germany 
FCS, heat inactivated 10% Invitrogen Karlsruhe, Germany 
Sodium pyruvate 1x Invitrogen Karlsruhe, Germany 
Non-essential amino acids 1x  Invitrogen Karlsruhe, Germany 
L-glutamine 1x  Invitrogen Karlsruhe, Germany 
Penicillin Streptomycin  1x Invitrogen Karlsruhe, Germany 	  
induced pluripotent stem cell (iPSC) medium 
Reagent Concentration Manufacturer Registered office 
DMEM/F-12 1x Invitrogen Karlsruhe, Germany 
KnockOutTM Serum 
Replacement 
20% Invitrogen Karlsruhe, Germany 
GlutaMAXTM-I Supplement 1x Invitrogen Karlsruhe, Germany 
Non-essential amino acids 100 µM Invitrogen Karlsruhe, Germany 
β-mercaptoethanol 100 µM Invitrogen Karlsruhe, Germany 
Penicillin Streptomycin  1x Invitrogen Karlsruhe, Germany 
Basic-FGF 4 ng/ml Sigma Aldrich Deisenhofen, Germany 	  
Neural stem cell freezing medium 
Reagent Concentration Manufacturer Registered office 
Serum replacement 70% Invitrogen Karlsruhe, Germany 
CytocoonTM Buffer II 20% Evotec Hamburg, Germany 
DMSO 10% Sigma Aldrich Deisenhofen, Germany 
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FCS-based freezing medium 
Reagent Concentration Manufacturer Registered office 
FCS, heat inactivated 90% Invitrogen Karlsruhe, Germany 
DMSO 10% Sigma Aldrich Deisenhofen, Germany 
 
Virus freezing medium 
Reagent Concentration Manufacturer Registered office 
Hepes buffered solution 
(HBS) 
92%   
BSA solution (7.5%) 8% Invitrogen Karlsruhe, Germany 
 
2.6. Cell culture additives 
Reagent Concentration Solvent Manufacturer Registered office 
Ascorbic acid 200 mM H2O Sigma Aldrich Deisenhofen, Germany 
B27 pure supplement mix pure supplement mix Invitrogen Karlsruhe, Germany 
BrdU 10 mg/ml H2O Invitrogen Karlsruhe, Germany 
Chloroquin 50 mM H2O Sigma Aldrich Deisenhofen, Germany 
DAPT 10 mM DMSO/Ethanol (1:4) Sigma Aldrich Deisenhofen, Germany 
DNAse  0.1% PBS Cell Systems St. Katharinen, Germany 
Doxycycline 1 mg/ml H2O Sigma Aldrich Deisenhofen, Germany 
EGF 10 µg/ml 0.1% BSA in H2O R&D Systems Wiesbaden, Germany 
FGF2 10 µg/ml 0.1% BSA in H2O R&D Systems Wiesbaden, Germany 
G418 50 mg/ml H2O PAA Pasching, Austria 
Puromycin  1 mg/ml H2O PAA Pasching, Austria 
 
 	    
Materials 
 26	  
2.7. Cell culture solutions 
HEPES Buffered Solution (HBS) 
Reagent Concentration Manufacturer Registered office 
NaCl 16 mg/ml Sigma Aldrich Deisenhofen, Germany 
HEPES 10 mg/ml Sigma Aldrich Deisenhofen, Germany 
KCl 0.76 mg/ml Sigma Aldrich Deisenhofen, Germany 
Na2HPO4 0.25 mg/ml Sigma Aldrich Deisenhofen, Germany 
Glucose 0.25 mg/ml Sigma Aldrich Deisenhofen, Germany 
H2O; adjust  
pH = 7.05 
   
 
Poly-L-ornithine (PO) coating solution 
Reagent Concentration Manufacturer Registered office 
H2O 100%   
Poly-L-ornithine (PO) 10 mg/ml Sigma Aldrich Deisenhofen, Germany 
 
Laminin (Ln) coating solution 
Reagent Concentration Manufacturer Registered office 
H2O 100%   
Laminin (Ln) 1 µg/ml Sigma Aldrich Deisenhofen, Germany 
 
Matrigel (MG) coating solution 
Reagent Concentration Manufacturer Registered office 
DMEM:F12 97% Invitrogen Karlsruhe, Germany 
Matrigel (MG) 3% BD Biosciences Heidelberg, Germany 
 
Trypsin/EDTA (TE) 1x 
Reagent Concentration Manufacturer Registered office 
PBS 90% Invitrogen Karlsruhe, Germany 
Trypsin/EDTA (TE) 10x 10% Invitrogen Karlsruhe, Germany 
 
Trypsin inhibitor (TI) 
Reagent Concentration Manufacturer Registered office 
PBS 100% Invitrogen Karlsruhe, Germany 
Trypsin inhibitor (> 700 units/mg) 0.25 mg/ml Invitrogen Karlsruhe, Germany 
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2.8. Plasmids 
Plasmid  Source or parent DNA sequence 
pMD2.G Gift from Didier Trono, Lausanne, Switzerland 
psPAX2 Gift from Didier Trono, Lausanne, Switzerland 
pAAV-SEPT-Acceptor Gift grom Todd Waldman, Washington, USA 
pAAV-RC Stratagene 
pHELPER Stratagene 
pLVX-EF1α Modified from pLVX-Tight-Puro (Clontech) 
pLVX-EF1α RFP.NLS RFP cDNA from pCMVBrainbow 1.1 (Gift from Daniel Trageser) 
pLVX EF1α Cre Cre cDNA from pCMV-HTN.Cre (Gift from Michael Peitz) 
 
2.9. Bacterial Artificial Chromosomes 
BAC  Tag MCB Source or parent DNA sequence 
AURKA LAP MCB_0002476 Gift from Ina Poser, Dresden, Germany* 
CDK2AP1 LAP MCB_0003855 Gift from Ina Poser, Dresden, Germany* 
FGD1 LAP MCB_0003318 Gift from Ina Poser, Dresden, Germany* 
JARID1C LAP MCB_0003325 Gift from Ina Poser, Dresden, Germany* 
JUN LAP MCB_0005073 Gift from Ina Poser, Dresden, Germany* 
MAP1LC3B NFLAP MCB_0005264 Gift from Ina Poser, Dresden, Germany* 
MARK2 LAP MCB_0002195 Gift from Ina Poser, Dresden, Germany* 
MECP2 LAP MCB_0003305 Gift from Ina Poser, Dresden, Germany* 
N-PAC LAP MCB_0003407 Gift from Ina Poser, Dresden, Germany* 
NCL LAP MCB_0002472 Gift from Ina Poser, Dresden, Germany* 
NCSTN LAP MCB_0003576 Gift from Ina Poser, Dresden, Germany* 
PCNA murine LAP MCB_0002066 Gift from Ina Poser, Dresden, Germany* 
PCNA LAP MCB_0005616 Gift from Ina Poser, Dresden, Germany* 
PSEN1 NFLAP MCB_0003584 Gift from Ina Poser, Dresden, Germany* 
PSEN2 NFLAP MCB_0003586 Gift from Ina Poser, Dresden, Germany* 
RBP-J LAP MCB_0004087 Gift from Ina Poser, Dresden, Germany* 
RPS27A LAP MCB_0003652 Gift from Ina Poser, Dresden, Germany* 
RUVBL1 LAP MCB_0002791 Gift from Ina Poser, Dresden, Germany* 
SETD1B LAP MCB_0004774 Gift from Ina Poser, Dresden, Germany* 
UHRF1 LAP MCB_0003868 Gift from Ina Poser, Dresden, Germany* 
VCP LAP MCB_0004449 Gift from Ina Poser, Dresden, Germany** 
*Max Planck Institute for Molecular Cell Biology and Genetics, Hyman Group, Dresden, Germany 
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2.10. Primers 
Cloning primers* 
Target  Identification Sequence (5’ à  3’)  
EF1α 
Ef1α- 
BamHI-fw 
GCGGCGGGATCCGGGTCGAAATTCCTCACGACACC 
Ef1a- 
ClaI-rev 
GCGGCGATCGATGCGCCCGACGATAAGCTTTGC 
Cre 
Cre- 
NotI-fw 
GCAGCAGCGGCCGCGCCGCCACCATGGGCCATCACCATCACCATC 
Cre- 
MluI-rev 
GCAGCAACGCGTTCATCAAATCGCCATCTTCCAGCAG 
dTomatoe.N
LS 
dTom- 
NotI-fw 
GCAGCAGCGGCCGCGCCGCCACCATGGTGAGCAAGGGCGAGG 
dTom.NLS 
MluI-rev 
TGCTGCACGCGTTTACTACACCTTCCTCTTCTTCTTCAACATGCCTCCGCCCTTGTACAGCTCG
TCCATGCCG 
Cre mRNA 
Cre-T7 
Kozak-FLAG-fw 
GCAGCATAATACGACTCACTATAGGGGCAGCAGCCGCCACCATGGATTACAAGGATGACGAC
GATAAGGGCCATCACCATCACCATCACGG 
Cre-PolyA-rev 
 
TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTCAATCGCCATCTTCCAGCAGGC 
Atxn3 N-
Term. LHA 
ATXN3-201-LHA 
(EcoRINotI)-fw 
GCAGCAGAATTCGCGGCCGCGCCGTTGGCTCCAGACAAATAAACATG 
ATXN3-201-LHA 
(KpnI)-rv 
GCAGCAGGTACCGTGCCAAAGCTGTCCTGGGGAAGGC 
Atxn3 N 
Term. RHA 
ATXN3-201-RHA 
(BamHI)-fw 
GCAGCAGGATCCATGGTATCATGTTTCATAATAGTTTC 
ATXN3-201-RHA 
(SalI,NotI)-rv 
GCAGCAGTCGACGCGGCCGCACTAAGAGGGATTTCTTTCGGGTAAG 
Selection 
Cassette 
Atxn3 N-
Term 
FIRESNEO 
(SmaI)-fw 
GCAGCACCCGGGATAACTTCGTATAGCATACATTATACGAAGTTATGGAATTAATTCGC 
FIRESNEO 
(XhoI)rv 
GCAGCACTCGAGATAACTTCGTATAATGTATGCTATACGAAGTTATTCCCAACTCATC 
Atxn3 N-
Term 
mutagenesis 
primer 
ATXN3-201 (LHA-
ATG-FLAG)fw 
CTCCAGACAAATAAACATGGATTACAAGGACGACGATGACAAGGAGTCCATCTTCCACGAGA 
ATXN3-201 (LHA-
ATG-FLAG)rv 
TCTCGTGGAAGATGGACTCCTTGTCATCGTCGTCCTTGTAATCCATGTTTATTTGTCTGGAG 	  
Sequencing primers* 
Target (direction) Identification  Sequence (5’ à  3’) 
Upstream of Tet response element (à 3’) seqTet_fw ATCGATGAGGCCCTTTCGTCTTCACTCGAG 
Downstream of PGK promoter (à 5’) seqPGK_rv CCTACCGGTGGATGTGGAATG 
Upstream of T7 sequence (à 3’) seqT7_fw TAATACGACTCACTATAGG 
* All primers were obtained from Life Technologies, Karlsruhe, Germany. 
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2.11. siRNA 
Target Identification Sequence (5’ à  3’) 
IRF3 
Irf3.1_sense GGAGGAUUUCGGAAUCUUC-dTdT 
Irf3.1_antisense GAAGAUUCCGAAAUCCUCC-dTdG 
siRNA was obtained from Biomers, Ulm, Germany. 
2.12. Antibodies 
Primary antibody  Dilution Source 
Actin 1:2000 Sigma Aldrich 
β-III-tubulin (TuJ1; ms) 1:1000 Covance 
β-III-tubulin (rb) 1:3000 Covance 
BACE1 (AB7520) 1:1000 Walter et al. 2001 
BrdU 1:50 Becton Dickinson 
cleaved Notch1 (Val1744) 1:1000 Cell Signaling 
Cre (ms, MMS-106P) 1:500 Covance 
DACH1 1:50 ProtenTech 
GFP (rb) 1:3000 Abcam 
GFP (ms) 1:500 Roche 
FLAG-tag 1:800 Sigma Aldrich 
GABA 1:500 Sigma Aldrich 
GFAP  1:1000 DAKO 
MAP2ab 1:500 Chemicon 
Nestin 1:500 R&D Systems 
NeuN 1:100 Millipore 
Neurofilament (HO14) 1:100 gift from Virginia Lee, Philadelphia, USA 
Nicastrin 1:2000 Sigma Aldrich 
Nurr1 1:50 Santa Cruz 
Otx2 1:200 R&D Systems 
PLZF 1:50 Calbiochem 
PS1 (AB3109) 1:500 Prager et al. 2007 
PS1 (APS18) 1:200 GeneTex 
Sox2 1:300 R&D Systems 
TH 1:500 Chemicon 
ZO1 1:50 Zymed 
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Secondary antibody  Dilution Source 
Cy3 gt-anti-ms 1:250 Jackson / Dianova 
Cy3-gt-anti-rb 1:250 Jackson / Dianova 
Cy3-dk-anti-gt 1:250 Jackson / Dianova 
Cy3-gt-anti-rat 1:250 Jackson / Dianova 
Cy5-gt-anti-rat 1:250 Jackson / Dianova 
Cy5-gt-anti-ms 1:250 Jackson / Dianova 
FITC-gt-anti-ms 1:250 Jackson / Dianova 
FITC-gt-anti-rb 1:250 Jackson / Dianova 
HRP-gt-anti-ms 1:10000 Thermo Scientific 
HRP-gt-anti-rb 1:10000 Thermo Scientific 
ms = mouse; rb = rabbit; gt = goat; dk = donkey 
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2.13. Molecular biology reagents 
Affinity purification lysis buffer (AP-lysis) 
Reagent Concentration Manufacturer Registered office 
NaCl 150 mM Sigma Aldrich Deisenhofen, Germany 
Tris pH 7,5 50 mM Sigma Aldrich Deisenhofen, Germany 
Glycerol 5% Sigma Aldrich Deisenhofen, Germany 
IGEPAL-CA-630 1% Sigma Aldrich Deisenhofen, Germany 
MgCl2 1 mM Sigma Aldrich Deisenhofen, Germany 
Benzoase 200 U Merck Darmstadt, Germany 
EDTA-free complete protease inhibitor 1 Roche Basel, Schweiz 	  
Affinity purification wash buffer I (AP-wash-I) 
Reagent Concentration Manufacturer Registered office 
NaCl 150 mM Sigma Aldrich Deisenhofen, Germany 
Tris pH 7,5 50 mM Sigma Aldrich Deisenhofen, Germany 
Glycerol 5% Sigma Aldrich Deisenhofen, Germany 
IGEPAL-CA-630 0,05% Sigma Aldrich Deisenhofen, Germany 	  
Affinity purification wash buffer II (AP-wash-II) 
Reagent Concentration Manufacturer Registered office 
NaCl 150 mM Sigma Aldrich Deisenhofen, Germany 
Tris pH 7,5 50 mM Sigma Aldrich Deisenhofen, Germany 
Glycerol 5% Sigma Aldrich Deisenhofen, Germany 
 
Affinity purification elution buffer (AP-elution) 
Reagent Concentration Manufacturer Registered office 
Urea 2 M Sigma Aldrich Deisenhofen, Germany 
Tris pH 7,5 50 mM Sigma Aldrich Deisenhofen, Germany 
Chloroacetamide 5 mM  Sigma Aldrich Deisenhofen, Germany 
 
Blotting buffer (10x) 
Reagent Concentration Manufacturer Registered office 
Tris 30 g Sigma Aldrich Deisenhofen, Germany 
Glycin 144 g Sigma Aldrich Deisenhofen, Germany 
H2O to 1000 ml; add 20% methanol 
before use to 1x blotting buffer 
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Borate Buffer 
Reagent Concentration Manufacturer Registered office 
Sodium borate 3.8 g Sigma Aldrich Deisenhofen, Germany 
H2O to 100 ml (pH 8.5) add   
 
Blocking solution 
Reagent Concentration Manufacturer Registered office 
PBS 90% Invitrogen Karlsruhe, Germany 
FCS 10% Invitrogen Karlsruhe, Germany 
Triton-X-100 (intracelluar epitopes) 0.1% Sigma Aldrich Deisenhofen, Germany 
 
DNA loading buffer 
Reagent Concentration Manufacturer Registered office 
Tris solution (0.1 M; pH 8.0) 70% Sigma Aldrich Deisenhofen, Germany 
Glycerol 29.2% Sigma Aldrich Deisenhofen, Germany 
Bromphenol blue 0.4% Sigma Aldrich Deisenhofen, Germany 
Xylene cyanol 0.4% Sigma Aldrich Deisenhofen, Germany 
 
LB medium 
Reagent Concentration Manufacturer Registered office 
Tryptone 10 g Sigma Aldrich Deisenhofen, Germany 
Yeast extract 5 g Sigma Aldrich Deisenhofen, Germany 
NaCl 5 g Sigma Aldrich Deisenhofen, Germany 
NaOH solution (1 M) 1 ml Sigma Aldrich Deisenhofen, Germany 
H2O to 1000 ml;  
autoclave and store at 4°C 
add   	  
LB agar plates 
Reagent Concentration Manufacturer Registered office 
Agar 7 g Sigma Aldrich Deisenhofen, Germany 
LB medium to 1000 ml;  
autoclave and store at 4°C 
add   
 
Mowiol/DABCO 
Reagent Concentration Manufacturer Registered office 
Tris solution (0.2 M; pH 8.5) 12 ml Sigma Aldrich Deisenhofen, Germany 
H2O 6 ml   
Glycerol 6 g Sigma Aldrich Deisenhofen, Germany 
Mowiol 2.6 g Sigma Aldrich Deisenhofen, Germany 
DABCO 0.1 g Sigma Aldrich Deisenhofen, Germany 
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Paraformaldehyde (PFA) fixation solution (4%) 
Reagent Concentration Manufacturer Registered office 
Paraformaldehyde 40 g Sigma Aldrich Deisenhofen, Germany 
H2O to 1000 ml  
(heat to dissolve; filter; pH 7.4) 
add   
 
Protein loading buffer 
Reagent Concentration Manufacturer Registered office 
Tris solution (0.1 M; pH 6.8) 76% Sigma Aldrich Deisenhofen, Germany 
Glycerol 20% Sigma Aldrich Deisenhofen, Germany 
SDS 4% Sigma Aldrich Deisenhofen, Germany 
Bromphenol blue 0.25% Sigma Aldrich Deisenhofen, Germany 
 
Resolving gel buffer 
Reagent Concentration Manufacturer Registered office 
1.5 M Tris solution (pH 8.8) 99.6% Sigma Aldrich Deisenhofen, Germany 
SDS 0.4% Sigma Aldrich Deisenhofen, Germany 
 
Stacking gel buffer 
Reagent Concentration Manufacturer Registered office 
1.5 M Tris solution (pH 6.8) 99.6% Sigma Aldrich Deisenhofen, Germany 
SDS 0.4% Sigma Aldrich Deisenhofen, Germany 
 
SDS-PAGE running buffer 
Reagent Concentration Manufacturer Registered office 
Tris 30 g Sigma Aldrich Deisenhofen, Germany 
Glycin 144 g Sigma Aldrich Deisenhofen, Germany 
SDS 10 g Sigma Aldrich Deisenhofen, Germany 
H2O to 1000 ml (pH 8.0) add   
 
Saline-sodium citrate (SaSoC) buffer (20x) 
Reagent Concentration Manufacturer Registered office 
NaCl 3 M Sigma Aldrich Deisenhofen, Germany 
Trisodium citrate 300 mM Sigma Aldrich Deisenhofen, Germany 
pH 7.0    
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TBST (10x) 
Reagent Concentration Manufacturer Registered office 
Tris 121 g Sigma Aldrich Deisenhofen, Germany 
NaCl 87 g Sigma Aldrich Deisenhofen, Germany 
Tween-20 1% Sigma Aldrich Deisenhofen, Germany 
H2O to 1000 ml add   
 
2.14. Molecular biology enzymes, kits and compounds 
Enzyme / Kit Manufacturer 
5-Methylcytidine-5'-Triphosphate Trilink 
Antarctic Phosphatase New England Biolabs 
FastAPTM Phosphatase Thermo Scientific 
LongAmp® Taq DNA Polymerase New England Biolabs 
MEGAScript® T7 Kit Ambion 
mini Quick Spin RNA Columns Roche 
NucleoBond® BAC 100 Macherey-Nagel 
peqGOLD™ Gel Extraction Kit PeqLab 
peqGOLD™ Plasmid Miniprep Kit I PeqLab 
Phusion® High-Fidelity DNA Polymerase New England Biolabs 
Poly(A) Polymerase Tailing Kit Epicentre 
Pseudouridine-5'-Triphosphate Trilink 
PureLink™ HiPure Plasmid Filter Maxiprep Kit Invitrogen 
QuikChange® Agilent 
Restriction Endonucleases  New England Biolabs 
ScriptCap 2'-O-Methyltransferase Epicentre 
ScriptCap m7G Capping System Epicentre 
T4 DNA Ligase New England Biolabs 
Taq DNA Polymerase Invitogen 
Zymoclean™ DNA Clean & Concentrator-25 Hiss Diagnostics 
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2.15. Software 
Computer program Manufacturer 
ApE - A Plasmid Editor 2.0.39 M. Wayne Davis 
AxioVision 40 4.5.0.0 Carl Zeiss 
Brain Explorer 2 Allen Reference Atlas 
Cytoscape 2.7 The Cytoscape Collaboration 
Excel 2008 Microsoft 
FlowJo 6.8 Tree Star 
Fiji 1.47n http://fiji.sc/ 
GenomeStudio 2011 Illumina 
Image J 1.42q NIH 
InDesign CS5 Adobe 
MaxQuant 1.2.2.5 MPI for Biochemistry, Munich 
Quantity One 4.6.8 Bio Rad 
Perseus 1.1.0.17 MPI for Biochemistry, Munich 
Photoshop CS3 Adobe 
Prism 5 Graphpad 
QuikChange® Primer Design Agilent 
UniProt UniProt Consortium 
Word 2011 Microsoft 
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3. Methods 
3.1. Generation of iPS cells 
All cell culture experiments were performed in a sterile vertical/horizontal laminar flow 
hood with sterile media, plastic and glass instruments. Prepared buffers and 
solutions were autoclaved, where applicable, or filtered using a 0.2 µm sterile filter. 
Cells were cultivated in an incubator at 37°C, 5% CO2 and saturated air humidity. 
Adult human fibroblasts were cultivated in mouse embryonic fibroblast (MEF) 
medium on gelatin-coated dishes. For infection, 70 000 cells were transferred to a 
gelatin-coated well of a 12-well dish and cultivated to a confluency of 80-90%. Four 
Sendai viral vectors each expressing Klf4, Oct3/4, Sox2 or c-Myc were used for 
transduction at a multiplicity of infection (MOI) of 4. 24 h later, the medium was 
changed and cells were cultivated for additional 7 days. At day 8, transduced adult 
human fibroblasts were separated using TrypLE Select and 50 000 cells were 
transferred to irradiated MEFs and cultivated in iPSC medium for the following 3-4 
weeks. Emerging colonies were mechanically isolated using a scalpel, transferred to 
MEF covered dishes and cultivated for ≥5 passages. Generated iPSC lines were 
characterized by analysis for the expression of the pluripotency markers Tra1-60 and 
Tra1-81. Genome-wide single nucleotide polymorphism analysis was performed to 
validate genomic integrity of derived iPSC lines and teratoma assays to validate 
pluripotency (Wesselschmidt, 2011). 
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3.2. In vitro differentiation of hPS cells into lt-NES cells 
HPS cells were cultivated on a layer of irradiated mouse fibroblasts in hPSC medium, 
which was changed daily. Cells were passaged using collagenase IV (1 mg/ml). 
Differentiation of hPSC (hESCs and iPSCs) into lt-NES cells was performed as 
described previously (Koch et al., 2009). Embryoid bodies were generateded by 
cultivation of hPSCs in EB medium as floating aggregates for four days. EBs were 
transferred to poly-l-ornithine (PO) coated tissue culture dishes and propagated in N2 
(PAA) medium containing FGF2 (10 ng / ml; R&D Systems). Within 10 days, neural 
tube-like structures developed in the EB outgrowth and were mechanically isolated 
and propagated for another three days as free-floating neurospheres in N2 medium 
containing FGF2 (10 ng/ml). Neurospheres were dissociated by incubation with 
trypsin/EDTA (TE, Invitrogen) and trypsin inhibitor (TI, Invitrogen), mechanically 
triturated into single cells and plated on poly-l-ornithine (3h, 37°C) Laminin (≥ 12h, 
4°C; PO/Ln; Sigma Aldrich) coated tissue culture dishes. Generated lt-NES cell lines 
were cultivated in N2 medium containing FGF2, EGF (each 10 ng / ml) and B27 
supplement (1 µl/ml; Invitrogen) on PO/Ln coated tissue culture dishes, passaged 
using TE/TI and seeded at densities of 0.5 - 0.8 x 106 cells / cm2. Lt-NES cell lines 
show a highly clonogenic potential, and can be passaged for more than 100 
passages and were monitored daily regarding proliferation rate and morphological 
integrity. lt-NES cells were stored after TE/TI treatment in neural stem cell freezing 
medium initially at -80°C (<7 days), for long-term storage in liquid nitrogen storage 
tanks. 
 
3.3. In vitro differentiation of lt-NES cells into neuronal cultures 
For initiation of terminal differentiation, lt-NES cells were transferred to matrigel 
(MG)-coated tissue culture dishes and cells were grown to confluence. The culture 
medium was changed to NGc medium, which was exchanged every other day. 
Usually, cells were analyzed four weeks after induction of differentiation but could be 
matured for more than three months. 
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3.4. BAC transfection of lt-NES cells 
Bacterial artificial chromosomes (BACs) have the ability to carry large amounts of 
genetic information (up to 350 kb) and can easily be modified by recombination 
methods. Most genomic loci can be found on established mapped BAC libraries, 
originating from human genome sequencing projects. Tagged variants of these BACs 
were provided as stab culture by Ina Poser (Max Planck Institute for Molecular Cell 
Biology and Genetics, Dresden, Germany). BACs were prepped according to 
manufacturers instructions (BAC-100, Macherey-Nagel). lt-NES cells from iPSCs or 
hESCs were pelleted (250 g, 5 min), resuspended and incubated in CytocoonTM 
Buffer II (30 min, RT). 2 µg circular BAC DNA (≤6 µl) were transferred to a 
nucleofection cuvette, cells were resuspended in Nucleofection Buffer V (100 µl, 
Amaxa) and added directly to the DNA. Immediately after nucleofection (program A-
33), cells were replated. Chemoselection was initiated 5 days after nucleofection by 
addition of G418 (50 µg / ml). Concentration of G418 was increased in 50 µg steps 
every other day until increased cell death could be detected. Cells were cultivated 
without selection for two passages and chemoselection was reapplied at last-used 
concentrations, increasing each day until concentrations of 75 µg were reached. 
Generated BAC-transgenic cell lines were continuously cultivated in proliferation 
medium supplemented with G418 (≥ 50 µg / ml). 
 
3.5. Immunocytochemical analysis 
Cells were fixed in 4% PFA (10 min, RT), washed twice with PBS and blocked with 
10% FCS. For staining of intracellular epitopes 0,1% TritonTM X-100 was added. 
Respective primary antibodies (listed) were applied in blocking solution (2h, RT), and 
cells were washed thrice with PBS (10 min) before secondary antibodies were 
applied (1h, RT). DAPI (5 min, RT) or TO-PRO®3 (15 min, RT; Life technologies) 
solution was used for nuclear counterstaining. Cells were rinsed thrice with PBS 
before mounting with Moviol/DABCO and covering with a glass coverslip. 
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3.6. Fluorescence activated cell sorting (FACS) analysis 
For FACS analysis, single cells were prepared by trypsinization with subsequent 
inhibition of trypsin (TE/TI), centrifuged and resuspended in PBS (3x105 cells / 100 
µl). Cells were analyzed with the FACSCalibur® cytometer equipped with an argon-
ion laser (488 nm) and the following values were recorded: forward scatter (FSC), 
side scatter (SSC) and GFP fluorescence. Further data analysis was performed 
using the FlowJo software. 
 
3.7. Western immunoblotting 
Cells were scraped from dishes in the presence of PBS, pelletized and incubated for 
1 h on ice in RIPA buffer (Sigma Aldrich) containing protease inhibitors (Roche 
c0mplete ULTRATM). Lysates were clarified by centrifugation (>20.000 g, 15 min, 4 
°C) and stored in aliquots (-80 °C) or used directly. Protein lysates were mixed with 
6x Lämmli buffer and boiled (10 min, 95 °C) before separation on a SDS-PAGE gel 
(10%). Briefly, the SDS-PAGE gel was composed of a stacking gel (5%) and a 
resolving gel, consisting of 30% acrylamide/bisacrylamide (37,5:1, Carl Roth), 
TEMED, 10% APS and the respective gel buffers. Prepared protein lysates were 
loaded on SDS-PAGE gels and run in MINI-protean chambers (Bio-Rad) at 150V for 
up to 1,5 h. Separated proteins were blotted from the gel to a previously with MeOH 
activated PVDF membrane (0,45 µm, Millipore) at 30V o/n. Resulting membranes 
were blocked with milk powder (1%) solved in PBS-T for 30 min, incubated with an 
appropriate primary antibody (o/n at 4°C on a rotator) and washed thoroughly the 
next day. The membranes were incubated with an HRP-linked secondary antibody 
(1h, RT) and developed using chemoluminiscence (SuperSignal West Dura, Thermo 
Scientific). 
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3.8. Fluorescence in situ hybridization (FISH) 
I3 ES cell derived lt-NES cell lines transgenic for BACs containing the AURKA, Jun 
or PCNA gene were subjected to fluorescence in situ hybridization (FISH). Probes 
were generated by nick translation of respective complete BACs (AURKA.GFP, 
Jun.GFP or PCNA.GFP) using biotin-dUTP. Individual chromosomes were stained 
using digoxigenin-dUTP labeled whole chromosome paint probes generated by 
degenerative oligonucleotide priming PCR (DOP-PCR) (Solovei et al., 2002). For 
FISH, cells were fixed in 4% PFA, washed in PBS (3x5 min), incubated in 0.5% 
TritonTM X-100 in PBS for 10 min, and equilibrated in 20% glycerol in PBS (30 min). 
Cells were frozen in liquid nitrogen and thawed to RT (5 times). Following a PBS 
washing step (5min, RT) they were incubated for 5 min in 0,1 N HCl, rinsed in 
2xSaSoC and stored in 50% formamide/2xSaSoC for ≥ 1 h. The labeled probes were 
dissolved in a mixture of 50% formamide, 10% dextran sulfate and 1xSaSoC, applied 
to the cells and sealed. Following a 75°C denaturation step for 2 min, hybridization 
was carried out in a humid atmosphere at 37°C for 48 h. Cell nuclei were 
counterstained using DAPI and signals acquired using standard fluorescence 
microscopy. 
Dr. Irina Solovei (University of Munich (LMU) Biozentrum, Department of Biology II 
Anthropology & Human Genetics, Martinsried) performed FISH analysis and probe 
generation. 
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3.9. Design of lentiviral vectors 
As a conditional overexpression system, a modified variant of the Lenti-XTM Tet-On 
Advanced system (Clonetech) was used (the CMV promoter had been exchanged by 
an EF1α promoter in the pLVX-Tet-On plasmid to regulate expression of rtTAAdv. 
protein). The cDNA for the respective protein was amplified by PCR (cloning primers 
listed) from image plasmids (BioCat) or total lt-NES cell cDNA. PCR products were 
separated by agarose gel electrophoresis, extracted by manual excision of the 
respective band, isolated by gel purification (peqGOLD™ Gel Extraction Kit, Peqlab), 
digested using appropriate restriction enzymes (listed) and ligated (T4 DNA Ligase, 
NEB) into linearized, dephosphorylated (FastAPTM, Fermentas) pLVX-Tight-Puro 
vector under control of the inducible TREtight promoter, resulting in pLVXTP-gene 
vectors (listed). 
 
3.10. Production and concentration of lentiviral particles 
For production of lentiviral particles, HEK293-FT cells were grown on a poly-
ornithine-coated 15 cm dish in MEF medium.  80-90% confluent cells were co-
transfected with lentiviral plasmids of the second generation by calcium-phosphate 
precipitation as described previously (Kutner et al, 2009). Briefly, 7 µg of the 
envelope plasmid pMD2.G and 15 µg of the packaging plasmid psPAX2 together with 
30 µg of the transfer vector were mixed, and H2O was added to a final volume of 
1400 µl. 178 µl of CaCl2 solution (2,5 M) was added, and the solution was slowly 
mixed with 1400 µl of 2xHBS buffer (pH=7,05). The suspension was incubated for 40 
min at RT and added drop wise to the 293FT cells that were pre-incubated with with 
chloroquin (25 µM, 5 min, 37°C in MEF). The next day, transfected cells were 
washed with PBS (37°C) once. The supernatants of day two and three were pooled, 
filtered through a 0,45 µm filter and concentrated by centrifugation (44000 g; 4°C, 
2h). Viral particles were resuspended in virus freezing medium and stored in aliquots 
at -80°C. 
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3.11. Lentiviral transgenesis of lt-NES cells 
To generate a lt-NES cell line for conditional overexpression, lt-NES cells from hES 
cell line I3 were first transduced with lentiviral particles containing the EF1α regulated 
rtTAAdv protein. Following chemoselection with G418 (100 µg / ml, PAA), cells were 
transduced with the respective pLVXTP-gene virus to obtain inducible cell lines for the 
respective gene. Cell lines were continuously cultured in G418 and puromycin 
containing culture media (Puromycin: 1 µg / ml, Sigma Aldrich; G418: 100 µg / ml, 
PAA). 
 
3.12. Live cell imaging of lt-NES cell populations 
In order to discriminate individual cells within lt-NES cell populations naturally 
growing at high densities, a fraction the cells was transduced with lentiviral particles 
containing the red fluorescent protein (RFP) cDNA fused to a nuclear localization 
sequence (NLS; RFP.NLS) under transcriptional control of the eukaryotic translation 
elongation factor 1 alpha (EF1α) at a multiplicity of infection (MOI) between 1 and 2 
(corresponding to 63-83% of affected cells). Cells were thawed and seeded at 
densities of 50.000 cells / cm2 one day before image acquisition, which was 
performed using a microscope attached to a humidified chamber at 37°C containing 
5% CO2. 	  
3.13. Affinity-based protein-protein interaction analysis 
Cell pellets were lyzed in AP-lysis buffer (on ice; 30 min), incubated with magnetic 
antibody-covered beads (anti-GFP, mouse, Miltenyi), washed 3x with buffer AP-
wash-I, 2x with buffer AP-wash-II, loaded to an equilibrated magnetic column, 
digested at RT for 30 min by addition of 150 ng trypsin (Promega), eluted twice using 
AP-elution buffer, and stored on two C18 Stage Tips at 4°C. Pulldown was performed 
on an automated liquid-handling platform (Freedom EVO 200; Tecan). For LC-
MS/MS analysis, peptides were eluted from tips and separated on line to the mass 
spectrometer using an easy nano-LC system (Proxeon Biosystems), coupled to a 
mass spectrometer (LTQ-Orbitrap, Thermo Fischer Scientific) via a nanoscale LC 
interface (Proxeon Biosystems). Data was processed using MaxQuant software, 
searching against the human database concatenated with reversed copies of all 
sequences and supplemented with frequently observed contaminants using 
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MASCOT. Volcano plots were generated by combining t test p-values with ratio 
information, while significance lines in the volcano plot were chosen to correspond to 
a given false discovery rate (FDR) by a permutation-based method using the 
software R and the provided script QUBIC-LABELFREE.R (Hubner et al., 2010a). 
Marco Hein (Max Planck Institute of Biochemistry, Martinsried, Germany) performed 
affinity purification, measurement and statistical processing and provided normalized 
data and volcano plots. 
 
3.14. Design of AAV targeting constructs 
AAV constructs were designed to target specific sites within a human cell. For that, 
respective genomic regions were analyzed for interspersed repeats and low 
complexity DNA sequences (RepeatMasker.org). Homology arms up- and 
downstream of a synthetic exon promoter trap (SEPT) containing a G418 resistance 
gene were chosen to each contain less than 50% of masked repeats and span a 
region of 1000 BP while primers were designed to exclusively bind in non-masked 
regions (Figure 3.1). 
 
Figure 3.1: Design of AAV targeting constructs 
The targeting construct for adeno-associated virus (AAV) mediated gene targeting consists of two 
homology arms (≥1000 bp) with less than 50% of interspersed repeats and low complexity DNA 
sequences containing the modified exon. The synthetic exon promoter trap flanked by loxP Cre 
recombination sites is introduced between both homology arms. The neomycin resistance gene is 
linked by an internal ribosomal entry site (IRES) to the transcriptional control of the promoter 
controlling the targeted locus. 
 
Homology arms were amplified with cloning primers (LongAmp® Taq DNA 
Polymerase, NEB), purified by agarose gel electopuration, extracted (peqGOLD™ 
Gel Extraction Kit, Peqlab), digested (appropriate restriction enzymes, NEB) and 
ligated in a linearized, dephosphorylated (FastAPTM, Fermentas) pAAV-SEPT-
Acceptor together with a purified SEPT cassette to result in a pAAV-gene-SEPT 
vector. Subsequently, a FLAG tag was introduced by mutagenesis PCR 
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(QuikChange®, Agilent) directly after the initiating ATG of the first exon, resulting in a 
N-terminally tagged pAAV-FLAG-gene-SEPT vector (Fig. 3.1). 
3.15. Production of AAV vectors 
For production of AAV particles, 293-AAV cells were grown on poly-ornithine-coated 
dishes in MEF medium. 80-90% confluent cells were co-transfected with plasmids 
pHELPER and pAAV-RC (Stratagene) by calcium-phosphate precipitation as 
described previously (Kim et al., 2008). The medium was exchanged the next day, 
and cell monolayers were scraped into 1 ml PBS and subjected to 4-5 freeze/thaw 
cycles (-80°C/37°C). The lysate was cleared by centrifugation (20000 g, 10 min, RT). 
The virus-containing supernatant was aliquoted and stored at -80°C. 	  
3.16. Production of synthetic pseudotyped mRNA 
As co-transcriptional incorporation of a cap analogue results in incomplete capping, 
enzymatic capping and additional 2’O-methylation of in vitro transcription products 
was conducted supplementary to the introduction of stabilizing nucleotides, resulting 
in a modified mRNA (Fig. 3.17). cDNA templates for in vitro RNA transcription were 
created by PCR-based introduction of T7 promoter and 3-prime poly-adenylation 
sites. RNA was produced according to the manufacturers manual (Ambion). Briefly, 
ribonucleic acids (ATP, GTP, Kit) together with stable, artificial analogues of UTP 
(Pseudouridine, Trilink) and CTP (5'-Methylcytidine, Trilink) were used to assemble 
stable RNA constructs. The resulting RNAs were purified using mini Quick Spin RNA 
columns (Roche, according to manual) and modified at the 5-prime end using the 
ScriptCap m7G capping system together with the ScriptCap 2'-O-methyltransferase 
kit (Epicentre, according to manual). To further enhance stability within cells, the C1-
capped mRNAs were polyadenylated (Poly(A) Polymerase Kit, desired A-repeats: 
200, Epicentre). To eliminate any residual triphosphates, phosphatase was added for 
30 min at 37°C after purification (FastAP, Fermentas) and heat inactivated by 
incubation at 65°C for 5 min. Resulting C1-capped and polyadenylated mRNA was 
aliquoted and stored at -80°C. 
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3.17. mRNA transfection of cultured cells  
Two days before transfection of artificial mRNA into a cell line, these cells were 
transfected with a siRNA targeting the interferon regulatory factor 3 (IRF3) to avoid 
RIG-I and MDA-5 based transduction of innate immune recognition signaling.  
Briefly: 0,25 µg IRF3 siRNA were diluted in 200 µl Opti-MEM I and 6 µl of RNAi-MAX 
were diluted in a second vial containing 200 µl Opi-MEM I. Both vials were mixed and 
incubated for 15 min at RT before addition to the cells. Cell media was changed 4h 
later. Two days later, 1 µg Cre recombinase mRNA was diluted in 200 µl Opti-MEM I 
while 6 µl RNAi-MAX was diluted in a second vial under same conditions. The growth 
medium of the cells was replaced with Optifect medium (Opti-MEM I, 0,5% BSA). 
After mixture of both vials the suspension was incubated for 15 min at RT and added 
to the cells hereafter. The medium was exchanged after 4h with normal growth 
medium and cells were recovered for 2 days under normal culture conditions. 	  
3.18. Statistical analysis 
Quantitative data was generated in ≥two biological and ≥three technical replicates 
unless otherwise mentioned. All results show means ±standard deviation (SD). 
Means and SD were computed using Microsoft Excel 2008 and GraphPad Prism 
software. A student’s t-test was performed to determine whether a significant 
difference between groups exits. A one-way ANOVA in conjunction with a Dunnett’s 
multiple comparison test was performed to determine whether a significant difference 
exists between control and test group. For volcano plots, results were plotted using 
the open source statistical software R and the script QUBIC-LABELFREE.R (Hubner 
et al., 2010a). 	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4. Results 
4.1. Human pluripotent stem cell-derived neural stem cells for the study of 
protein-protein interactions 
Human pluripotent stem (hPS) cells provide a virtually unlimited source for the 
generation of a stable neural precursor population and authentic human neurons 
derived thereof. The first part of the presented work is aimed at harnessing human 
neural stem cells and their neuronal derivatives for the exploration of protein-protein 
interactions (PPI) of several proteins involved in diseases (APH1A, APH1B, AURKA, 
BACE1, CDK2AP1, FGD1, JARID1C, JUN, MAP1LC3B, MARK2, MECP2, MGA, N-
PAC, NCL, NCSTN, P53, PCNA, PSEN1, PSEN2, RBPJ, RUVBL2, SETD1B, Sin3A, 
SmcHD1, RPS27A, Tau, TMEM132A, UHRF1, VCP) introduced by transfection of 
bacterial artificial chromosomes (BAC) harboring their GFP-tagged isoforms. 
4.1.1. Transfection of BACs is suitable for the generation of stable long-term 
neuroepithelial-like stem (lt-NES) cell line 
To permit endogenous expression and regulation of tagged proteins, bacterial 
artificial chromosome (BAC) vectors carrying C- or N-terminally GFP-tagged 
candidate proteins containing most, if not all, regulatory elements (Fig. 4.1 a and b, 
Poser et al., 2008) were used for the generation of transgenic lt-NES cell lines (Fig. 
4.1 c). Nucleofection of lt-NES cells with circular BACs (5 µg, 1x106 cells) was 
followed by a multistep chemoselection process that was developed to permit the 
derivation of transgenic polyclonal cultures (pools) of homogenous lt-NES cells (Fig. 
4.1 c). Routinely, the percentage of GFP-positive cells was quantified by flow 
cytometric analysis (FACS), the size of the fusion protein assessed by Western 
immunoblotting (GFP epitope) and the intracellular protein localization examined by 
fluorescence microscopy (Fig. 4.1 c). 
By design, insoluble membrane-associated complexes are less likely to be detected 
using standard sample processing for AP-MS/MS approaches (Havugimana et al., 
2012). Proteins involved in such complexes are less amenable to affinity enrichment 
and therefore were systematically excluded from experiments (Dubinsky et al., 2012; 
Schirle et al., 2012). Hence, soluble-, cytoskeleton- or nucleus-associated proteins 
were primarily used for the generation of BAC-transgenic lt-NES cell lines.  
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Figure 4.1: BAC-mediated protein tagging 
a and b: Schematic composition of bacterial artificial chromosomes used for introduction of tagged 
proteins: Whole-genomic regions of the gene of interest encompasses 5’- and 3’-UTRs, Exons (Ex) 
and introns (In). Tag composition: TEV cleavage site (T), S-peptide (S) PreScission cleavage site (P), 
enhanced green fluorescent protein (GFP). a: The C-terminal tag is introduced within the last used 
exon just before the stop codon. An internal ribosomal entry site (IRES), enables the simultaneous 
expression of the neomycin resistance (neo); a gb3 bacterial promoter allows bacterial amplification of 
the construct. b: The N-terminal tag variant is composed of GFP containing an artificial intronic site 
with phosphoglycerate kinase (PGK) promoter enabling constitutive expression of the neomycin 
resistance gene fused to the initial exon (Exfirst); sd = splice donor, sa = splice acceptor. c: Timeline for 
generation of BAC transgenic cell lines based on lt-NES cells. Nucleofection of lt-NES cells was 
followed by recovery for 5 days; G418 initially was applied at 50 µg/ml and increased to 100 µg/ml at 
day 3 of the first selection interval. After a 7 days recovery period, a second selection interval with 100 
µg/ml (2 days) and 150 µg/ml for 1 day was conducted, followed by recovery (6 days) and propagation 
of the cell line under continuous application of antibiotics (100 µg/ml). 
 
 
 
 
4.1.2. BAC-transgenic lt-NES cell lines retain their differentiation potential  
Selected BAC-transgenic pools were analyzed for the maintenance of neural stem 
cell characteristics and their differentiation potential. Immunocytochemical analysis 
for the expression of the specific rosette-type neural stem cell markers PLZF, Nestin, 
Dach1, Sox2 as well as apically accentuated ZO-1, a marker typically found in 
rosette-stage neural stem cells, was positive for all lines investigated (Fig. 4.2 a, c 
and e). For analysis of preserved neuronal differentiation potential, growth factors 
were omitted from the culture. Expression of the neuronal markers MAP2ab and β3-
tubulin together with a typical change of the cellular morphology could be observed 
after 4 weeks (Fig. 4.2 b, d and e).  
  
a
b
c
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Figure 4.2: Characterization of BAC transgenic cell lines 
a: Characterization of control and BAC transgenic proliferating lt-NES cells: Phase contrast image 
shows a confluent culture of lt-NES cells, immunocytochemical analysis for nestin, PLZF, Sox2 and 
ZO-1 indicate preserved neural stem cell identity b: Immunocytochemical analysis for β3-tubulin and 
microtubuli-associated protein 2a+b (MAP2ab) demonstrates efficient neurogenic potential of cells. c: 
BAC transgenic lt-NES cells (exemplary shown for RPS27A) demonstrate preserved lt-NES cell 
marker expression and neurogenic potential (d). Scale bar = 10 µm. e: The expression of neural stem 
cell markers and neurogenic potential of BAC transgenic cell lines were confirmed for all lines 
analyzed.  
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4.1.3. Characteristic protein localization is maintained in GFP-tagged proteins 
of BAC-transgenic lt-NES cells  
The cultivation of BAC-transgenic lt-NES pools under continuous application of 
antibiotics together with the tag design of the predominantly used C-terminally fused 
GFP (Fig. 4.1 a) ensures the simultaneous expression of both the tagged protein and 
the resistance gene, while N-terminal tagging (Fig. 4.1 b) may also yield resistant 
non-expressing cells. Proteins involved in cancer, mental retardation or other 
developmental-associated diseases were selected and grouped in proteins involved 
in (I) protein modification/signaling, (II) histone modification and (III) other functions. 
Among group (I) were (a) aurora kinase A (AURKA), a cell cycle-regulated mitotic 
serine/threonine kinase localized to mitotic spindles that is overexpressed in many 
cancers (Xia et al., 2013), (b) the faciogenital dysplasia 1 protein (FGD1), an 
activator of CDC42, a member of the Ras-like family of Rho- and Rac proteins 
involved in Aarskog-Scott syndrome and predominantly detected at microtubules 
(Lebel et al., 2002), (c) the ribosomal protein S27A (RPS27A), a cytoplasmic fusion 
protein of ubiquitin and protein S27A (Kirschner and Stratakis, 2000) and (d) the 
nuclear ubiquitin-like with PHD and ring finger domains 1 (UHRF1) protein, a 
member of a subfamily of RING-finger type E3 ubiquitin ligases, which was reported 
to be overexpressed in diverse forms of human cancer (Sabatino et al., 2012). The 
group of proteins involved in histone modification (II) predominantly localize to the 
nucleus and consisted of (a) cyclin-dependent kinase 2-associated protein 1 
(CDK2AP1), a protein forming a core subunit of the nucleosome remodeling and 
histone deacetylation (NuRD) complex reported to be deleted in oral cancers (Peng 
et al., 2006), (b) the recombination signal binding protein for immunoglobulin kappa J 
region (RBPJ), a transcriptional regulator that is involved in Adams-Oliver syndrome 
3 and recruits chromatin remodeling complexes containing histone deacetylase or 
histone acetylase proteins to Notch signaling pathway genes (Hassed et al., 2012), 
(c) the RuvB-like protein 2 (RUVBL2), a DNA helicase and component of the NuA4 
histone acetyltransferase complex reported to be overexpressed in some tumors 
(Rousseau et al., 2007) and (d) the SET domain containing protein 1B (SETD1B), a 
histone methyltransferase that specifically methylates 'Lys-4' of histone H3 (Lee and 
Skalnik, 2012). Members of the last group of proteins used for the generation of 
BAC-transgenic lt-NES cells (III) comprise (a) the nuclear JUN proto-oncogene 
(JUN), a transcription factor binding to the enhancer heptamer motif 5'-TGA[CG]TCA-
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3', that was reported to induce cell transformation (Hartl et al., 2003), (b) the 
microtubule-associated protein 1 light chain 3 beta (MAP1LC3B), a protein involved 
in microtubule assembly that has been reported to be involved in autophagy-related 
mechanisms (Mikhaylova et al., 2012), (c) the nuclear methyl CpG binding protein 2 
(MECP2), a protein binding to methylated DNA that is associated with for the X-
linked mental retardation of the Rett syndrome (Amir et al., 1999) and (d) the 
proliferating cell nuclear antigen (PCNA), a cofactor of DNA polymerase delta often 
used as diagnostic marker for tumors (Cappello et al., 2006). For assessment of 
naive fluorescence of GFP-fusion proteins and an evaluation of the percentage of 
cells expressing it, flow cytometric analysis (FACS) was performed and revealed 
robust and homogenous expression of GFP-tagged candidate proteins in the majority 
of pools (Figs. 4.3, 4.4 and 4.5; FACS (b; e; h; k)). In order to validate the expression 
of fully intact fusion proteins, expected protein sizes were correlated with signals 
observed in Western immunoblots. To that end, protein sizes were calculated for the 
GFP tag (C-terminal 29, 9 kDa, N-terminal 35 kDa), added to the protein weights 
(Table 4.1) and compared to sizes detected by Western immunoblotting using an 
anti-GFP antibody (Fig. 4.3, 4.4 and 4.5; Western Blot (c; f; i; l)). Proteins of the 
expected size could be detected in most cases (AURKA, CDK2AP1, JUN, MECP2, 
PCNA, RBPJ, RPS27A, RUVBL2, UHRF1) but were close to or beneath the 
detection threshold for SETD1B, MAP1LC3B and FGD1.  
 
Table 4.1: Calculated sizes of GFP fusion proteins and tag position 
	  
	  
	  
Protein	  size	  
(kDa)	  
Tag	  size	  
(kDa)	  
Fusion	  protein	  
(kDa)	   Tag	   Western	  Blot	  
AURKA	   45,8	   29,9	   75,7	   C-­‐terminal	   double	  band	  
CDK2AP1	   12,4	   29,9	   42,3	   C-­‐terminal	   positive	  
FGD1	   106,6	   29,9	   136,5	   C-­‐terminal	   weak	  signal	  
JUN	   35,7	   29,9	   65,6	   C-­‐terminal	   weak	  signal	  
MAP1LC3B	   14,7	   35,0	   49,7	   N-­‐terminal	   weak	  signal	  
MECP2	   52,4	   29,9	   82,3	   C-­‐terminal	   positive	  
PCNA	   28,8	   29,9	   58,7	   C-­‐terminal	   positive	  
RBPJ	   55,6	   29,9	   85,5	   C-­‐terminal	   positive	  
RPS27A	   18,0	   29,9	   47,9	   C-­‐terminal	   positive	  
RUVBL2	   51,2	   29,9	   81,1	   C-­‐terminal	   positive	  
SETD1B	   208,7	   29,9	   238,6	   C-­‐terminal	   no	  signal	  
UHRF1	   89,8	   29,9	   119,7	   C-­‐terminal	   positive	  
The size of proteins (protein size) present on employed BAC constructs is shown for their predominant 
isoform. Dependent on the localization of the GFP tag to the N- or the C-terminus, the linking element 
has a different size (Tag size), resulting in the calculated size of the fusion protein. Ratings of signal 
intensities for protein analyses (Western Blot) are stated. 
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Figure 4.3: Characterization of BAC transgenic cell lines involved in protein modification or 
signaling, group (I) 
Confocal immunofluorescence microscopy: BAC transgenic cell lines (AURKA.GFP (a), 
FGD1.GFP (d), RPS27A.GFP (g) and UHRF1.GFP (j)) were stained with an anti-GFP antibody and 
localization of fluorescent signals was analyzed. Confocal images were reconstructed from a z-stack 
of ≥8 1 µm optical sections. FACS: The percentage of cells expressing naïve-fluorescent GFP-fusion 
proteins was assessed using flow cytometry (b, e, h and k). Western: The size of fusion proteins was 
analyzed by Western immunoblotting (c, f, i and l).  
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Figure 4.4: Analysis of cells harboring GFP-tagged proteins involved in histone modification, 
group (II) 
Confocal immunofluorescence microscopy: Lt-NES cell lines harboring CDK2AP1.GFP (a), 
RBPJ.GFP (d), RUVBL2.GFP (g) and SETD1B.GFP (j) were analyzed for the localization of 
fluorescent signals using an anti-GFP antibody. Confocal images were reconstructed from a z-stack of 
≥8 1 µm optical sections. FACS: The fraction of cells expressing naïve-fluorescent GFP-fusion 
proteins was evaluated using flow cytometric analysis (b, e, h, k). Western: Western immunoblotting 
was used for analysis of fusion protein size (c, f, I and l). 
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Figure 4.5: Characterization of BAC transgenic cell lines, group III 
Confocal immunofluorescence microscopy: Lt-NES cell lines transgenic for BACs encoding 
JUN.GFP (a), MAP1LC3B.GFP (d), MECP2.GFP (g) and PCNA.GFP (j) were analyzed by confocal 
micoscropy using an anti-GFP antibody. Confocal images were reconstructed from a z-stack of ≥8 1 
µm optical sections. FACS: Flow cytometric analysis was used for evaluation of percentage of cells 
expressing a naïve-fluorescent GFP-fusion protein (b, e, h, k). Western: The size of GFP-fusion 
proteins was analyzed by Western immunoblotting (c, f, I and l). 
 
Most importantly, all transgenic cell lines were subjected to confocal fluorescence 
microscopic analysis, and recruitment of GFP-tagged proteins into expected 
subcellular compartments (uniprot.org) could be confirmed for almost all proteins 
(immunofluorescence, Fig. 4.3, 4.4 and 4.5). The only exception was RUVBL2, 
reported to mainly localize to the nucleus (Sigala et al., 2005). However, a scattered 
non-nuclear signal within the corresponding lt-NES cell lines was observed (Fig. 4.4 
g).  
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4.1.4.  BAC transgenesis results in cell lines with low copy number integrations  
To assess the number of integration sites, a set of BAC transgenic lt-NES cell lines 
including Aurora kinase A (AURKA Fig. 4.6 a), the Jun proto-oncogene (JUN, Fig. 4.6 
b) and proliferation-associated cellular nuclear antigen (PCNA, Fig. 4.6 c) was 
subjected to fluorescence in situ hybridization (FISH). To that end, chromosome 
painting probes suitable for the endogenous locus of AURKA (chromosome 20), JUN 
(chromosome 1) and PCNA (chromosome 20) were applied together with 
corresponding FISH probes that were generated using the respective BAC 
(conducted by Dr. Irina Solovei). For quantification, metaphase spreads comprising a 
diploid set of the respective endogenous chromosome were analyzed. Unaltered 
healthy cell populations exhibit two sites in their genome, corresponding to their 
alleles, while e.g. a duplication of an allele or the random integration of a BAC 
construct increases the number of observed signals. Here, an arithmetically 
averaged signal of BAC probes in AURKA.GFP (n=3) and PCNA.GFP cells (n=15) of 
3,0 ± 0,0 loci per cell was observed, while 3,18 ± 0,4 sites in JUN.GFP lt-NES cells 
were detected (Fig. 4.6 d). Previous studies investigating BAC integration 
frequencies reported a repetitive integration of multiple BAC copies per locus 
(Sparwasser and Eberl, 2007). While FISH analysis predominantly is used for 
detection of translocations or amplifications of large chromosomal fragments, 
approaches for the quantitative assessment of FISH signals are established (Iourov 
et al., 2005). Hereby, the signal intensity of known sites can be correlated with that of 
unknown sites. Based on this ratio, the size of the unknown section can be 
estimated. To evaluate the number of copies per site, the signal intensity of each site 
was compared to averaged signal intensities of endogenous sites and resulted in 
similar signal intensities for AURKA.GFP (n=9) and Jun.GFP (n=19) (≥ 75% of 
endogenous sites, about equivalent to a single copy integration) while PCNA.GFP 
(n=16) cells had increased signal intensities (> 187% of endogenous sites, 
corresponding to double or multiple copy integrations), indicating integrations of 
several copies of the construct per locus (Fig. 4.6 e). Notably, in every analyzed line 
a fraction of cells showed decreased signal strengths of the newly introduced loci, 
possibly originating from an incompletely integrated BAC fragment (Fig. 4.6 e). 
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Figure 4.6: Characterization of BAC transgenic cell lines 
Fluorescence in situ hybridization (FISH) analysis using BAC-specific probes was applied to determine 
the number of genomic sites with high analogy after stable integration of the BAC transgene. a: The 
AURKA-targeting probe detects two signals (green) on chromosome 20 (HSA20) harboring the 
endogenous loci of the AURKA gene as well as one further locus on another chromosome (upper 
panel metaphase spread, lower panel prophase analysis). b: The endogenous copies of JUN are 
located on chromosome 1 (HSA1), detectable by the flourescent probe (green) with one additional 
signal on another chromosome. c: The endogenous sites of PCNA, located on chromosome 20 
(HSA20), as well as one additional locus on a different chromosome can be detected by the probe 
(green). d: The column diagram shows the number of detected loci per cell for 3 different lines: 
AURKA.GFP (3,0 ± 0,0; n=3), JUN.GFP (3,18 ± 0,4; n=16) and PCNA.GFP (3,0 ± 0,0; n=15). e: 
Fluorescence signal intensity analysis for additional BAC copies using ImageJ. BAC-transgenic lt-NES 
lines AURKA.GFP and JUN.GFP show an average signal intensity corresponding to one copy/locus 
(0,76 ± 0,28 respectively 0,75 ± 0,51) while PCNA.GFP signals correspond to two copies/locus (1,87 ± 
0,62). Graphs show mean ± SD. FISH images were kindly generated by Dr. Irina Solovei. 	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4.1.5. Proteins expressed by integrated BACs are localized and regulated in 
response to cell cycle and differentiation  
In previous reports, the influence of protein tags and their positional impact by fusion 
to N- or C-terminal sequences was evaluated (Poser et al., 2008; Riesen et al., 
2002). Hereby, functional examinations of tagged proteins were conducted and 
confirmed in most cases that correctly localized proteins were able to fulfill their 
physiological functions.  
In correspondence to these studies, two GFP-tagged candidate proteins were 
chosen and the corresponding lt-NES cell lines investigated. One candidate used 
was the tagged Aurora kinase A (AURKA.GFP). This protein has previously been 
reported to localize to mitotic spindles and centrosomes during mitosis while being 
evenly distributed throughout the cell otherwise (Ding et al., 2011). In AURKA.GFP 
transgenic lt-NES pools, the GFP signal during the long-lasting (30 h) interphases 
was weak and evenly distributed. During metaphase, an increasing intensity could be 
observed, presumably localizing to centrosomes and mitotic spindles, dissolving after 
completion of mitosis (6 h, Fig. 4.7 a). The analysis of the protein size via Western 
immunoblotting failed due to insufficient protein levels present in proliferating 
AURKA.GFP lt-NES cell lines. In order to enrich cells in mitosis, the spindle 
degradation was blocked by application of Taxol, a compound that binds to ß-tubulin 
and thereby inhibits the degradation of the microtubules involved in mitosis (24 h, 0,3 
and 1 µM, Fig. 4.8 b, c). Flow cytometry analysis was used to examine the proportion 
of cells with enriched AURKA.GFP expression compared to controls and revealed 
that a concentration of 1 µM Taxol was sufficient for an increased AURKA.GFP 
expression in comparison to untreated AURKA.GFP cells (Fig. 4.7 b). The 
upregulation of the AURKA.GFP protein level in Taxol-treated cells was also 
reflected in Western immunoblotting analysis and revealed proteins of two distinct 
sizes, consistently with previous observations (Fig. 4.8 c, Seki et al., 2008). 
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Figure 4.7: Analysis of cell cycle dependent expression of AURKA.GFP 
a: Aurora kinase A (AURKA) GFP lt-NES cells show scattered signals for GFP during interphase 
(DAPI/actin/AURKA.GFP) and concentration to subcellular structures during mitosis, presumably 
representing centrosomes and spindle microtubules (arrows). Scale bars = 10 µm. Images were 
recorded in cooperation with Nicolas Berger, MPI-CBG Dresden. b: Following taxol treatment for 24 h, 
(0,3 and 1 µM), flow cytometry analysis demonstrated a significant enrichment of cells with increased 
AURKA.GFP expression (1 µM). Graphs show mean ± SD. c: Western blot analysis for AURKA.GFP 
lt-NES cells under standard proliferation conditions resulted in no detectable signal for the calculated 
size of the fusion protein of AURKA and GFP (76 kDa) while AURKA.GFP was detectable after taxol 
treatment (1 µM, 24 h). Two different sizes of AURKA have been described previously (Seki et al., 
2008).  
 
To address the question whether BAC-mediated expression of proteins is regulated 
analogously to their endogenous equivalents, a protein reported to be exclusively 
expressed in proliferating cells, the proliferating cell nuclear antigen (PCNA), was 
chosen for further analysis (Dietrich, 1993). PCNA.GFP transgenic lt-NES cells were 
differentiated under neuronal induction conditions that give rise to increasing 
numbers of postmitotic neurons in the course of differentiation (Koch et al., 2009). In 
order to observe this process, cells were analyzed before, 7, 14 and 21 days after 
induction of differentiation. With progressing differentiation and concomitant 
emergence of post-mitotic neurons (MAP2ab+), the proportion of PCNA.GFP positive 
cells declined from more than 90% under proliferative conditions to less than 40% 
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three weeks later (Fig. 4.8 a, b). These immunofluorescence-based observations 
were supported by Western immunoblotting analysis, since increasing amounts of 
β3-tubulin, an early cytoskeletal neuron-specific marker, correlated with decreasing 
PCNA.GFP levels (Fig. 4.8 d).  
Although minor differences that could be caused by the GFP tag in binding affinities 
or protein half-life might exist, both exemplary investigations recapitulate 
physiological alterations in expression levels and subcellular localization. 
 
 
Figure 4.8: Analysis of PCNA.GFP regulation during differentiation 
a: A time course (0, 7, 14 and 21 days after initiation of differentiation) of proliferating cell nuclear 
antigen (PCNA) GFP cells reveals an increase of mature neurons (MAP2ab; red), and a decrease of 
PCNA.GFP (green) cells over time. Scale bars = 10 µm. b: A diagram shows the quantity of 
PCNA.GFP and MAP2ab positive cells during a 3-week period. Graphs shown mean ± SD; n=400. c: 
Western immunoblotting analysis for PCNA.GFP and β3-Tubulin shows a decline of PCNA.GFP and 
an increase of early neuronal marker β3-Tubulin over time. Actin was analyzed as loading control. 
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4.1.6. Endogenously expressed GFP-tagged proteins can be used to visualize 
dynamics of protein trafficking in live cell imaging 
For live cell imaging, the AURKA.GFP expressing lt-NES cell line was chosen based 
on its GFP-fusion protein fluorescence intensity and specific GFP localization pattern. 
AURKA is a serine/threonine kinase involved in the regulation of centrosome 
maturation, spindle assembly, centrosome separation and mitotic checkpoint control 
(Ding et al., 2011). In order to discriminate individual cells within lt-NES cell 
populations naturally growing at high densities, a fraction of the cells was labeled 
using a red fluorescent protein (RFP) with a nuclear localization signal. During live 
cell imaging, the recruitment of AURKA.GFP to mitotic spindles and centrosomes 
during mitosis could be visualized (Figure 4.9). 
 
Figure 4.9: Live cell imaging of BAC transgenic lt-NES cell lines 
Life cell imaging of AURKA.GFP lt-NES cells under proliferative conditions. The displayed cell is 
imaged during its mitotic phase, showing AURKA.GFP recruitment to mitotic spindles and 
centrosomes during mitosis (20 min) and its dissociation following cytokinesis (40 and 60 min). Live 
cell microscopy was performed in cooperation with Nicolas Berger, MPI-CBG Dresden. Scale bars = 
10 µm. 
 
This data demonstrates that BAC-mediated expression of a GFP-tagged protein is 
sufficient for live-cell visualization of subcellular localization. 	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4.1.7. Interactors of GFP-tagged proteins expressed by integrated BACs can be 
detected by mass spectrometry 
Protein-protein interaction analyses can be conducted in multiple systems by using a 
variety of techniques. For the discovery of novel interactors possibly associated with 
multiple complexes, co-immunoprecipitation-based methods are employed 
predominantly. Traditionally, quantitative proteomic approaches rely on stable 
isotope labeling by amino acids in cell culture (SILAC) with a subsequent high-
resolution liquid chromatography (LC) tandem MS (LC-MS/MS). Here, the unaltered 
cell line is cultured in medium containing the C12N14 light form of lysine while the 
tagged cell line is cultured in a medium containing the C13N15 heavy form of lysine. 
Subsequently, separate pull-downs are performed, eluates merged, peptides 
identified by LC-MS/MS and quantified by comparison of relative intensities of the 
light and heavy forms of each peptide present in the mass spectrum (Hubner et al., 
2010a). In this work, label-free quantitative interaction proteomics by LC-MS/MS was 
used in conjunction BAC transgenesis (Fig. 4.10 a, Vermeulen et al., 2008). This 
approach avoids the application of heavy amino acids by employing a label-free 
technique where eluates from pull-downs of tagged and control cells were not 
combined but analyzed separately by LC-MS/MS with a subsequent software-based 
quantification of proteins (MaxQuant, label-free algorithm, Cox and Mann, 2008).  
For the analysis of interactors of tagged proteins within lt-NES cells, transgene-free 
and transgenic lt-NES cells (1,5 x 108) were produced. Cell pellets were frozen (-
80°C) as technical triplicates, stored and processed in large batches to avoid 
variations caused by measurements at different days. Quantitative BAC-green 
fluorescent protein interactomics (QUBIC) was performed by Marco Hein, MPI 
Martinsried as described previously (Fig. 4.4 a Hubner et al., 2010a). Data was 
obtained either as statistically processed volcano plots (Fig. 4.10 b) or as pre-filtered 
and normalized raw data (Fig. 4.10 c). Further analysis of raw data was performed by 
using hierarchical clustering with Euclidean distance in the Perseus software to 
exclude concealment of significant interactors by statistical filters used for the 
generation of the volcano plots (Fig. 4.10 c). Previous studies successfully applied 
QUBIC for the analysis of protein-protein interactions and complex composition in 
human cell lines (Hubner et al., 2010a; Smits et al., 2013; Spruijt et al., 2010). Taken 
Results 
 61	  
together, this approach provides a both sensitive and selective technique suitable to 
identify protein interactors with good confidence. 
 
Figure 4.10: Detection of enriched interactors by mass spectrometry 
a: Schematic procedure for stable isotope labeling by amino acids in cell culture (SILAC) opposing to 
label-free quantitative proteomics performed with LC-MS/MS. In SILAC-based quantitative proteomics, 
separate pulldowns are performed and eluates mixed directly after elution by in-column digestion 
whereas eluates in label-free approaches are analyzed separately by LC-MS/MS. SILAC probes are 
quantified by direct comparison of the relative intensities of the light and heavy forms of peptides 
present in the mass spectrum. Proteins in the label-free approach are quantified using the label-free 
algorithm in MaxQuant. Scheme adapted from Hubner et al., 2010. b: In volcano plots, the logarithmic 
ratio of protein intensities is plotted against the negative logarithm of the p-values of the t-test 
performed from triplicates. A hyperbolic curve separates significantly enriched proteins (with a p-value 
of ratio significance <0.03) marked in black (red dotted line) from background (blue dots; green dots 
are linked to ribosomal proteins). c: Heat plot view from technical triplicates of control and 
SETD1B.GFP transgenic lt-NES cells generated with the software Perseus. Known interactors of 
SETD1B that are significantly enriched are magnified.  
a
b cSetD1B
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4.1.8. Comparison of generated protein-protein interaction (PPI) data with 
bioinformatics databases comprising known and predicted PPIs 
demonstrates new and established interactors  
Analysis of protein-protein interaction data has to be performed very carefully, 
especially when accessing latest methods in measurement and data processing. All 
proteins marked as significantly enriched were counter-checked with public protein or 
gene databases (genecards.org, uniprot.org, string-db.org or proteinatlas.org; access 
11/2013) and classified corresponding to findings previously reported. Principally, 
every generated BAC-transgenic lt-NES cell line with markedly detectable signals in 
immunoblots for the introduced tagged protein was used for quantitative BAC-green 
fluorescent protein interactomics (QUBIC) based analysis of interacting proteins. 
However, it was often difficult to interpret these data when few proteins that were 
expected to be interactors were present among significantly enriched proteins. This 
chapter is focused on the detailed description of PPI data generated from GFP 
tagged proteins where proteins usually reported to interact were significantly 
enriched in coprecipitates of the respective transgenic cell lines. For analysis of 
proteomic mapping of interactors, four lt-NES cell lines expressing PCNA.GFP, 
CDK2AP1.GFP, SETD1B.GFP and RUVBL2.GFP were chosen. 
PCNA, a gene highly expressed in proliferating cells, is involved in the control of 
eukaryotic DNA replication by increasing the processibility of DNA polymerase delta 
during elongation of the leading strand. In QUBIC analysis, several significantly 
enriched proteins were detected (Fig. 4.11 a). Amongst them, members of the 
replication factor C (RFC1, RFC2 and RFC4), a heteropentameric AAA+ protein 
clamp loader of PCNA, were enriched (Bowman et al., 2004b; Yao et al., 2003). 
Another interactor previously also detected in a yeast two-hybrid screen was 
p15/PAF1, which has been reported to compete with p21 for binding to PCNA (Chen 
and Scheller, 2001b). The enriched protein DNA (Cytosine-5)-methyltransferase 1 
(DNMT1) is another known interactor of PCNA that maintains the methylation pattern 
in the newly synthesized strand and is essential for epigenetic inheritance (Hervouet 
et al., 2010; Viré et al., 2006). Several proteins with physiological functions that can 
be associated with auxiliary tasks of PCNA (23) were also enriched. Amongst them 
are proteins that may be indirectly linked like the cell division cycle and apoptosis 
regulator 1 (CCAR1) via non-detected cyclin-dependent kinase inhibitor 1A 
(p21/CDKN1A), or large fractions of the p15/PAF1-linked cleavage and 
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polyadenylation specific factor complex (CPSF1, CPSF2, CPSF4 Nagaike et al., 
2011) and the herewith interconnected CSTF2 (Fig. 4.11 a).  
Another bait that allowed the copurification of the majority of the members from its 
complex, the Mi-2/nucleosome remodeling deacetylase (NuRD) complex, was cyclin-
dependent kinase 2 associated protein 1 (CDK2AP1) GFP fusion protein. Elements 
of this complex were previously described as interacting elements of CDK2AP1 using 
BAC transgenesis together with SILAC based quantitative proteomics in HeLa cells 
(Spruijt et al. (2010). This complex is functionally associated with transcriptional 
repression and consists of the chromodomain helicase DNA binding protein 4 
(CHD4/Mi2), the histone deacetylase 2 (HDAC2), the metastasis-associated proteins 
1, 2 and 3 (MTA1, MTA2, MTA3), the GATA zinc finger domain containing 2B 
(GATAD2B), the Methyl-CpG binding domain protein 3 (MBD3) and the 
retinoblastoma-binding protein P46 and P48 (RBAP46, RBAP48) and dissociates in 
active open chromatin loci (Denslow and Wade (2007a). A comparison of interactors 
previously reported with the set of proteins detected in this work revealed, that its 
components all co-purify with the tagged variant of CDK2AP1.GFP (Fig. 4.11 b). 
Furthermore, four additional proteins could be observed: H3.3, a histone variant 
found in nucleosomes of active genes (Tagami et al. (2004a), BCAR1, a kinase 
involved in cell migration (Modzelewska et al., 2006), g22p1, a single stranded DNA-
dependent ATP-dependent helicase (Reeves and Sthoeger, 1989a) and ZNF219, a 
transcriptional repressor (Sakai et al., 2003a). 
Using SETD1B.GFP as bait, the Set1-like multiprotein methyltransferase complex 
(COMPASS complex) could be detected with its components ASH2L, RBBP5, 
SetD1A, DPY30 and CXXC1 (Fig. 4.8 c). In this context, histone H3.3 (H3.3A) was 
co-purified, which is a target of the WD repeat-containing protein 5 (WDR5) involved 
in positioning the N-terminus of histone H3 for efficient trimethylation by the human 
Set1A-B complex (Garapaty et al., 2009). In addition, a large set of candidates with 
functions that are yet unknown in connection with this complex was enriched: 
KIAA0035, Nbla00526, RL6IP4, EPB41L5, ACTL6A, SNRPA, Cgi-25, G22P, RPA12, 
IPI00908469, RPA12, FNBP3, HSP105, FIR and CFR1. 
When analyzing a GFP-tagged variant of the Holliday junction ATP-dependent DNA 
helicase RuvB-like 2 (RUVBL2.GFP) by QUBIC, members of several complexes 
interacting with RUVBL2 were enriched. A total of 23 proteins were detected with 14 
interactors that were already known to interact with RUVBL2. RUVBL2 acts as a 
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subunit or catalytic unit in the multisubunit ATP-dependent chromatin remodeling 
complex INO80, the nutrient sensing complex URI/Prefoldin, the chromatin 
remodeling complex SRCAP and the NuA4 histone acetyltransferase complex 
(Conaway and Conaway, 2009a; Doyon et al., 2004b; Sardiu et al., 2008a; Wong et 
al., 2007). In QUBIC measurements, representatives from all complexes could be 
detected: From the INO80 complex, the members INO80H/RuvB-like 1, 
INO80C/C18orf37, INO80N/ACTR8, INO80A/INO80, ACTR5 and 
INO80K/ACTL6A/BAF53 were detected. As members of the SRCAP complex, 
RUVBL1, INO80K/ACTL6A/BAF53 and DMAP1 were found. Copurified members of 
the NuA4 complex were RUVBL1, EP400/CAGH32, TRRAP/PAF400, DMAP1, 
EPC2, SRCAP/KIAA0309 and INO80K/ACTL6A/BAF53. Of the URI complex, 
PFDN2, URI and RuvBl1 were enriched. The generated data confirmed a previous 
report that described the association of PDRG1 with RUVBL2 but could not assign a 
biological role to their interaction (Jeronimo et al., 2007a). Furthermore, 9 novel 
candidate interactors RPN1, RPN2, NEF3, HZGJ, FNDP3, CAS, CKAP4, G22P1 and 
FIP1 were enriched significantly.  
All detected interactors of the three proteins involved in gene regulation – SETD1B 
as a histone methyltransferase, CDK2AP1 as member of the gene regulating NuRD 
complex (Denslow and Wade, 2007a) and RUVBL2 as member of the Nu4A histone 
acetyltransferase complex – were clustered using Cytoscape (Fig. 4.12). The only 
common interactor of all three proteins was XRCC6, a single stranded DNA-
dependent ATP dependent helicase. RUVBL2 and SETD1B are linked via CSE1L 
and CSTF3, while CDK2AP1 and SETD1B are linked via SPATS2, CORO1C and 
H3F3A, and RUVBL2 and SETD1B are linked via PRPF40A. 
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Figure 4.11: Analysis of mass spectrometry data 
Proteins shown in these illustrations were all detected as significantly enriched. a: PCNA.GFP used as 
bait copurified together with established interaction partners DNMT1, P15, RFC1, RFC2, RFC5 and 23 
novel candidates. b: CDK2AP1.GFP as part of the NuRD complex copurified together with the majority 
of its members including MI-2, HDAC2, RBAP46, RBAP48 MBD3, GATAD2B, MTA1, MTA2, MTA3 
and the three candidates H3.3A, BCAR1 and G22P1. c: SETD1B as part of the COMPASS complex 
copurified with its members H3.3A, SETD1A, ASH2L, CXXC1, DPY30 and RBBP5 as well as 15 
candidate interactors. d: RUVBL2 is a member of multiple complexes, resulting in enrichment of 
representatives from all of them: The NuA4-, the SRCAP-, the INO80- and URI complex together 
encompass EP400, TRRAP, DMAP1, SRCAP BAF53, ACTR5, INO80C, INO80N, INO80A, URI, 
PFDN2 and RUVBL1. Further proteins copurified with RUVBL2 were the previously reported 
interactors EPC2 and PDRG1 as well as 9 candidates.  
 
PCNA.GFPa CDK2AP1.GFPb
c SETD1B.GFP d RUVBL2.GFP
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Figure 4.12: Network view of enriched interactors 
Cytoscape network view for interactors of RUVBL2 (left), CDK2AP1 (up) and SETD1B (right). 
Common interactors are illustrated in red, interactors in green and baits are displayed blue. RUVBL2 
and SETD1B are linked via CSE1L and CSTF3, CDK2AP1 and SETD1B are linked via SPATS2, 
CORO1C and H3F3A, RUVBL2 and SETD1B are linked via PRPF40A while XRCC6, a single 
stranded DNA-dependent ATP dependent helicase, was observed as a common interactor of all three 
proteins. 
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4.1.9. The composition of protein complexes is dependent on cellular fate  
The observation that protein complexes are highly dynamic systems with the ability to 
change their protein composition dependent on cell cycle, cell fate decisions and 
environmental influences, increasingly challenges the classical model of defined core 
complexes (Colucci-D’amato et al., 2011; Havugimana et al., 2012). To investigate 
differentiation-associated differences in complex composition, BAC transgenic lt-NES 
cells were differentiated for 4 weeks before cells were harvested and analyzed by 
QUBIC. In order to detect differences in complex composition, cell lines harboring 
tagged proteins that maintained expression in postmitotic neurons were chosen. A 
comparison of each BAC-transgenic lt-NES cell line in its proliferative and 
differentiated state revealed variations of interactors caused by the differentiation 
process.  
CDK2AP1 as part of the nucleosome remodeling and histone deacetylation (NuRD) 
complex presumably contributes to epigenetic regulation during differentiation (Spruijt 
et al., 2010). In BAC-transgenic CDK2AP1.GFP+ neuronal cell populations, 
significant differences in the composition of the NuRD complex were observed when 
compared to CDK2AP1.GFP+ lt-NES cells: While the H3.3A variant of histone 3, 
discovered only at active genomic loci and both retinoblastoma-binding proteins P46 
and P48 and involved in histone acetylation and deacetylation, were significantly 
enriched in lt-NES cells, they were not detectable in postmitotic cell copurifications 
(Chow et al., 2005). Furthermore, GATAD2A, a transcriptional repressor, and 
HDAC1, a histone deacetylase, both copurified with CDK2AP1 only in differentiated 
cultures (Fig. 4.13 a).  
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Figure 4.13: Differentiation-dependent variations in protein interactor levels of CDK2AP1 
Illustrated proteins were all annotated as significantly enriched in respective QUBIC analyses.  
a: In contrast to CDK2AP1 transgenic lt-NES cells, b: H3.3A, RBAP46 and RBAP48 were not 
detectable in neuronal cells while HDAC1 and GATAD2A were enriched. 
In SETD1B transgenic lt-NES cells, the majority of the reported members of the 
COMPASS complex were present including RBBP5, H3.3A, ASH2L, CXXC1, DPY-
30 and SETD1A. SETD1B is a component of the SET1 histone methyltransferase 
complex, specifically methylating 'Lys-4' of histone H3 under the prerequisite that the 
neighboring 'Lys-9' is not already methylated (Fig. 4.14 a). This targeted methylation 
represents a specific tag for epigenetic transcriptional activation (Lee et al., 2007). 
Following differentiation of lt-NES cells, three components of the COMPASS complex 
could not be copurified in differentiated SETD1B.GFP cells: DPY-30, a core 
component of several methyltransferase-containing complexes (Wang et al., 2009b), 
the active variant of Histone H3 (H3.3A; Chow et al 2005) and SETD1A, a Set1/Ash2 
histone methyltransferase complex subunit (Fig. 4.14 b). SETD1A recognizes a 
a
b
proliferating lt-NES cells
postmitotic neurons
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different set of target sequences than SETD1B and contributes in a non-redundant 
manner to the epigenetic control of chromatin structure and gene expression (Lee et 
al., 2007). 
 
Figure 4.14: Differentiation-dependent variations in protein interactor levels of SETD1B 
Illustrated proteins were all annotated as significantly enriched in respective QUBIC analyses.  
a: SETD1B complex composition of lt-NES cells. b: In SETD1B.GFP transgenic differentiated cells, 
SETD1A, H3.3A and DPY30 of the COMPASS complex were not detectable. 
The analysis of RUVBL2 interactors in both conditions (Fig. 4.15 a, b) showed a 
massive rearrangement of interactors. Here, EPC2 (enhancer of polycomb homolog 
2) was bound by RUVBL2 exclusively in proliferating lt-NES cultures. Along with the 
dissociation of the nuclear precursor complex core component BAF53 (53 kDa 
BRG1-associated factor A) in neurons, which facilitates transcriptional activation of 
specific genes by antagonizing chromatin-mediated transcriptional repression, 
several members of all major complexes could not be detected by QUBIC in 
differentiated neuronal cultures. These included TRRAP, an adaptor protein of the 
histone acetyltransferase (HAT) complexes from the NuA4 complex (Cai et al., 
2003), PFDN2 (Prefoldin subunit 2) from the URI complex, INO80 and 
INO80N/ACTR8 (Actin-related protein 8) from the INO80 complex and ACTR5 (Actin-
related protein 5) from the SRCAP (Snf2-related CBP activator) complex. This shift in 
composition was accompanied by the recruitment of INO80D, a member of the 
INO80 complex and ACTL6B/BAF53B (BRG1-associated factor 53B), a core 
component of the neuron-specific chromatin remodeling complex nBAF, which is 
required for postmitotic neuronal development and dendritic outgrowth (Yoo et al., 
2011b). Together, these data indicate that the differentiation state of the cell type 
deployed for QUBIC notably influenced the composition of the protein complexes.  
a b
proliferating lt-NES cells postmitotic neurons
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Figure 4.15: Differentiation-dependent variations in protein interactor levels of RUVBL2 
Illustrated proteins were all annotated as significantly enriched in respective QUBIC analyses.  
a: In RUVBL2.GFP transgenic lt-NES cells representatives of the SRCAP-, the NuA4-, the INO- and 
the URI complex were detected. b: In differentiated cells, several of these proteins were absent, 
including TRRAP of the Nu4A complex, ACTR5 of the SRCAP complex, INO80N, INO80A and 
INO80K of the INO80 complex and PFDN2 of the URI complex. In RUVBL2.GFP neurons, a member 
of the neuron-specific nBAF complex, ACTL6B was enriched. Both candidates linked with TRRAP 
complexes, ribophorin I/III (RPN1/2), were absent in neuronal cultures.	  
a
b
proliferating lt-NES cells
postmitotic neurons
Results 
 71	  
4.2. Translation of BAC transgenesis to iPSC-derived lt-NES cells  
Protein-protein interaction data generated in ES cell-derived neural stem cells and 
their neuronal progeny can help to characterize a variety of cellular processes 
including aspects of metabolism, signaling and differentiation. In order to analyze 
influences of specific mutations on binding affinities, mutated bait proteins could be 
used. While these approaches are likely to raise essential data and may lead to a 
more comprehensive understanding of the concept of diseases, multifactorial 
disorders or diseases with spontaneous onset remain difficult to study. In order to 
investigate differences in protein binding affinities in complex diseases or in diseases 
with unknown genetical cause, QUBIC analysis has to be transferred into a relevant 
cell population derived from affected individuals. Therefore, data should be 
generated in cell populations derived from patients with clinical manifestation of 
respective diseases, providing not only one aberrant protein isoform but the whole 
complex proteomic environment leading to the clinical picture. To explore this 
approach, induced pluripotent stem (iPS) cells from patients and healthy controls 
were generated, differentiated to lt-NES cells, and protocols adapted to permit the 
generation of stable BAC transgenic donor-specific cell lines that were subsequently 
used for QUBIC analysis. 
 
4.2.1. Generation and validation of iPSCs 
To generate human iPSC lines from adult dermal fibroblasts, cells were transduced 
with the non-integrating Sendai virus particles for the transient expression of the 
transcription factors KLF4, c-Myc, Oct3/4 and Sox2 (Fig. 4.16 a). Seven days 
following transduction and cultivation in iPSC medium containg 20% serum 
replacement and bFGF, transduced fibroblasts were transferred to a layer of 
irradiated murine fibroblasts and cultured in iPS medium until clonal growth of arising 
colonies was observed (between week 3 and 4 after transduction). By mechanical 
isolation of single iPSC colonies, clonal cell lines were generated that showed a 
clear-zoned colony-shaped growth (Fig. 4.16 b) and were positive for the 
pluripotency markers Tra 1-60, Tra 1-81 and SSEA4 and negative for the viral 
hemagglutinin-neuraminidase protein (HN, Kajiwara et al., 2012), indicating the 
absence of active virus (Fig. 4.16 c). In order to select iPSC lines that had not 
acquired overt chromosomal aberrations during the process of reprogramming, each 
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line was tested by genome-spanning single nucleotide-polymorphism (SNP) analysis 
(Fig. 4.16 d Mayshar et al., 2010). From 23 analyzed lines, 2 lines acquired 
duplications on chromosome 14 while no further abnormalities could be observed 
using standard settings of the CNV partition plugin v3.2.0 that highlights 
chromosomal copy number changes of regions ≥ 1 Mb containing ≥ 50 continuous 
SNP probes (Fig. 4.16 e). Using this method, a sufficient number of lines could be 
generated from each individual, resulting in one or more intact, fully functional iPS 
cell line.  
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Figure 4.16: Generation and quality control of induced pluripotent stem cells 
a: Schematic illustration of experimental workflow for the generation of human induced pluripotent 
stem cells (iPSCs). Healthy control and patient-derived fibroblasts were transduced with Sendai virus 
coding for c-Myc, Oct3/4, Sox2 and Klf4 and cultivated for 3 weeks until colonies formed. Colonies 
were isolated mechanically, propagated for 3 weeks and validated. b: Phase contrast image of iPSC 
colony before mechanical isolation. Scale bar = 200 µm. c:	   Immunocytochemical analysis for viral HN 
protein (red) of iPSC clones with silenced (left) and maintained (right) viral HN expression (discarded 
clone). Scale bar = 100 µm. d: Immunocytochemical analysis for pluripotency-associated proteins Tra 
1-60, Tra 1-81 and SSEA4. Scale bar = 150 µm. e: Representative genome-spanning single 
nucleotide polymorphism analysis of a iPSC line with no detectable abnormalities. f: Exemplary 
chromosomal aberration on chromosome 14 (shown lines 4247 #8 (normal), 4247 #2 (altered)). 
Results 
 74	  
4.2.2. Derivation of stable lt-NES cell lines from integration-free iPSCs  
The stable and reproducible generation of well-defined neural stem cells and 
neuronal cultures from different hESC and iPSC lines is an important prerequisite for 
the reproducibility and comparability of quantitative PPI analysis. Commonly applied 
‘run-through’ protocols, where hPSCs are directly differentiated into mature neuronal 
cultures often suffer from non-neural cell contaminants due to incomplete 
differentiation, varying neurogenic potential of different hPSC lines and batch-to-
batch variations, which are inherent to lengthy differentiation protocols (Kim et al., 
2011). Lt-NES cells represent a stable intermediate multipotent stem cell population 
between pluripotent stem cells and differentiated neuronal cultures. Once 
established, lt-NES cells can self-renew as a homogenous population across many 
passages, stably give rise to mature cultures of postmitotic human neurons and are 
readily accessible to genetic modification. In fact, lt-NES cells can be propagated for 
more than 60 passages while maintaining doubling times and avoiding senescence 
(Falk et al., 2012). In order to generate lt-NES cells, human ES- or iPS cells were 
detached, differentiated as free floating embryoid bodies (EBs) and allowed to 
differentiate for 5 days (Fig. 4.17 a). Following plating, neural tube-like structures 
emerged (Fig. 4.17 b), which were mechanically isolated, grown as neurospheres for 
7 days (Fig. 4.17 c), dissociated and further cultured as a homogenous lt-NES cell 
line in the presence of FGF2, EGF and B27 (Fig. 4.17 d).  
 
Figure 4.17: Generation of long-term neuroepithelial like stem cells (lt-NES cells)  
a: Schematic illustration of the lt-NES generation workflow. iPS/ES colonies cultured on fibroblasts 
were dissociated by collagenase treatment, cultured as free-floating embryoid bodies (EB) for 5 days, 
plated on PO/L TC dishes and differentiated for 10 days in N2 medium containing FGF2. Neural tube-
like structures were mechanically isolated, expanded as free-floating aggregates until neurospheres 
emerged after 3 days, which were then triturated to single cells serving as starting population for lt-
NES cell cultures. b: Neural tube-like structures in plated EBs. c: Floating neurosphere. Scale bar = 
100 µm. d: Phase contrast image of established lt-NES cells. Scale bar = 25 µm. 
b
a
c
100 µm
d
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Human iPS-derived lt-NES cells grow as a homogenous population expressing 
PLZF, Sox2 and DACH1 in the nucleus, nestin as an intermediate filament and ZO1, 
a tight junction protein typically found in an apical location in the center of the rosette 
structures (Fig. 4.18, Koch et al., 2009). Analogous to hESC-derived lt-NES cells, this 
cell population can be cultured in the presence of growth factors for >60 passages as 
stable stem cell population and, upon growth factor withdrawal, differentiates to major 
fractions of β3-tubulin- and MAP2ab- positive postmitotic neurons and a minor 
fraction of glial fibrillary acidic protein (GFAP)-positive astrocytes (Fig. 4.18 a, c).  
 
Figure 4.18: Characterization of proliferative and differentiated lt-NES cells 
a: Schematic illustration of differentiation timeline. Differentiation was induced by withdrawal of growth 
factors. 4 weeks of differentiation generated immature neurons, which could be matured for more than 
10 additional weeks. b: Phase contrast image and immunoflourescent images for DAPI (blue), nestin 
(white), DACH1 (red), PLZF (red), Sox2 (red) and ZO1 (white) of lt-NES cell line 4247#8.  
c: Neuronal cultures after 4 weeks of differentiation were stained for neuronal markers β3-tubulin, 
MAP2ab and the astrocytic marker GFAP. Scale bars = 50 µm. 	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4.2.3. The interactome of human iPS-derived lt-NES cells is similar to hES-
derived lt-NES cells 
To validate the amenability of iPS cell-derived lt-NES cells for PPI studies, protocols 
for transfection and enrichment were adapted using the BAC harboring PCNA.GFP. 
For generation of transgenic cell lines, transfection protocols were adopted but G418 
concentrations were generally reduced by 50%. A complete validation of lt-NES-
specific marker expression for iPS cell-derived lt-NES cells showed no significant 
difference while PCNA.GFP signal distribution (Fig. 4.19 a) and FACS analysis 
revealed similarly high transgene incorporation (Fig. 4.19 b). QUBIC analysis 
resulted in an analogous pattern of known interaction partners as detected in ES-cell 
derived cells but generally showed an increase of more significantly enriched 
interaction candidates (46 versus 28, data not shown; Fig. 4.19 c). The results 
demonstrate that the established technique of BAC-mediated protein expression can 
be applied to iPS-derived lt-NES cells and will should thus allow further studies of 
protein-protein interactions in neural and neuronal cell populations from patients e.g. 
with neurological diseases. 
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Figure 4.19: BAC-based protein-protein interaction analysis in iPSC-derived lt-NES cells 
a: PCNA.GFP-BAC transgenic iPS-derived (control#8) lt-NES cells. GFP (green), DAPI (blue). Scale 
bar = 10 µm. b: FACS analysis of PCNA.GFP-BAC transgenic iPS-derived lt-NES cells (green) 
opposed to non-transgenic lt-NES cells (grey). c: QUBIC analysis of PCNA interactors in iPSC-derived 
lt-NES cells. The heat plot shows enrichment of multiple proteins in both iPSC and ESC-derived lt-
NES cells positive for PCNA.GFP. Both populations show enrichment for RFC1, RFC2, RFC3, RFC4, 
PAF15 and DNMT1, key components of the PCNA complex. Heat plot rendering using the software 
Perseus. 	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4.3. Evaluation of Adeno-associated virus (AAV)-mediated gene targeting 
as tool for the integration of epitope tags into endogenous genes 
Although BAC-mediated protein expression is well suitable for most - if not all - 
proteins, the size of a GFP protein as tag together with the probability of a slight 
overexpression due to the additional copy caused by the integrated BAC might be 
insufficient for some studies. Therefore, it would be preferable for some applications 
to perform an epitope tagging of endogenous genes rather than inserting an 
additional copy (Kim et al., 2008). To explore the feasibility of such an approach, 
recombinant AAV particles were generated to introduce a FLAG tag to the N-
terminus of Ataxin-3 (rAAV-Atxn3N), a deubiquitinating enzyme that causes an 
aggregation of its C-terminal fragments in patients with Machado-Joseph disease 
(MJD) when containing pathologically enriched numbers of CAG repeats. 
Subsequently, a N-FLAG-Atxn3 tagged lt-NES cell line derived from a patient with 
MJD was generated in a proof-of-principle study. 
 
4.3.1. AAV-mediated gene targeting permits the labelling of endogenous 
proteins by introduction of epitope tags 
AAV-based targeting systems rely on the modification of the viral targeting 
sequences that usually mediate the integration of the provirus sequence to the 
AAVS1 locus on chromosome 19 (Deyle and Russell, 2009; Kohli et al., 2004). For 
the design of targeting constructs, the following requirements have to be met: The 
composition of the target region has to contain less than 50% of interspersed repeats 
and low complexity DNA sequences, encompass at least one exon for modification 
and comprise at least 2 kb. This region is then divided into two 1 kb segments, while 
the central sequence always has to be a region in between processed exons. A 
synthetic exon promoter trap cassette (SEPT) is placed between these elements to 
facilitate enrichment of correctly targeted cells by application of antibiotics (Fig. 4.20 
a). However, an inserted SEPT cassette prevents the complete transcription of the 
targeted gene (Kim et al., 2008). In order to eliminate the SEPT cassette, it can be 
flanked by loxP sites to enable its excision by Cre expression. Here, Cre was 
transiently expressed by transfection of transgenic lt-NES cells with synthetic 
modified mRNA to prevent further genomic alteration of the targeted cells. By this 
method, the expression of an epitope-tagged endogenous protein can be achieved. 
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Figure 4.20: Design and experimental procedure of AAV-mediated gene targeting 
a: The construct for AAV-mediated gene targeting consists of two homology arms (≥ 1000 bp) and the 
exon containing the FLAG tag. A synthetic exon promoter trap (SEPT) flanked by loxP Cre 
recombination sites is located between both homology arms. b: Five days after transduction of cells, 
G418 (0,2 - 0,5 µg / ml G418, 168 h) was applied to select for transgenic cells. Cell pools were 
expanded and transfected with synthetic modified Cre recombinase mRNA in order to…. 
 
4.3.2. Epitope-tagged endogenous proteins can be used to determine their 
localization pattern and size  
Using engineered AAV particles, a precise manipulation of a distinct locus of the 
genome was conducted to introduce a FLAG tag directly before the initiating 
methionine, resulting in N-terminally tagged Atxn3 protein variants. Lt-NES cells 
derived from patients suffering from Machado-Josephs disease were transduced and 
enriched using antibiotics (0,2 – 0,5 µg / ml G418, 168h). From a pool of 2x106 cells, 
approximately 5 - 30 resistant colonies emerged, which was reported to be 
dependent on the quality of the flanking strand (Vasileva and Jessberger, 2005).  
 
a
b
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The disease-associated isoform of Ataxin-3 contains an increased number of CAG 
repeats that are causative for disease development (Rüb et al., 2013). In MJD 
patients, usually both the normal ATXN3 (42 kDa) and an expanded ATXN3 (58 kDa, 
Koch et al., 2011) can be found and therefore easily be distinguished by their sizes. 
Successful targeting was analyzed after Cre-mediated excision of the SEPT cassette 
by Western immunoblotting, resulting in two FLAG-positive proteins of 42 kDa and 58 
kDa (Fig. 4.21 a). The observed protein sizes correspond to the calculated protein 
sizes of FLAG-tagged Atxn3 proteins that are either pathologically elongated (58 
kDa) or unaltered (42 kDa). In immunohistochemical analyses using an antibody 
directed against the FLAG epitope tag, fluorescent signals in targeted MJD lt-NES 
cells were observed (Fig. 4.21 b). 
 
Figure 4.21: AAV-mediated gene targeting in lt-NES cells derived from MJD patients 
a: A Western immunoblot using FLAG antibody shows two protein variants corresponding to the sizes 
of non-elongated Atxn-3 and extended poly glutamine Atxn-3, indicating a modification of both alleles 
present in these cells by introduction of a FLAG tag. b: Immunocytochemical analysis of Atxn3-
targeted lt-NES cells shows the expression of FLAG tag positive proteins in targeted cells. Scale bars 
= 50 µm.	  
 
These results demonstrate, that, in principle, the technique of AAV-mediated epitope 
tagging can be applied to lt-NES cells to generate somatic cell populations with 
endogenously tagged proteins. The observation that both, the disease and the 
healthy allele of Atxn3 in lt-NES cells derived from a patient suffering from Machado-
Joseph disease were successfully targeted using an AAV-based approach, might 
enable AAV-based gene correction approaches. 	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5. Discussion 
5.1. Suitability of different cellular systems for the analysis of protein-protein 
interactions 
The high degree of standardization required for reliable protein-protein interaction 
(PPI) studies deterred scientists for decades from using primary cells obtained from 
multiple tissue donors in their studies. Instead, naturally occurring immortal cells, 
derived from various isolated tumors, were employed and provided an identical 
genetic background particularly suitable for repeatable scientific experiments (HeLa, 
293, Scherer et al., 1953; Schneider et al., 1977). The growing demand for cells 
derived from a specific tissue or certain cellular subtypes resulted in the 
establishment of many immortalized cell lines using a variety of molecular biological 
techniques including random mutagenesis, introduction of viral genes, the expression 
of cell cycle manipulating proteins or the cellular fusion with other tumor-derived cells 
(Cohen et al., 2007; Graham et al., 1977; Milstein, 1999; Varma and Leavitt, 1988). 
Most PPI studies rely on the utilization of tagged genes for the analysis of their 
interaction partners. Immortal cell lines usually represent a genetically readily 
accessible resource that allows the quick establishment of clonal cell lines. The 
majority of present findings concerning cell signaling cascades, protein complex 
composition, the spatial distribution of proteins in subcellular compartments and the 
detection of targets for pharmaceutical intervention in cellular processes were 
obtained using immortalized cells. However, their application has some significant 
drawbacks: Most protocols for the generation of transgenic cell lines are highly 
adapted to “classic” lines like HeLa or 293 cells and allure scientists to conduct their 
studies using a set of prefabricated protocols and biological materials, saving time by 
avoiding an elaborate establishment of adapted protocols. Data generated in this 
context is rarely tissue specific and in some cases could lead to false-positive results 
as introduced bait-proteins can interact with proteins their physiological environment 
normally would prevent them from or to false-negative results when potential 
interaction partners are absent. For example, if a neuron-specific protein is 
exogenously expressed in the ovarial carcinoma cell line HeLa, it may interact with 
proliferation-associated proteins that naturally are nonexistent in postmitotic cells. In 
many cases, cell lines of tissues corresponding to the physiological setting of the bait 
protein exist and would enable tissue specific analyses.  
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The high degree of standardization of cultivation techniques enabled the distribution 
of these cell lines to different laboratories as well as the independent investigation 
and validation of specific findings, facilitating a detailed characterization of employed 
lines. However, tissue-specific cell lines are rarely used for PPI analyses as common 
lines as e.g. HeLa or 293T are widely spread, backed by a rich collection of adapted 
protocols and exhibit a broad protein expression pattern suitable for most problems 
(Havugimana et al., 2012; Trinkle-Mulcahy et al., 2008). In addition, cell lines have 
acquired significant mutations to become immortal: Immortalization alters the biology 
of the cell substantially and leads to dysregulation of proteins associated with cell 
cycle regulation and its associated metabolism. To overcome issues associated with 
immortal cell lines or tissue specificity, experiments are also conducted in animals – 
in most cases serving as subsequent validation steps. Here, the function of certain 
proteins can be assessed directly in the tissue of interest e.g. by the generation of 
genetically engineered animals or the cultivation of specific cell populations of certain 
tissues derived from these animals for a limited period of time. While the 
interpretation of data raised in mice provides impeccable information concerning 
murine proteins, data generated from investigations of human proteins in such an 
environment should be treated with caution: Despite conservation of most functional 
domains and high similarities between murine and human proteins, a difference of 
one single amino acid can lead to entirely different structures with altered interaction 
partners or a complete incapacitation of relevant protein binding sites (Anfinsen, 
1973). When aiming for most authentic PPI data possible, non-transformed human 
cells of matching tissue represent the ideal candidates. While primary cells have the 
advantage to resemble the tissue of interest closely, they lack the capacity for self-
renewal or enter senescence after about 15 passages – a circumstance that requires 
a permanent replenishment of primary cells from varying sources with naturally 
occurring batch-to-batch variations (Golemis, 2005). Furthermore, the high variability 
of transfection efficiencies for different primary cells poses major obstacles for the 
introduction of expression constructs. While numerous methods for transfection, e.g. 
like different electroporation protocols, liposome-based transfection methods or 
CaPO4-based complexes, were developed, few of them are comparable to 
transfection efficiencies of common cell lines. When aiming for the generation of 
primary cells with stable transgene integration, retroviral-based methods have to be 
used. As primary cultures consist primarily of postmitotic cells, only lentivirus-based 
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vectors are suitable for their transduction (Blömer et al., 1997; Graham and van der 
Eb, 1973).  
 
Pluripotent stem cell-derived cell populations exhibit proteomic environments 
closely related to somatic cell populations  
The cellular system, in which PPI studies are conducted, strongly influences the 
proteins enriched for the respective bait (Aebersold and Mann, 2003). This 
phenomenon is attributable to a multitude of factors, acting directly on binding 
characteristics: The proteome of a cell is subject to change during progression of the 
cell cycle and can vary in response to extrinsic stimuli or developmental clues, 
inducing an up- or down regulation of certain protein levels. Additionally, the degree 
of differentiation of generated cell populations as well as cell fate decisions are able 
to induce or deplete the existence of large sets of cell type specific proteins, either 
allowing or preventing interactions with the bait. For in-depth analysis of tissue-
specific protein complex compositions or effects of disease-induced changes, such 
studies ideally should be conducted in the cell type relevant for the effect to be 
examined. Moreover, investigations aimed at the characterization of disease-linked 
alterations of protein binding patterns would be desirable in cells affected by the 
disease of interest. In this context, pluripotent stem cells provide an intriguing 
platform that can be used to generate any desired cell type, provided a tailored 
differentiation protocol is available. 
 
Lt-NES cells and their neuronal progeny as a CNS-model for PPI analyses 
Due to the limited availability of standardized and defined primary tissue from healthy 
or diseased individuals and its restricted accessibility to genetic manipulation, most 
PPI studies up to now were conducted in transformed or tumor cell lines derived from 
a subset of tissues. This problem is even more relevant for primary human brain 
tissue, consisting of a multitude of cell types, delicate to separate, manipulate and 
even harder to standardize. Therefore, cultures of human neurons generated from 
hPS cells provide a promising alternative for the study of PPIs in the relevant cell 
type. One important prerequisite for harnessing human stem cell-derived neuronal 
cultures for PPIs is the stable and efficient production of highly enriched neuronal 
cultures. In commonly applied run-through protocols, hPS cells are directly 
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differentiated into neuronal cultures, yet often contain cell contaminants and 
significant batch-to-batch variations. Pluripotent stem cell-derived long-term self-
renewing neuroepithelial stem cells (lt-NES cells) are a stable and robust cell 
population, which enable the fast generation of authentic human neurons. 
Furthermore, this population features continuous expandability, a stable neuronal 
and glial differentiation competence, a characteristic transcription factor profile, a 
regional identity resembling an anterior ventral hindbrain specification amenable to 
regional patterning as well as the capacity to generate functionally mature neurons 
(Falk et al., 2012). In the course of this study, hES- and iPS cell-derived lt-NES cells 
were used as a starting population for genetic manipulation, yielding highly enriched 
neuronal cultures within four weeks of differentiation in both manipulated and wild 
type condition. Without application of patterning cues, the default neuronal subtypes 
generated using this approach are GABAergic interneurons (Koch et al., 2009). By 
application of developmental cues in form of growth factors like RA/FGF2/EGF/SHH 
or SHH/FGF8/AA, different neuronal subtypes including motoneurons of ventral 
spinal cord or tyrosine hydroxylase positive neurons with ventral midbrain identity, 
respectively, can be generated. The preserved regional plasticity of lt-NES cell 
populations therefore allows for a subtype-specific evaluation of PPI differences 
(Elkabetz and Studer, 2008). Recapitulating, present protocols for lt-NES- and 
neuronal cell derivation represent a reliable method for the reproducible generation of 
highly enriched cultures of human neuronal precursors and mature neurons that 
should be suitable for standardized mass spectrometric PPI analysis. Furthermore, 
the option to generate diverse neuronal subtypes enables specific investigations in 
affected neuronal subpopulations for various diseases. 
5.2. Overexpression versus BAC-mediated expression of tagged proteins 
Cells have to tightly regulate their proteins in response to cell cycle-dependent, 
metabolic, environmental or developmental influences to fulfill their physiological role 
within the tissue. In this work, it was a key prerequisite to introduce tagged proteins 
and analyze their binding behavior by mass spectrometry in a manner as close to the 
endogenous situation as possible while retaining the capacity to perform this task in a 
streamlined and timely efficient manner. The introduction of a tagged protein into a 
cell can be accomplished by a large variety of techniques with individual benefits and 
drawbacks. While most highly efficient transgenic strategies rely on the introduction 
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of a cDNA under control of a strong and small promoter (e.g. CMV), the main 
mechanisms of endogenous regulation or processing are prevented. A site-specific 
manipulation by targeted introduction of gene modifications via homologous 
recombination meets these criteria but used to be highly inefficient until genome-
editing techniques like the TALEN or CRISPR/Cas9 platforms were developed (Fu et 
al., 2013; Miller et al., 2011). An alternative to site-specific genome editing is the 
application of bacterial artificial chromosome (BAC)-based expression vectors. These 
constructs are expected to contain most, if not all, regulatory elements and all intronic 
and exonic elements. Applying these large constructs, stable cell lines can be 
generated and were successfully used in numerous studies (Hubner et al., 2010a; 
Placantonakis et al., 2009; Poser et al., 2008; Spruijt et al., 2010). The evaluation of 
the best strategy for BAC transgenesis in lt-NES cells for more than 30 constructs 
was enabled by the availability of a vast library of tagged genes present on BACs 
generated within the framework of the DiGtoP consortium (a NGFN funded network). 
N-terminal tagged forms contain a GFP fused to the first exon with an artificial intron 
containing a PGK driven neomycin resistance gene (neoR) while C-terminal tagged 
forms exhibit a tag fused to the last exon followed by an IRES-linked neoR. The 
generated transgenic lt-NES cell lines were investigated for protein localization by 
confocal microscopy, the proportion of cells comprising naïve fluorescent GFP-fusion 
proteins by flow-cytometry, alternative protein spliceforms by western immunoblotting 
and exemplary functional assays for the evaluation of protein regulation. Correct 
protein localization is one of the most important aspects when investigating PPIs as 
the spatial organization of proteins within a cell – and especially in neurons – 
substantially influences the classes of possible protein interaction partners. 
Trafficking elements on mRNA level or on protein precursors can influence protein 
levels in confined compartments of the cell more than the transcriptional control of 
the gene itself (Snee et al., 2002). An abundant presence of a protein, being the case 
in an overexpression setting, increases the risk, that it enters incorrect cell 
compartments and then interacts with proteins that it never normally contacts 
(Gibson et al., 2013). The BAC-transgenic lt-NES cell lines generated in this study 
exhibited a protein localization pattern closely resembling previously observed or 
predicted patterns (Uniprot database and Poser et al., 2008). For HeLa cells, 
expression levels of the tagged proteins using BAC-transgenesis have been reported 
previously to correspond to endogenous levels since these constructs contain 
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unaltered promoter regions (Hubner et al., 2010a; Poser et al., 2008; Stadler et al., 
2013). herefore in this study, protein expression was assessed by flow cytometric 
and Western immunoblotting analysis detecting the fluorescent tag rather than 
protein-specific Western immunoblotting avoiding the need to establish more than 30 
antibody-specific protocols.  
The regulation of gene expression is not exclusively accomplished by modulation of 
the quantity or localization of the encoded protein but also by providing mRNA splice 
variants resulting in different protein isoforms (Black, 2003). By employing BACs for 
genetic manipulation of a target cell population, the regulation of this machinery is 
preserved, relying on the presence of all intronic- and exonic elements, except in the 
case of alternative first (for N-terminal tagging) or last (for C-terminal tagging) exons.  
In this study, the endogenous-like behavior of tagged proteins expressed by BAC 
transgenesis was exemplarily addressed in context of the cell-cycle dependent 
protein regulation for Aurora kinase A, a microtubule-associated cell-cycle regulated 
kinase (AURKA), which was enriched in mitosis and localized to centrosomes and 
spindle microtubules, as described previously (Ding et al., 2011). Moreover, the 
differentiation-induced downregulation of a BAC-expressed protein was validated by 
neuronal differentiation assays using PCNA, a protein exclusively expressed in 
proliferating cells, were performed. The tagged protein not only was downregulated in 
the whole culture but also was completely absent in neurons expressing a post-
mitotic mature neuronal marker, MAP2ab. The regulation was sufficiently precise to 
allow for fluorescence-based readouts in multiwell assays applying proliferation-
impairing substances. Although this approach relied on the utilization of cell pools 
rather than clonal lines, neither Western blot analysis nor flow cytometry indicated a 
truncated protein or an expression in a minor fraction of cells. This behavior could 
largely be attributed to the IRES-linked expression of the selection marker, rendering 
it virtually impossible for a truncated form of a protein or the resistance gene alone to 
be expressed. Taken together, BACs as expression constructs facilitate endogenous-
like expression of tagged proteins in a cell-type specific manner and BAC 
transgenesis can reliably be performed in lt-NES cells.  	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5.3. Protein-protein interaction analysis 
In most cases, the analysis of localization and interaction of an endogenously 
expressed protein together with phenotypic data from loss-of-function studies is 
sufficient to analyze its molecular role. Unfortunately, many PPI datasets rely on the 
overexpression of tagged proteins consisting of a single splice form in transformed 
cell lines. Transformed and tumor cell lines are known to express a wide range of 
proteins, which are not assembled within healthy somatic tissue, much less a single 
somatic cell type (Uhlen et al., 2010b). This circumstance might already have led to 
well-accepted assumptions of putative protein-protein interactions that physiologically 
never exist. Likewise, important information regarding weak or indirect protein-protein 
interactions in non-transformed somatic cells might have gone unnoticed.  
In this study, PPI analysis was performed using quantitative interaction proteomics 
together with BAC transgenesis to introduce a tagged protein expressed at 
physiological levels in a somatic neural stem cell population or neurons derived 
thereof. Using this approach, artifacts due to the application of protein-specific 
antibodies with varying specificity can be avoided since the same antibody for every 
GFP-tagged protein is used. Furthermore, endogenous expression of the tagged 
protein facilitates the study of protein complex composition upon differential, 
environmental- or developmental cues with high specificity (Hubner et al., 2010b). In 
the following section, available PPI databases and proteins that were used as baits 
as well as their identified potential interaction partners are discussed in detail. 
5.3.1. Publicly available databases for the validation of PPI  
Publicly available PPI databases were initially built to serve as a central interface to 
access data previously generated in multiple experiments from various laboratories. 
Hereby, different approaches for data collection were chosen to generate an easily 
accessible comprehensive representation of the current state of knowledge in the 
field. However, the more data was integrated in these databases, the more data 
sources had to be employed and this circumstance prevented the preservation of a 
consistent quality at the expense of credibility. Therefore, most databases can be 
configured to present a certain analysis level but generally are designed for specific 
user groups. An example for a very comprehensive PPI database is the ‘Search Tool 
for the Retrieval of Interacting Genes/Proteins’ (STRING) and can be used for the 
visualization and generation of functional protein association networks  
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(http://string-db.org/). It is a database of known and predicted protein interactions and 
includes direct (physical) and indirect (functional) associations derived from four 
sources: The genomic context filter allows displaying genes in immediate 
neighborhood on the genome (within 300 bp on the same strand) while protein 
conservation can be analyzed by a phylogenetic display. A powerful text-mining 
algorithm enables the up-to-date analysis of full text PubMed entries and can display 
whether certain proteins were co-mentioned or can analyze these data in a context-
dependent manner. The integration of real experimental data in form of conserved 
co-expression databases as well as data generated by high-throughput experiments 
is also possible (Franceschini et al., 2013; Jensen et al., 2009; Snel et al., 2000; 
Szklarczyk et al., 2011; von Mering et al., 2003; von Mering et al., 2007).  
The ‘Comprehensive Resource of Mammalian protein complexes’ (CORUM) 
database provides a resource of manually annotated protein complexes from 
mammalian organisms (http://mips.helmholtz-muenchen.de/genre/proj/corum/). The 
specialty of this database is that data are collected exclusively from publications in 
which PPI were validated and exclude data from high throughput experiments. As a 
consequence, the output of protein complexes is of high quality but seldom provides 
a uniform result as usually multiple complexes are reported for an individual protein 
while the process of manual annotation comes at the expense of actuality (Ruepp et 
al., 2008; Ruepp et al., 2010). 
A more specialized database is the ‘Biological General Repository for Interaction 
Datasets’ (BioGRID) database and archives and disseminates genetic and protein 
interaction data from model organisms and humans (http://thebiogrid.org). The 
content of this database is exclusively extracted from data generated by either high 
throughput or low throughput associations and can be filtered accordingly. In contrast 
to the STRING resource, it contains far less entries but each entry is backed by 
experimental data rather then presenting predictions of likely interactors based on 
text mining approaches (Breitkreutz et al., 2008; Chatr-Aryamontri et al., 2013; Stark 
et al., 2011; Stark et al., 2006). 
Another valuable tool is the ‘Universal Protein Resource’ (UniProt), and contains 
protein sequence and annotation data (http://www.uniprot.org). The database itself is 
not strictly designed as a resource for reporting individual PPI data but contains 
many informations of the protein itself, including protein function, subcellular 
localization, post-translational modification and its subunit structure where 
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information on established protein interactors can be found. UniProt is a consortium 
currently consisting of the European Bioinformatics Institute (EMBL-EBI), Swiss 
Institute of Bioinformatics (SIB) and the Protein Information Resource (PIR). 
In order to evaluate whether detected interaction partners are new or unknown or 
why a protein that has been reported to always coprecipitate with a certain protein is 
at once is missing, all databases have to be consulted to get the best understanding 
of the particular situation. 
 
5.3.2. PCNA 
Proliferating cell nuclear antigen (PCNA) forms a homotrimer and acts as an auxiliary 
protein of DNA polymerase delta, thereby increasing the processivity of leading 
strand synthesis during DNA replication (Liu et al., 2003b). PPI analysis for PCNA 
resulted in the enrichment of proteins of components associated with the function of 
PCNA: Among those were members of the replication factor c, RFC1, RFC2, RFC3, 
RFC4 and RFC5, that acts as a clamp loader and catalyzes the loading of PCNA 
onto DNA (Bowman et al., 2004a), DNA-methyltransferase 1 (DNMT1), which has 
been reported to associate with DNA replication sites in S phase sustaining the 
methylation pattern in the newly synthesized strand and thereby maintains epigenetic 
inheritance (Doyon et al., 2004a; Frauer et al., 2011), RNA Polymerase II-Associated 
Factor 1 Homolog (PAF1/p15) that has previously been shown to associate with 
PCNA during DNA repair events (Simpson et al., 2006), members of the cleavage 
and polyadenylation specific factor complex (CPSF1, 3 and 4, Nagaike et al., 2011), 
the WD repeat domain 33 (WDR33), which is part of the pre-mRNA 3’processing 
complex (Chen and Scheller, 2001a) and the Wilms tumor 1-associated protein 
(WTAP), a regulator of the pre-mRNA splicing machinery (WTAP, Ortega et al., 
2003). In the present study, functional assays were conducted in order to validate the 
characteristic proliferation-associated expression profile of PCNA (Liu et al., 2003a). 
Here, PCNA.GFP ceased to be expressed upon differentiation and PPI analysis only 
detected highly specific and enriched proteins in the subfraction of remaining 
proliferative lt-NES cells with sustained PCNA.GFP expression (section 4.1.6).  
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5.3.3. CDK2AP1 
Cyclin-dependent kinase 2-associated protein 1 (CDK2AP1) is a homodimer and acts 
as a specific inhibitor of the monomeric unphosphorylated cell-cycle kinase CDK2 
(Ertekin et al., 2012). Recently, CDK2AP1 was described as a bona fide subunit of 
the nucleosome remodeling and histone deacetylase (NuRD) complex (Spruijt et al., 
2010). PPI analysis for CDK2AP1 in the present study confirms these results as all 
members of the NuRD complex, except for histone deacetylase 1 (HDAC1) and 
GATA zinc finger domain-containing protein 2A (GATAD2A), were detectable:  
Metastasis associated protein 1 (MTA1), MTA2, MTA3, methyl-CpG-binding domain 
protein 3 (MBD3), retinoblastoma-binding protein p48 (RBAP48), chromodomain-
helicase-DNA-binding protein 4 (MI-2/CHD4), histone deacetylase 2 (HDAC2) and 
the histone H3.3A variant. The absence of HDAC1 could be linked to its role as 
transcriptional regulator, deacetylating the N-terminal part of the core histones (H2A, 
H2B, H3 and H4, Spruijt et al., 2010). Apart from these complex members, only 
breast cancer anti-estrogen resistance protein 1 (BCAR1), zinc finger protein 219 
(ZNF219) and X-Ray Repair Complementing Defective Repair In Chinese Hamster 
Cells 6 (XRCC6, G22P1) were enriched in our PPI screens. While BCAR1 primarily 
is reported as an interaction partner of RBAP48 (Yarden and Brody, 1999), ZNF219 
has been described to act as a transcriptional repressor and therefore may be 
involved in cooperation with the histone deacetylation activity of the NuRD complex 
(Sakai et al., 2003b). The enrichment G22P1 as a DNA-dependent ATP-dependent 
helicase may support a negative regulation of transcription together with APEX1, 
which was not detected in the present analysis (Reeves and Sthoeger, 1989b).  
Upon differentiation, RBAP48, H3.3A, BCAR1 and G22P1 were no longer enriched in 
CDK2AP1 PPI analyses while GATAD2A and HDAC1 are appearing. In the context 
of a predominantly postmitotic cell population, the dissociation of the active histone 
variant H3.3A together with the recruitment of HDAC1 and GATAD2A, both 
contributing to an inactive chromatin and associated with processes of differentiation, 
is plausible (Brackertz et al., 2002). Since RBAP48 is also a core histone-binding 
subunit and associated with multiple complexes involved in transcriptional repression 
including the chromatin assembly factor 1 (CAF1) complex, the core histone 
deacetylase (HDAC) complex and the nucleosome remodeling factor (NURF) 
complex, a decay of the NuRD complex in differentiating cells might be attributable to 
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the necessity of developing neurons to express genes that were previously silenced 
(Zhang et al., 2000). 
5.3.4. SETD1B 
The histone-lysine N-methyltransferase SET domain containing 1B (SETD1B) as part 
of the complex proteins associated with set1 (COMPASS) complex specifically 
methylates the 'Lys-4' residue of histone H3, provided that the neighboring 'Lys-9' 
residue is not already methylated, thereby activating transcription (Lee et al., 2007; 
Mohan et al., 2010). In PPI analysis of lt-NES cells, all proteins of the COMPASS 
complex were detected except for host cell factor 1 (HCF1), WD repeat-containing 
protein 5 (WDR5) and WD repeat-containing protein 82 (WDR82): The histone-lysine 
N-methyltransferase SET domain containing 1A (SETD1A), the Set1/Ash2 histone 
methyltransferase complex subunit Ash2 (Absent, Small, Or Homeotic)-Like 
(Drosophila) (ASH2L), dpy-30 homolog (DPY30), retinoblastoma-binding protein 5 
(RBBP5), CXXC Finger Protein 1 (CXXC1/CFP1) and histone H3.3 (H3.3A). The 
presence of an active form of histone H3.3A supports the concept of its existence 
within actively transcribed loci (Tagami et al., 2004b). Although HCF1 has been 
regarded as a member of the COMPASS complex, this protein was not identified 
within the complex, probably due to its role as a tethering compound between the 
transcription activating COMPASS and the repressing SIN3 transcription regulator 
family member A (Sin3a) complex (Denslow and Wade, 2007b). Both WDR5 and 
WDR82 are absent in lt-NES PPI analyses, which might be du to their initiating 
function within the COMPASS complex: WDR82 mediates the recruitment of the 
complex to specific sites (Lee and Skalnik, 2008a), while WDR5 is postulated to 
position the N-terminus of histone H3 for efficient trimethylation (Patel et al., 2009). 
Upon differentiation, the active histone H3.3A disappeared from the complex as well 
as DPY30, a core component of several methyl transferase complexes (Wang et al., 
2009a). Furthermore, SETD1A was not found in the complex anymore, underlining its 
non-redundant contribution to the epigenetic control of chromatin structure and gene 
expression (Lee and Skalnik, 2008b). 
5.3.5. RUVBL2 
RuvB-Like AAA ATPase 2 (RUVBL2) has a single-stranded DNA-dependent ATPase 
and 5’ to 3’ ATP-enabled DNA helicase activity (Doyon et al., 2004b). RUVBL2 is a 
member of multiple protein complexes including the Nu4A (histone acetylation), the 
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Snf2-Related CREBBP Activator Protein (SRCAP, exchange of H2AZ/H2B dimers 
with H2A/H2B, Auger et al., 2008) the unconventional prefoldin RPB5 interactor 1 
(URI, TOR kinase dependent transcription program, Gstaiger et al., 2003) and the 
INO complex (chromatin remodeling, Aoyama et al., 2008). In PPI analysis of lt-NES 
cells, representatives from each of these complexes were detected: E1A Binding 
Protein P400 (EP400), transformation/transcription domain-associated protein 
(TRRAP), DNA methyltransferase 1-associated protein 1 (DMAP1), the helicase 
SRCAP, actin-like protein 6A (ACTL6A, BAF53), RuvB-like AAA ATPase 1 
(RUVBL1), actin-related protein 5 (ACTR5), INO80 complex subunit C (INO80C), the 
DNA helicase INO80 (INO80), Actin-related protein 8 (INO80N), URI and prefoldin 
subunit 2 (PFDN2). 
Upon differentiation, proteins typically associated with proliferation, i.e. members of 
the INO80 complex, INO80A and INO80N, both involved in DNA replication 
(Conaway and Conaway, 2009b), a member of the NuA4 complex associated with 
normal cell cycle progression, TRRAP (Doyon et al., 2004a; Sardiu et al., 2008b), the 
proliferation associated ACTR5 as a member of the SRCAP complex and PFDN2 as 
a growth-dependent compound of the URI complex (Jeronimo et al., 2007b), 
dissociated from the RUVBL2-interacting complexes. Furthermore, BAF53 also was 
not enriched anymore for RUVBL2 in neuronal cultures. BAF53 is a multifunctional 
protein present in a multitude of different complexes and is required for the 
proliferation of neural progenitors. During neural differentiation, which was modeled 
by withdrawing growth factors from the lt-NES cell cultures, a switch from a neural 
stem cell population to post-mitotic neurons requires post-mitotic chromatin 
remodeling. This process is conducted by the neuronal-specific BAF (nBAF) complex 
with its BAF53 homologue ACTL6B/BAF53B, a protein absent in our proliferative lt-
NES cells that emerged only in neuronal cultures (Li and Jin, 2010; Yoo et al., 
2011a). In addition, ribophorin 1/2 (RPN1/2) as compounds of the oligosaccharyl 
transferase (OST) complex and enhancer of polycomb homolog 2 (Drosophila) 
(EPC2) could not be detected as RUVBL2 interacting candidates in differentiated 
neuronal cultures. 
 
Taken together, BAC-based PPI analysis in lt-NES cells and their neuronal progeny 
is sufficiently sensitive and specific to observe differentiation-specific changes in 
protein complexes/interactions associated with epigenetic imprinting, gene regulation 
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through histone acetylation/methylation and nucleosomal rearrangement. The 
observations presented here encompass dynamic changes, which have not yet been 
reported and may thus contribute to a deeper insight into human-specific PPIs 
occurring during the differentiation of neural stem cells into postmitotic neurons. The 
presented method is sufficiently streamlined to perform medium-throughput analyses 
of PPIs while retaining the sensitivity of detecting second-order or indirect interactors 
and the specificity of an approach using endogenous protein levels. At the time of 
composing this thesis, no study aimed at the analysis of PPIs generated postmitotic 
somatic cells without the application of chemotherapeutics or compromising 
conditions. The present study combines both highly sophisticated methods to obtain 
physiological expression of the bait protein and state-of-the-art analysis of interacting 
proteins by AP-MS/MS with a unique somatic cell population. Lt-NES cells are well 
suited for this approach as they are amenable to confident genetic manipulation, 
stable proliferation and exhibit a highly neurogenic potential. Thus, this work presents 
an unprecedented way to investigate PPIs of a broad range of proteins in a 
physiological context. 	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5.4. Limitations of BAC-mediated PPI analysis 
Despite many advantages BAC-mediated protein expression in the context of PPI 
analysis exhibits, this system still suffers from some disadvantages including a large 
tag size affecting protein folding and binding (I), unpredictable integration sites (II), 
occasionally multiple integrations of the construct (III), the possibility of non-tagged 
protein isoforms (IV) and the restriction to proteins already expressed in lt-NES cells, 
when C-terminal tags are used, since in this case the expression of the chemo-
selection resistance gene is linked with the expression of the gene of interest (V).  
I) The size of the protein tag 
Although GFP is a versatile marker for live cell monitoring of protein localization - as 
shown exemplarily for AURKA.GFP expression in this study - its size may limit its 
usefulness as a protein tag. As protein complexes typically consist of a large and - 
depending on their actual physiological role – fluctuant number of proteins, the 
inclusion of some members within this complex or the direct interaction with the 
tagged protein itself may be sterically hindered by the presence of the tag. 
Additionally, the tag itself may recruit other proteins normally avoiding contact with 
the complex. During data evaluation, compensation for unspecific binding proteins 
was performed but displacement due to the tag may permanently prevent detection 
of bona fide interactors. Furthermore, the GFP tag may affect the stability of the 
protein and prolong or delay its half-life period.  
II) Locus of integration  
By using an electroporation-based approach to generate BAC-transgenic cell lines, 
the position of integration on the genome cannot be predicted as the integration 
process is predominantly mediated by non-homologous end joining (NHEJ) and 
therefore may increase the risk for disruption of a tumor-suppressing gen or altering 
the fate of a cell permanently, both potentially leading to a re-modulation of protein 
expression patterns in a cell. Derived PPI data therefore may lead to wrong 
conclusions. Associated with a random integration is an unknown chromatin status of 
the BAC environment on the genome, a phenomenon previously described as a 
chromatin positional effect. However, due to the size of BAC-based constructs, they 
normally encompass most, if not all cis-regulatory elements and therefore are less 
likely to be influenced by chromatin positional effects. In rare cases, regulation can 
still take place in trans or by epigenetic regulation that might cover chromosomal 
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regions larger than a BAC construct (Blaas et al., 2012). Therefore an authentic 
endogenous regulation cannot be assumed.  
III) Integration frequency 
Although the integration frequency was monitored for several lines by fluorescence in 
situ hybridization (FISH) in this study, a valid definition guaranteeing BAC integration 
at only one locus cannot be made. In analyses where only one additional locus was 
detected, investigations using the fluorescence signal intensity per spot to evaluate 
the DNA amount per locus in relation to endogenous intensities showed an average 
integration rate of one BAC copy per locus (lines AURKA.GFP, Jun.GFP) with the 
exception of PCNA.GFP, featuring two copies per integration. These observations 
correspond to previous studies, reporting that integration frequencies generally are 
low but multiple integrations per locus may occur (Sparwasser and Eberl, 2007). 
Multiple integrations of a BAC within a cell expressing a tagged protein most likely 
result in a low overexpression if not compensated by regulatory mechanisms. 
Additionally, the protein itself will be present as tagged and non-tagged variant, 
originating from three different loci of the genome.  
IV) Dependency on splice variants 
One major limitation is based on the GFP tag localization, restricting the composition 
of tagged protein variants to those containing the first CDS-coding exon (for N-
terminal tags) or the last CDS-coding exon (C-terminal tags). Hereby, shorter 
variants or alternatively spliced proteins lacking the first or last exon, respectively, are 
not subject to investigations.  
V) Limitations by the choice of the selection cassette 
In principle, two different systems for expression of the chemoselection gene were 
available from the BACE database (http://hymanlab.mpi-cbg.de:81/bac/) and each 
showed individual advantages and limitations. BAC constructs harboring an N-
terminal GFP tag consisted of an artificial intron comprising an independent, 
constitutive active small promoter, phosphoglycerate kinase (PGK), facilitating a 
strong expression of the Neomycin resistance gene (NeoR). These constructs allow 
the chemoselection of cells that do not exhibit active expression of the gene 
introduced by BAC constructs but simultaneously can lead to resistant cells with 
incompletely integrated constructs, lacking the expression of tagged proteins or 
featuring an incorrect regulation. Therefore, the integrity of the construct has to be 
tightly monitored as truncated BAC expression constructs have been described 
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before (Chandler et al., 2007). In BAC constructs containing a C-terminal protein tag, 
the expression of the NeoR gene is directly linked to the regulatory elements of the 
introduced gene itself via an internal ribosomal entry site (IRES) sequence. Hereby, 
the enrichment of transgenic cells is limited to genes that are actively expressed by 
the desired cell population but usually give rise to cell lines containing the complete 
gene with most of its regulatory elements. Therefore, it was impossible to generate 
BAC transgenic cell lines of C-terminally tagged genes expressed at very low 
endogenous levels or genes exclusively present in fully differentiated and postmitotic 
cells.  
Taken together, aspects concerning tag design, integration site and -frequency may 
be of individually pronounced significance in the outcomes of PPI analysis. However, 
this approach facilitates a highly sensitive as well as specific PPI assessment most 
closely resembling an endogenous setting that is still fit for a streamlined approach to 
screen a broad spectrum of disease-associated proteins within a somatic cell 
population.  
 
5.5. Alternative approaches for PPI studies using epitope-tagged proteins 
Most limitations of a BAC-based expression system concerning tag size, integration 
site and frequency can be circumvented by the application of systems facilitating the 
modification of endogenous genes in order to express epitope-tagged proteins. One 
approach is the utilization of AAV-mediated site-directed manipulation to equip 
endogenous genes with a small epitope-tag. This approach not only avoids the 
introduction of an additional gene copy but also results in a smaller tag size, less 
likely to influence binding affinities of prospective interactors. Complementary studies 
using authentic endogenously tagged proteins utilizing the AAV technique should be 
able to tackle these problems and potentially provide benefits over BAC-mediated 
protein tagging. However, establishment, validation and employment of large 
numbers of individually engineered AAV vectors not only is impractical but clearly 
unsuitable for streamlined applications and therefore can only serve as a tool for the 
investigation of individual proteins addressing particular issues. Alternatively, 
transcription activator-like effector nucleases (TALEN) represent a versatile tool that 
can quickly be engineered to bind practically any DNA sequence and induce 
precisely located double strand breaks. Exploiting the endogenous non-homologous 
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end joining (NHEJ) machinery or homology directed repair, foreign DNA can be 
introduced to these sites when present as exogenous double-stranded DNA 
fragments (Hockemeyer et al., 2011). Another approach relying on the targeted 
introduction of double strand breaks is the newly established technique of genome 
editing that uses the RNA-guided Cas family of nucleases based on the clustered 
regularly interspaced short palindromic repeats (CRISPR) type II system. Here, the 
precise targeting of genomic sites is guided by target-sequence containing RNAs 
without the need of generating sequence specific binding proteins. This technique 
facilitates either the disruption of genomic sites or the integration of foreign DNA 
sequences using the same cellular repair mechanisms mentioned in context of the 
TALEN technique (Chang et al., 2013; Cho et al., 2013). Due to simultaneous 
publicizing of a genome-spanning database together with the CRISPR-based 
genome editing approach, the generation of suitable targeting constructs is now 
available to the whole scientific community (Mali et al., 2013). Refined techniques for 
the validation of correctly targeted sites like the ‘Advanced Analytical’s Fragment 
Analyzer’ and DNAWorks software specifically composed for the design of necessary 
oligonucleotides should enable the setup of a streamlined system fit to reliably target 
arbitrary proteins in a proteome-wide approach. However, a library of constructs 
containing a donor DNA consisting of the tag flanked by sequences homologue to the 
targeted site would be necessary as well. The ongoing development of innovative 
techniques and critical scrutinizing of present data will aid to advance the field of 
protein interaction analysis to a grade that may be one day at eye level with our 
current comprehension of the human genome. 	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5.6. Outlook 
Within the framework of the present work, comprehensive systems and methods 
were established that on the one hand necessitate further validation studies of the 
generated data and on the other hand give rise to novel technical opportunities. In 
the following sections, several aspects will be discussed in detail. 
 
 
Validation of protein-protein interactions 
The streamlined approach for the assessment of PPI presented in this study is well 
suitable for the fast generation of multiple interactomes for several proteins. 
However, for a detailed analysis of specific interactions that include parameters not 
measurable by QUBIC or to validate interaction partners, the following approaches 
are conceivable. 
I) In order to validate the interaction of a certain protein, reciprocal PPI studies can 
be conducted, as demonstrated previously. Here, the availability of QUBIC and an 
almost genome-spanning library of tagged proteins enables the examination whether 
a former prey can be used as bait to enrich the former bait. This method illustrates a 
straightforward and powerful approach that has already been used by a number of 
studies (Hubner et al., 2010a; Spruijt et al., 2010).  
II) In order to address the impact of individual proteins for the complex composition 
and its stability, loss-of-function studies like RNAi or novel genome editing 
technologies like the CRISPR-Cas9-system can be used as a tool to deplete specific 
members of a complex (Carlin et al., 2011; Chang et al., 2013; Krastev et al., 2011).  
III) The combination of RNAi and BACs containing RNAi-site-specific silent mutations 
or BAC-mediated reconstitution of a cellular protein deficiency can further enhance 
the sensitivity of measurements by depleting endogenous proteins that are 
competing for binding partners with the tagged variants. Hereby, the proportion of 
tagged proteins within a complex can be increased and thus contribute to a better 
understanding of the protein function. 
IV) The combination of RNAi and BACs containing a silent and an affecting mutation 
can be employed to analyze the impact of certain mutations on particular binding 
sites for interaction partners, leading to a deeper understanding of the involved 
domains.  
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Comparative analysis of complex composition in neuronal subtypes 
The present study primarily uses human neural stem cells and their GABAergic 
neuronal derivatives for the analysis of PPI and therefore allows for the analysis of 
complex composition changes during differentiation for a limited number of proteins. 
However, it would be conceivable to extend PPI studies to neuronal subtypes such 
as dopaminergic neurons or motor neurons in order to investigate the PPI network of 
long-discussed disease-associated proteins or key regulators of developmental 
processes directly in the in vitro correlate of the in vivo cell type. It can be assumed 
that postmitotic human neurons have a highly specific proteome and therefore it is of 
particular interest, whether PPI exist that are predominantly found in neuronal 
subtypes preferentially affected by specific neurodegenerative diseases like 
Parkinson’s disease, amyotrophic lateral sclerosis or Alzheimer’s disease. Direct 
comparison of the interactome of lt-NESCs and the various neuronal subpopulations 
might then reveal neuronal subtype-associated differences in the proteome. 
Furthermore, the advent of iPS technology enables the generation and manipulation 
of homogenous somatic cell types, which will enable the investigation of PPIs in a 
diseased environment. This approach is of particular interest for neurodegenerative 
diseases with unknown genetic cause as the assessment of PPI for proteins that 
might be relevant for disease progression might enable a better characterization and 
understanding of such cases. 
 
Further applications 
Most techniques that were initially developed to overcome a certain problem can be 
used to address a broader range of topics. For example, BAC transgenesis facilitates 
the real-time observation of proteins under reasonably physiological conditions, 
rendering the following exemplary topics attractive applications in context of cellular 
models of the human CNS. 
Reporter constructs for lineage selection 
The fact that BAC-based constructs exhibit almost complete regulatory elements, 
facilitates their application as reporter constructs as these constructs can be 
regulated almost identically to their endogenous counterparts. In these settings, cells 
with a specific fate can be identified either by expression of a visually detectable 
reporter gene like GFP or by expression of a resistance gene. Following identification 
of suitable reporter genes e.g. HB9 (motoneurons) or Pitx3 (midbrain dopaminergic 
Discussion 
 100	  
neurons), the generation of reporters suitable for the enrichment of specific neuronal 
subtypes is a straightforward task. Previous studies used a BAC-based technology 
for the genetic identification of defined hESC-derived neural cell types and thereby 
established a method for the otherwise difficult enrichment of human motor neurons 
with proper marker expression and electrophysiological activity (Placantonakis et al., 
2009). Another study established a protocol for transposon-mediated integration of 
BAC-based reporters for studies during development and differentiation in hESCs 
(Rostovskaya et al., 2012). Except for issues related with poor fluorescence intensity 
by low expression of such constructs or an altered protein stability caused by the tag, 
systems of this sort should be suitable for most applications and might facilitate the 
development of improved differentiation protocols. 
Reporter constructs for cellular stress 
With the development of ever more sophisticated analytic algorithms, complex 
assays for the identification of different stressors can be adapted for high-content 
data analyses by application of BAC transgenomics (Wink et al., 2014). Such 
constructs can be used as reporters on the genetic level (luciferase reporters) or on 
the protein level (fluorophore coupled proteins), detecting a broad range of cellular 
stress signals including oxidative stress (Keap1, Nrf2, Srxn1), endoplasmic reticulum 
stress (ATF4/XBP1, CHOP/BiP), inflammation (IκBα, RelA, ICAM1), DNA damage 
(53BP1, p53, p21), heat (HSF-1/2, HSP70/90), heavy metal (MTF-1, MTs) and 
hypoxia (VHL, HIF-1α, HUMMR, Wink et al., 2014). The high content evaluation of 
images generated using such assays enables the characterization of cellular stress 
responses that typically follow cell perturbations at the subcellular organelle level 
(Chan et al., 2012). However, these analyses are absolutely dependent on good 
fluorescence signals and therefore may be unsuitable for proteins expressed at very 
low levels as hereby artifacts of long-exposed images may lead to false-positive 
results. A particularly interesting feature is the possibility to mutate genes on BAC-
constructs for disease modeling. This is particular suitable for applications where 
genetically-linked protein aggregation is investigated: Instead of using common 
coaggregating proteins like firefly luciferase mutants as sensors of proteome stress 
(Gupta et al., 2011), the protein of interest can directly be monitored. However, each 
system has to be precisely monitored as fluorescent labeling of proteins was 
repeatedly reported to impair protein functionality (Brieger et al., 2012; Meyer et al., 
2007).	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6. Abbreviations 	  
Abbreviation Full name 
AA Ascorbic acid 
AAV Adeno-associated virus 
ACTL6A Actin-like 6A/BAF53 
ACTL6B Actin-like 6B 
ACTR5 ARP5 actin-related protein 5 homolog 
ALS Amyotrophic lateral sclerosis 
APH1 Anterior pharynx defective 1 homolog 
ATP Adenosine triphosphate 
Atxn3 Ataxin-3 
AP-MS Affinity purification coupled mass spectrometry 
AURKA Aurora kinase A 
BAC Bacterial artificial chromosome 
BACE1 β-Site APP cleaving enzyme 1 
BAF53 BRG1-associated factor 53A 
BB Brainbow 
BMP Bone morphogenic protein 
BrdU Bromdesoxyuridin 
Brn2 POU class 3 homeobox 2 
BSA Bovine serum albumin 
CA Cornu ammonis 
CAS CRK-associated substrate 
cAMP Cyclic adenosine monophosphate 
CD Cluster of differentiation 
CDK2AP1 Cyclin-dependent kinase 2 associated protein 1 
CFP Cyano fluorescent protein 
CHD4 Chromodomain helicase DNA binding protein 4 
CKAP4 Cytoskeleton-associated protein 4 
CMV Cytomegalie virus 
CNS Central nervous system 
CORO1C Coronin, actin binding protein, 1C 
Cre Cre recombinase derived from the P1 bacteriophage  
CSE1L CSE1 chromosome segregation 1-like 
CSTF3 Cleavage stimulation factor, 3' pre-RNA, subunit 3, 77kDa 
CXXC1 PHD finger and CXXC domain-containing protein 1 
Dach1 Dachshund homolog 1  
DAPI 4',6-Diamidino-2-phenylindole  
DAPT N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester 
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DMSO Dimethyl suphoxide 
DNA Deoxyribonucleic acid 
DNMT1 DNA-methyltransferase 1 
CPP Cell permeant proteins 
cPPT Central polypurine tract 
CPSF Cleavage and polyadenylation specific factor 
dNTPs Nucleoside triphosphate 
Dox Doxycycline 
dsRNA Double stranded RNA 
EB Embryoid body 
EDTA Ethylenediaminetetraacetic acid 
EF1α Elongation factor α 
EGF Epidermal growth factor 
ELISA Enzyme-linked Immunosorbent Assay  
EP400 E1A binding protein p400 
EPC2 Enhancer of polycomb homolog 2 
ER Endoplasmatic reticulum 
Ex Exon 
FACS Fluorescence activated cell sorting 
FCS Fetal calf serum 
FGD1 FYVE, RhoGEF and PH domain containing 1 
FGF2 Fibroblast growth factor 2 
FGF8b Fibroblast growth factor 8b 
FISH Fluorescence in situ hybridization 
FLAG Minimal protein tag 
FoxA2 Forkhead box A2 
FoxG1 Forkhead box G1 
FSC Forward scatter 
GABA Gamma-aminobutyric acid 
GATAD2A GATA zinc finger domain containing 2A 
GFAP Glial fibrillary acidic protein 
GFP Green fluorescent protein 
GMP Good manufacturing practice 
GSK-3α/β Glycogen synthase kinase 3 α/β 
H2A Histone H2A 
H2AZ H2A histone family, member Z 
H2B Histone H2B 
H3K4 Histone H3K4 
HDAC Histone deacetylase 
HEK cell Human embryonic kidney 
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hES cell Human embryonic stem cell 
hNF Human neurofilament 
hPS cell Human pluripotent stem cell 
HSPC231 PFDN2, Prefoldin 2 
IFNα Interferon α 
IFNβ Interferon β 
IKKα Nuclear factor NF-kappa-B inhibitor kinase alpha 
IKKβ Nuclear factor NF-kappa-B inhibitor kinase beta 
IκBα NF-kappa-B inhibitor alpha 
In Intron 
INO80 Putative DNA helicase INO80 complex homolog 1 / INO80A 
INO80N ARP8 actin-related protein 8 homolog 
IP10 Interferon-inducible protein 10 
iPS cell Induced pluripotent stem cell 
IRES  Internal ribosomal entry site 
IRF3 Interferon regulatory factor 3 
ISGF3 Interferon regulatory factor 9 
JARID1C Jumonji, AT rich interactive domain 1C 
JUN Jun proto-oncogene 
LC Liquid-Chromatography 
LC-MS/MS Liquid-Chromatography-Mass Spectrometry/Mass Spectrometry 
LIF Leukemia inhibitory factor 
Ln Laminin 
loxP Recognition site of Cre recombinase 
lt-NES cell long-term self-renewing neuroepithelial stem cell 
MAP Microtubuli-associated protein 
MAP1LC3B Microtubule-associated protein 1 light chain 3 beta 
MAPK MAP kinase 
MAPT Microtubuli-associated protein tau 
MARK2 MAP/microtubule affinity-regulating kinase 2 
Mash1 Achaete-scute homologue ash1 
MAVS Mitochondrial antiviral signaling protein 
MBD3 Methyl-CpG binding domain protein 3 
mC1-mRNA Modified C1-capped mRNA 
MDA5 Melanoma differentiation-associated protein 5 
MECP2 Methyl CpG binding protein 2 
MEF Mouse embryonic fibroblast 
MG Matrigel 
MGA MAX gene associated 
MJD Machado-Joseph disease 
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MOI Multiplicity of infection 
mRFP Monomeric red fluorescent protein 
miR micro RNA 
mmRNA Modified mRNA 
mRNA messenger RNA 
MTA3 Metastasis associated 1 family, member 3 
N-PAC Nuclear protein of 60 kDa 
nBAF Neuronal BRG1-associated factor 
NCL Nucleolin 
NCSTN Nicastrin 
neoR Neomycin resistance 
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells 
Ngn2 Neurogenin 2 
NLS Nuclear localization signal 
NPM1 Nucleophosmin 
NuA4 NuA4 histone acetyltransferase complex 
NuRD Nucleosome remodeling and histone deacetylase 
Olig2 Oligodendrocyte transcription factor 2  
Otx2 Orthodenticle homeobox 2 
OST Oligosaccharyltransferase 
P PreScission cleavage site 
p50 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 
p65 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 
pA Poly adenylation 
PAGE Polyacrylamid gel electrophoresis 
Pax6 Paired box 6 
PAF1 RNA polymerase II-associated factor 1 homolog 
PBS Phosphate buffered saline 
pCAG Poly glutamine 
PCR Polymerase chain reaction 
PDRG1 p53 and DNA-damage regulated 1 
PFA Paraformaldehyde 
PGK Phosphoglycerate kinase 
PLZF Promyelocytic leukemia-associated zinc finger 
PPI Protein-protein interaction 
PRPF40a PRP40 pre-mRNA processing factor 40 homolog A 
PSEN1 Presenilin 1 
PSEN2 Presenilin 2 
puroR Puromycin restance 
QAP Quantitative affinity purification 
Abbreviations 
 105	  
QUBIC Quantitative BAC InteraCtomics 
Rag2 Recombination activating gene 2 
RBBP Retinoblastoma-binding protein 
RBPJ Recombination signal binding protein for immunoglobulin kappa J region 
RIG-I Retinoic acid-inducible gene 1 protein 
RNA Ribonucleic acid 
RNAi RNA interference 
RFC Replication factor C 
RPN (1, 2) Ribophorin (1, 2) 
RPS27a Ribosomal protein S27a 
RT-PCR Reverse-transcriptase PCR 
RRE Rev responsive element 
rtTA reverse tetracycline-controlled transactivator 
RuvBL (1, 2) RuvB (E coli homolog)-like (1, 2) 
RV Rabies virus 
S S-peptide 
SA Splice acceptor 
SD Splice donor 
SDS Sodium dodecyl sulphate 
SEPT Synthetic exon promoter trap 
SetD1A Set1/Ash2 histone methyltransferase complex subunit SET1 
SetD1B SET domain-containing protein 1B 
SHH Sonic Hedgehog 
SILAC Stable isotope labeling by amino acids in cell culture 
SIN3A SIN3 transcription regulator homolog A... 
siRNA Short-interference RNA 
SMAD Mothers against decapentaplegic homolog 
SMCHD1 Structural maintenance of chromosomes flexible hinge domain containing 1 
SNP Single-nucleotide polymorphism 
Sox2 SRY-box 2 
SPATS2 Spermatogenesis associated, serine-rich 2 
SRCAP Snf2-related CREBBP activator protein 
SSC Side scatter 
SVZ Subventricular zone 
T TEV cleavage site 
TAB1 TGF-beta activated kinase 1/MAP3K7 binding protein 1 
TAB2 TGF-beta activated kinase 1/MAP3K7 binding protein 2 
TAB3 TGF-beta activated kinase 1/MAP3K7 binding protein 3 
TAK1 TGF-beta-activated kinase 1 
TALEN Transcription activator-like effector nucleases 
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TANK TRAF family member-associated NFKB activator 
TBK1 TANK-binding kinase 1 
TC Tissue culture 
TE Trypsin/EDTA 
TEMED Tetramethylethylenediamine 
tetOn Tetracycline regulatable gene induction system 
TF Transcription factor 
TGFβ Transforming growth factor β 
TH Tyrosine hydroxylase 
TI Trypsin inhibitor 
TLR3 Toll-like receptor 3 
TMD Transmembrane domain 
TMEM132A Transmembrane protein 132A 
TOR Target of rapamycin 
TRAF3 TNF receptor-associated factor 3 
TRAF6 TNF receptor-associated factor 6 
TREtight Tetracyclin-responsive element 
TRRAP Transformation/transcription domain-associated protein 
TTC Tetanus toxin fragment C 
Txl Taxol 
UbC Ubiquitin C 
UHRF1 Ubiquitin-like with PHD and ring finger domains 1 
URI Unconventional prefoldin RPB5 Interactor 
VCP Valosin containing protein 
WGA Wheat germ agglutinin 
WPRE Regulatory element of woodchuck hepatitis virus 
WTAP Wilms tumor 1-associated protein 
Y2H Yeast two hybrid 
YFP Yellow fluorescent protein 
Zic1 Zinc finger protein 1 
ZNF Zinc finger 
ZO1 Zona occludens 1 	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7. Summary 
While most approaches in cell-based disease modeling are focused on the effects of defined 
mutations on the molecular or cellular phenotype, the assessment of underlying alterations in 
the interactomes of disease-relevant proteins has faced several technical challenges. First, 
experiments were typically conducted using overexpression paradigms resulting in 
unphysiologically high protein levels and thus promoting unspecific interactions. Second, 
such studies have been relying mostly on transformed cell lines, which enable mass 
production of transgenic cells but do not exhibit a tissue-specific proteomic environment. For 
that reason, the present study aimed at addressing these issues by bacterial artificial 
chromosome (BAC)-based expression of tagged proteins in pluripotent stem cell-derived 
long-term neuroepithelial like stem cells (lt-NES cells), a stable and robust cell population, 
which generates authentic human neurons with high fidelity. Tagged proteins were found to 
be expressed at endogenous levels, and fluorescence in situ hybridisation (FISH) analyses 
revealed an average integration rate of one copy per genome for the majority of cell lines 
analyzed. Correct compartmentalization and size of the tagged proteins could be confirmed 
by high-resolution confocal and live cell imaging as well as Western immunoblotting analysis, 
respectively. Employing this approach, multiple cell lines were generated harboring tagged 
proteins associated with human developmental disorders, cancer and neurodegeneration. 
Representatives of these groups include Proliferating Cell Nuclear Antigen (PCNA), Aurora 
Kinase A (AURKA), Cyclin-Dependent Kinase 2-Associated Protein 1 (CDK2AP1), Set 
Domain-Containing Protein 1B (SETD1B), RuvB-Like 2 (RUVBL2), the Methyl CpG Binding 
Protein 2 (MECP2) and the Alzheimer’s disease-associated proteins Nicastrin (NCSTN) and 
Valosin-Containing Protein (VCP). Using a label-free, quantitative affinity purification-mass 
spectrometry approach, numerous novel interaction partner candidates of these proteins 
were identified. Direct comparison of protein-specific interactomes of proliferating lt-NES 
cells and their neuronal progeny further revealed changes in the composition of several 
chromatin-remodeling complexes, suggesting that this system is sufficiently sensitive and 
specific to identify the dynamic differential recruitment of individual proteins as a response to 
developmental switches. In a proof-of-concept study, the approach of BAC-mediated 
expression of tagged proteins with a subsequent analysis of interacting proteins was 
successfully transferred to induced pluripotent stem cell (iPS)-derived lt-NES cells in order to 
enable PPI analyses in the context of complex diseases in following studies.  
Finally, an adeno-associated virus based approach for epitope tagging of endogenous genes 
in iPS-derived lt-NES cells from a patient suffering from Machado-Joseph disease allowed 
the generation of cell pools exhibiting both the diseased and healthy isoform of N-terminal 
FLAG-tagged Ataxin-3. The present work demonstrates a successful establishment of two 
different methods for protein tagging in somatic cell populations that subsequently can be 
employed for a multitude of analytical techniques including fluorescent microscopic 
visualization of protein localization, dynamics of protein recruitment or the detection of PPI.  
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8. Zusammenfassung 
Während zellbasierte Ansätze der Krankheitsmodellierung vornehmlich auf die 
Auswirkungen definierter Mutationen des molekularen sowie zellulären Phänotyp fokussiert 
sind, müssen bei der Untersuchung zugrunde liegender Veränderungen im Interaktom von 
krankheitsrelevanten Proteine eine Reihe technischer Herausforderungen berücksichtigt 
werden. Einerseits werden Experimente typischerweise unter Überexpressions-Paradigmen 
durchgeführt, in deren Konsequenz durch unphysiologisch hohe Protein-Niveaus 
unspezifische Interaktionen gefördert werden. Andererseits wurden solche Studien meist 
unter Verwendung transformierter Zelllinien durchgeführt, was zwar eine einfache 
Bereitstellung großer Mengen transgenen Zellmaterials ermöglicht, jedoch in keinem 
gewebsspezifischen Kontext stattfindet. Vor diesem Hintergrund war es das Ziel der 
vorliegenden Arbeit, die auf bakteriellen artifiziellen Chromosomen basierende Expression 
markierter Proteinen in von pluripotenten Stammzellen abgeleiteten neuroepithelialen 
Stammzellen (lt-NES Zellen) zu etablieren. Diese stabile und robuste Zellpopulation 
ermöglicht es, authentische humane Neuronen in hoher Effizienz zu generieren. Hierbei 
konnte eine Expression der markierten Proteine auf endogenem Niveau beobachtet werden 
während gleichzeitig lediglich eine BAC-Integration von einer Kopie pro Genom für die 
meisten etablierten Linien durch Fluoreszenz-in-situ-Hybridisierungsstudien (FISH) 
nachgewiesen wurde. Eine korrekte Größe sowie subzelluläre Lokalisation konnten anhand 
von Western-Blot-Analysen sowie mit hochauflösender konfokaler und 
Lebendzellmikroskopie gezeigt werden. Durch Anwendung dieser Methodik konnten mehrere 
Zelllinien erstellt werden, welche markierte Proteine exprimieren, die eine veränderte 
Expression in humanen entwicklungsassoziierten Erkrankungen, Tumorerkrankungen oder 
neurodegenerativen Erkrankungen aufweisen. Vertreter dieser Gruppen umfassen das 
Proliferating Cell Nuclear Antigen (PCNA), Aurora Kinase A (AURKA), Cyclin-Dependent 
Kinase 2-Associated Protein 1 (CDK2AP1), Set Domain-Containing Protein 1B (SETD1B), 
RuvB-Like 2 (RUVBL2), das Methyl CpG Binding Protein 2 (MECP2) und Alzheimer-
assoziierten Proteine Nicastrin (NCSTN) und Valosin-Containing Protein (VCP). Durch das 
Verwenden einer Label-freien, quantitativen affinitätschromatographischen Anreicherung mit 
nachfolgender massenspektrometrischer Analyse konnte eine Vielzahl neuer möglicher 
Protein-Interaktionen identifiziert werden. Ein direkter Vergleich von proteinspezifischen 
Interaktomen von proliferierenden lt-NES Zellen und von diesen abgeleiteten Neuronen 
konnten zudem Veränderungen in der Zusammensetzung von einigen Chromatin-
Remodellierungskomplexen zeigen. Dies deutet darauf hin, dass das verwendete System 
sensitiv und spezifisch genug ist, um die dynamische Rekrutierung von einzelnen Proteinen 
als Auswirkung von Entwicklungs-assoziierten Prozessen zu detektieren. In einer 
Machbarkeitsstudie wurde die etablierte Methodik auf von iPS-Zellen abgeleiteten lt-NES 
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Zellen übertragen, um so eine Basis für die Analyse von Protein-Protein-Interaktionen im 
Kontext krankheits- und patientenspezifischer Zellen zu etablieren. Um Probleme, die bei der 
zufälligen Integration eines BACs entstehen können, zu umgehen, wurde schließlich  ein 
Adeno-assoziiertes virales System zur Epitopmarkierung endogener Gene etabliert. Es 
wurden exemplarisch von an Machado-Joseph Krankheit erkrankten Patienten abgeleitete lt-
NES Zellen generiert, welche jeweils eine N-terminal markierte krankhafte sowie eine 
gesunde Isoform des Proteins Ataxin-3 aufweisen. 
Die vorliegende Arbeit zeigt eine erfolgreiche Etablierung verschiedener Methodiken um 
Proteinmarkierungen in somatische Zellpopulationen einzubringen, welche sich durch eine 
weitgehend endogene Expression auszeichnen. Hierdurch ergibt sich die Möglichkeit, unter 
anderem Interaktionsstudien mit hoher Spezifität und Sensitivität an humanen gewebe- und 
krankheitsspezifischen Zellpopulationen durchzuführen als auch analytische Methoden wie 
fluoreszenzmikroskopische Lokalisierungsstudien oder Dynamiken der Proteinrekrutierungen 
anzuwenden.	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